SunOpta (STKL) 10-K 1 Mar 23 2022 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Feb. 24, 2023	Jul. 02, 2022
Entity Registrant Name	SUNOPTA INC.
Entity Shell Company	false
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Small Business	false
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2022
Amendment Flag	false
Document Period End Date	Dec. 31, 2022
Document Type	10-K
Entity Common Stock, Shares Outstanding		107,948,348
Entity Public Float			$ 650
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	Yes
Entity Filer Category	Large Accelerated Filer
Current Fiscal Year End Date	--12-31
Entity Central Index Key	0000351834
Entity File Number	001-34198
Entity Address, Address Line One	7078 Shady Oak Road
Entity Address, City or Town	Eden Prairie
Entity Address, State or Province	MN
Entity Address, Postal Zip Code	55344
City Area Code	952
Local Phone Number	820-2518
Entity Interactive Data Current	Yes
Entity Tax Identification Number	00-0000000
Entity Incorporation, State or Country Code	Z4
Document Transition Report	false
Document Annual Report	true
ICFR Auditor Attestation Flag	true
Auditor Name	Ernst & Young LLP
Auditor Location	Minneapolis
Auditor Firm ID	42
The Nasdaq Stock Market | Common Shares
Trading Symbol	STKL
Security Exchange Name	NASDAQ
Title of 12(b) Security	Common Shares
The Toronto Stock Exchange | Common Shares
Trading Symbol	SOY
Title of 12(b) Security	Common Shares

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Income Statement [Abstract]
Revenues	$ 934,662	$ 812,624	$ 789,213
Cost of goods sold	811,808	714,904	680,136
Gross profit	122,854	97,720	109,077
Selling, general and administrative expenses	89,312	76,599	89,463
Intangible asset amortization	10,282	9,950	8,946
Other expense, net	22,132	8,890	23,393
Foreign exchange loss (gain)	(1,748)	1,112	(1,640)
Earnings (loss) from continuing operations before the following	2,876	1,169	(11,085)
Interest expense, net	14,734	8,769	30,042
Loss on retirement of debt	0	0	8,915
Loss from continuing operations before income taxes	(11,858)	(7,600)	(50,042)
Income tax benefit	(2,340)	(6,428)	(7,650)
Loss from continuing operations	(9,518)	(1,172)	(42,392)
Earnings from discontinued operations	4,677	0	124,820
Net earnings (loss)	(4,841)	(1,172)	82,428
Dividends and accretion on preferred stock	(3,109)	(4,197)	(10,328)
Earnings (loss) attributable to common shareholders	$ (7,950)	$ (5,369)	$ 72,100
Basic and diluted earnings (loss) per share
Loss from continuing operations (Basic)	$ (0.12)	$ (0.05)	$ (0.59)
Loss from continuing operations (diluted)	(0.12)	(0.05)	(0.59)
Earnings from discontinued operations (Basic)	0.04	0	1.4
Earnings from discontinued operations (diluted)	0.04	0	1.4
Earnings (loss) attributable to common shareholders (Basic)	(0.07)	(0.05)	0.81
Earnings (loss) attributable to common shareholders (Diluted)	$ (0.07)	$ (0.05)	$ 0.81
Weighted-average common shares outstanding (000s)
Basic	107,659	104,098	89,234
Diluted	107,659	104,098	89,234

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Earnings (Loss) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Statement of Comprehensive Income [Abstract]
Loss from continuing operations	$ (9,518)	$ (1,172)	$ (42,392)
Earnings from discontinued operations	4,677	0	124,820
Net earnings (loss)	(4,841)	(1,172)	82,428
Other comprehensive earnings
Currency translation adjustment	0	0	2,405
Reclassification of accumulated currency translation adjustment of discontinued operations	0	0	10,229
Other comprehensive earnings	0	0	12,634
Comprehensive earnings (loss)	$ (4,841)	$ (1,172)	$ 95,062

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 01, 2022
Current assets
Cash and cash equivalents	$ 679	$ 227
Accounts receivable, net of allowances for credit losses of $584 and $889, respectively	74,903	84,702
Inventories	207,047	219,778
Prepaid expenses and other current assets	15,688	16,638
Current income taxes recoverable	4,040	8,259
Total current assets	302,357	329,604
Property, plant and equipment, net	322,391	219,537
Operating lease right-of-use assets	82,564	47,245
Intangible assets, net	135,646	148,440
Goodwill	3,998	3,998
Deferred income taxes	3,712	0
Other assets	5,184	5,930
Total assets	855,852	754,754
Current liabilities
Accounts payable and accrued liabilities	108,511	121,155
Income taxes payable	957	0
Current portion of long-term debt	38,491	9,760
Current portion of operating lease liabilities	13,074	12,203
Total current liabilities	161,033	143,118
Long-term debt	269,993	214,843
Operating lease liabilities	77,557	39,028
Long-term liabilities	0	2,241
Deferred income taxes	0	14,051
Total liabilities	508,583	413,281
EQUITY
Common shares, no par value, unlimited shares authorized, 107,909,792 shares issued (January 1, 2022 - 107,359,826)	440,348	436,463
Additional paid-in capital	33,184	23,240
Accumulated deficit	(155,688)	(147,738)
Accumulated other comprehensive income	1,363	1,363
Total shareholders' equity	319,207	313,328
Total liabilities and shareholders' equity	855,852	754,754
Series B-1 Preferred Stock [Member]
Current liabilities
Preferred Stock	$ 28,062	$ 28,145

Consolidated Balance Sheet (Par

Consolidated Balance Sheet (Parentheticals) - USD ($) shares in Thousands, $ in Thousands	Dec. 31, 2022	Jan. 01, 2022
Statement of Financial Position [Abstract]
Allowances for credit losses	$ 584	$ 889
Common Stock, No Par Value	$ 0	$ 0
Common Stock Shares Issued	107,909,792	107,359,826

Consolidated Statements of Shar

Consolidated Statements of Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands	Common shares [Member]	Additional paid-in capital [Member]	Accumulated deficit [Member]	Accumulated other comprehensive loss [Member]	Non-controlling interest [Member]	Total
Balance at Dec. 28, 2019	$ 318,456	$ 35,767	$ (214,469)	$ (11,271)	$ 1,888	$ 130,371
Balance (in shares) at Dec. 28, 2019	88,090
Employee share purchase plan	$ 462					462
Employee share purchase plan (in shares)	114
Stock incentive plan	$ 7,627	(6,041)				1,586
Stock incentive plan (in shares)	1,990
Withholding taxes on stock-based awards		(4,080)				(4,080)
Stock-based compensation		12,216				12,216
Net earnings (loss)			82,428		(301)	82,127
Dividends on preferred stock			(8,636)			(8,636)
Accretion on preferred stock			(1,692)			(1,692)
Currency translation adjustment				2,405	(44)	2,361
Capital contribution to majority-owned subsidiary					67	67
Dividend paid by subsidiary to non-controlling interest					(66)	(66)
Disposition of discontinued operations				10,229	(1,544)	8,685
Balance at Jan. 02, 2021	$ 326,545	37,862	(142,369)	1,363	0	223,401
Balance (in shares) at Jan. 02, 2021	90,194
Exchange of Series A preferred stock, net of share issuance costs of $287	$ 87,188					87,188
Exchange of Series A preferred stock, net of share issuance costs of $287 (in shares)	12,633
Employee share purchase plan	$ 583					583
Employee share purchase plan (in shares)	67
Stock incentive plan	$ 22,147	(15,004)				7,143
Stock incentive plan (in shares)	4,466
Withholding taxes on stock-based awards		(8,718)				(8,718)
Stock-based compensation		9,100				9,100
Net earnings (loss)			(1,172)			(1,172)
Dividends on preferred stock			(3,477)			(3,477)
Accretion on preferred stock			(720)			(720)
Balance at Jan. 01, 2022	$ 436,463	23,240	(147,738)	1,363	0	313,328
Balance (in shares) at Jan. 01, 2022	107,360
Employee share purchase plan	$ 575					575
Employee share purchase plan (in shares)	88
Stock incentive plan	$ 3,310	(2,257)				1,053
Stock incentive plan (in shares)	462
Withholding taxes on stock-based awards		(1,629)				(1,629)
Stock-based compensation		13,830				13,830
Net earnings (loss)			(4,841)
Dividends on preferred stock			(2,436)			(2,436)
Accretion on preferred stock			(673)			(673)
Balance at Dec. 31, 2022	$ 440,348	$ 33,184	$ (155,688)	$ 1,363	$ 0	$ 319,207
Balance (in shares) at Dec. 31, 2022	107,910

Consolidated Statements of Sh_2

Consolidated Statements of Shareholders' Equity (Parentheticals) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Income Statement [Abstract]
Share issuance cost	$ 0	$ 287	$ 0

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Operating activities
Net earnings (loss)	$ (4,841)	$ (1,172)	$ 82,428
Earnings from discontinued operations	4,677	0	124,820
Loss from continuing operations	(9,518)	(1,172)	(42,392)
Items not affecting cash:
Depreciation and amortization	37,673	34,641	30,308
Amortization of debt issuance costs	1,601	1,353	4,078
Deferred income taxes	(4,655)	(5,985)	2,643
Stock-based compensation	13,830	9,100	11,676
Loss on sale of sunflower business	23,227	0	0
Gain on sale of frozen fruit processing facility	(3,779)	0	0
Impairment of long-lived assets	0	3,206	7,803
Loss on foreign currency forward contract	0	0	12,658
Loss on retirement of debt	0	0	8,915
Other	3,600	1,090	(157)
Changes in operating assets and liabilities, net of sunflower business	(1,404)	(63,665)	17,131
Net cash provided by (used in) operating activities of continuing operations	60,575	(21,432)	52,663
Net cash provided by operating activities of discontinued operations	0	0	39,033
Net cash provided by (used in) operating activities	60,575	(21,432)	91,696
Investing activities
Additions to property, plant and equipment	(128,626)	(58,297)	(24,754)
Proceeds from sale of assets	20,293	2,300	0
Net proceeds from sale of sunflower business	7,833	0	0
Additions to intangible assets	0	(25,073)	0
Cash settlement of foreign currency forward contract	0	0	(12,658)
Other	0	0	41
Net cash used in investing activities of continuing operations	(100,500)	(81,070)	(37,371)
Net cash provided by (used in) investing activities of discontinued operations	(6,324)	(13,380)	361,889
Net cash provided by (used in) investing activities	(106,824)	(94,450)	324,518
Financing activities
Increase (decrease) in borrowings under revolving credit facilities	(19,821)	106,016	(175,990)
Borrowings of long-term debt	90,907	32,800	5,179
Repayment of long-term debt, including premium paid	(20,457)	(13,671)	(231,431)
Payment of debt issuance costs	(735)	(2,561)	(4,888)
Proceeds from the exercise of stock options and employee share purchases	1,628	7,726	2,048
Payment of withholding taxes on stock-based awards	(1,629)	(8,718)	(4,080)
Payment of cash dividends on preferred stock	(2,436)	(5,247)	(4,078)
Proceeds on issuance of preferred stock, net of issuance costs	(756)	0	26,804
Payment of share issuance costs	0	(287)	0
Other	0	0	(185)
Net cash provided by (used in) financing activities of continuing operations	46,701	116,058	(386,621)
Net cash used in financing activities of discontinued operations	0	(200)	(31,063)
Net cash provided by (used in) financing activities	46,701	115,858	(417,684)
Increase (decrease) in cash and cash equivalents during the year	452	(24)	(1,470)
Cash and cash equivalents of discontinued operations:
Balance at the beginning of the year	0	0	1,370
Foreign exchange gain on cash and cash equivalents	0	0	223
Less: Balance at the end of year	0	0	0
Cash and cash equivalents, beginning of the year	227	251	128
Cash and cash equivalents, end of the year	$ 679	$ 227	$ 251

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Significant Accounting Policies [Text Block]	1. Significant Accounting Policies Basis of Presentation These consolidated financial statements include the accounts of SunOpta Inc. and those of its wholly-owned subsidiaries (collectively, the "Company" or "SunOpta") and have been prepared by the Company in United States ("U.S.") dollars and in accordance with U.S. generally accepted accounting principles ("U.S. GAAP"). All intercompany accounts and transactions have been eliminated on consolidation. Fiscal Year The fiscal year of the Company consists of a 52- or 53-week period ending on the Saturday closest to December 31. Fiscal years 2022 and 2021 were each 52-week periods ending on December 31, 2022 and January 1, 2022, respectively, and fiscal year 2020 was a 53-week period ending on January 2, 2021. Fiscal year 2023 will be a 52-week period ending on December 30, 2023, with quarterly periods ending on April 1, 2023, July 1, 2023, and September 30, 2023. Revision of Prior Period Financial Statements During the fourth quarter of 2022, in connection with the filing of the Company's 2021 tax returns, management identified certain misstatements in income taxes that affected the results for the years ended January 1, 2022 and January 2, 2021. In accordance with ASC 250 – Accounting Changes and Error Corrections and Staff Accounting Bulletins No. 99 – Materiality and No. 108 – Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements, management assessed the materiality of these errors individually and in the aggregate and concluded that the effect of recording all corrections in the fourth quarter of 2022 would materially misstate the financial statements for the year ended December 31, 2022. Management also concluded that the errors were not material to the previously issued financial statements for the years ended January 1, 2022 and January 2, 2021. As a result, the Company has corrected these errors by revising the consolidated financial statements and related disclosures included herein for those prior fiscal periods. The tables that follow present the effect of these revisions, as well as the effect of previously identified immaterial out-of-period adjustments related to income taxes, inventory, and over accrual of expenses on the consolidated statements of operations and cash flows for the years ended January 1, 2022 and January 2, 2021, and the consolidated balance sheet as at January 1, 2022. In addition, the opening accumulated deficit for the year ended January 2, 2021 decreased by $0.5 million. Year Ended January 1, 2022 Year Ended January 2, 2021 As Previously Reported Adjustment As Revised As Previously Reported Adjustment As Revised $ $ $ $ $ $ Consolidated Statements of Operations Revenues 812,624 - 812,624 789,213 - 789,213 Cost of goods sold 714,539 365 714,904 680,136 - 680,136 Gross profit 98,085 (365 ) 97,720 109,077 - 109,077 Selling, general and administrative expenses 76,874 (275 ) 76,599 89,463 - 89,463 Intangible amortization 9,950 - 9,950 8,946 - 8,946 Other expense, net 8,890 - 8,890 23,393 - 23,393 Foreign exchange loss (gain) 1,112 - 1,112 (1,640 ) - (1,640 ) Earnings (loss) from continuing operations before the following 1,259 (90 ) 1,169 (11,085 ) - (11,085 ) Interest expense, net 8,769 - 8,769 30,042 - 30,042 Loss on retirement of debt - - - 8,915 - 8,915 Loss from continuing operations before income taxes (7,510 ) (90 ) (7,600 ) (50,042 ) - (50,042 ) Income tax benefit (3,366 ) (3,062 ) (6,428 ) (2,740 ) (4,910 ) (7,650 ) Earnings (loss) from continuing operations (4,144 ) 2,972 (1,172 ) (47,302 ) 4,910 (42,392 ) Earnings from discontinued operations - - - 124,820 - 124,820 Net earnings (loss) (4,144 ) 2,972 (1,172 ) 77,518 4,910 82,428 Dividends and accretion on preferred stock (4,197 ) - (4,197 ) (10,328 ) - (10,328 ) Earnings (loss) attributable to common shareholders (8,341 ) 2,972 (5,369 ) 67,190 4,910 72,100 Basic and diluted earnings (loss) per share: Earnings (loss) from continuing operations operations (0.08 ) 0.03 (0.05 ) (0.65 ) 0.06 (0.59 ) Earnings from discontinued operations - - - 1.40 - 1.40 Earnings (loss) attributable to common shareholders (0.08 ) 0.03 (0.05 ) 0.75 0.06 0.81 As at January 1, 2022 As Previously Adjustment As Revised $ $ $ Consolidated Balance Sheet Inventories 220,143 (365 ) 219,778 Total current assets 329,969 (365 ) 329,604 Total assets 755,119 (365 ) 754,754 Accounts payable and accrued liabilities 121,430 (275 ) 121,155 Deferred income tax liability - long-term 22,485 (8,434 ) 14,051 Total liabilities 421,990 (8,709 ) 413,281 Accumulated deficit (156,082 ) 8,344 (147,738 ) Total shareholders' equity 304,984 8,344 313,328 Total liabilities and shareholders' equity 755,119 (365 ) 754,754 Year Ended January 1, 2022 Year Ended January 2, 2021 As Adjustment As Revised As Adjustment As Revised $ $ $ $ $ $ Consolidated Statements of Cash Flows Earnings (loss) from continuing operations (4,144 ) 2,972 (1,172 ) (47,302 ) 4,910 (42,392 ) Items not affecting cash: Deferred income taxes (2,923 ) (3,062 ) (5,985 ) 7,553 (4,910 ) 2,643 Changes in operating assets and liabilities (63,755 ) 90 (63,665 ) 17,131 - 17,131 Net cash provided by (used in) operating activities of continuing operations (21,432 ) - (21,432 ) 52,663 - 52,663 Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Areas involving significant estimates and assumptions include: allowances for credit losses; inventory reserves; income tax liabilities and assets, and related valuation allowances; provisions for loss contingencies related to claims and litigation; useful lives of property, plant and equipment and intangible assets; expected lease terms and discount rates in measuring lease assets and liabilities; expected future cash flows used in evaluating long-lived assets for impairment; and reporting unit fair values in testing goodwill for impairment. The estimates and assumptions made require judgment on the part of management and are based on the Company's historical experience and various other factors that are believed to be reasonable in the circumstances. Management continually evaluates the information that forms the basis of its estimates and assumptions as the business of the Company and the general business environment changes. Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (that is, an exit price). Fair value measurements are estimated based on inputs categorized as follows: • Level 1 inputs include quoted prices (unadjusted) for identical assets or liabilities in active markets that are observable. • Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means. • Level 3 includes unobservable inputs that reflect the Company's own assumptions about what factors market participants would use in pricing the asset or liability. When measuring fair value, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs. Foreign Currency Translation Exchange gains and losses on transactions occurring in a currency other than an operation's functional currency are recognized in earnings. Foreign currency gains and losses related to the remeasurement of the Company's Mexican operations into its U.S. dollar functional currency are recognized in earnings. Cash and Cash Equivalents Cash and cash equivalents consist of cash and short-term deposits with an original maturity of 90 days or less. The Company places its cash and cash equivalents with institutions of high creditworthiness. A ccounts Receivable Accounts receivable includes trade receivables that are recorded at the invoiced amount and do not bear interest. The allowance for credit losses is an estimate of the amount of probable losses in existing accounts receivable. The Company routinely assesses the financial strength of its customers and believes that its accounts receivable credit risk exposure is limited. The Company closely monitors receivable balances and estimates an allowance for credit losses based on historical collection experience, and account aging analysis and trends, and evaluates the adequacy of the allowance each reporting period, considering individual customer account reviews, write-offs recorded in the period, sales forecasts and trends, and current and expected economic and customer-specific conditions. Account balances are charged off against the allowance when the Company determines the receivable will not be recovered. As at December 31, 2022, three long-term customers represented approximately 19%, 13% and 10%, respectively, of the Company's consolidated trade receivables balance. The Company does not believe it is exposed to any significant credit risks with respect to these customers. Inventories Inventories are valued at the lower of cost and net realizable value on a first-in, first-out basis. Shipping and handling costs are included in cost of goods sold on the consolidated statements of operations. Property, Plant and Equipment Property, plant and equipment assets are stated at cost, less accumulated depreciation. Cost includes capitalized interest on borrowings during the construction of major capital projects. Depreciation begins when an asset is ready for its intended use. Property, plant and equipment assets, other than land, are depreciated on a straight-line basis over the estimated useful lives of the assets, as follows: Buildings 20 - 40 years Machinery and equipment 5 - 20 years Enterprise software 3 - 5 years Office furniture and equipment 3 - 7 years Vehicles 3 - 7 years Leases At the lease commencement date, the Company recognizes a right-of-use lease asset for an amount equal to the lease liability, less any lease incentives. The lease liability is determined based on the present value of future lease payments over the lease term. The lease term includes the noncancellable term of the lease, together with periods covered by options to extend the lease that the Company is reasonably certain to exercise. The discount rate used to determine the present value of the future lease payments is the implicit rate in the lease if readily determinable. When that rate is not readily determinable, the Company applies its incremental borrowing rate, which its estimated using relevant interest rate yield curves and credit spreads derived from available market data and the Company's corporate credit rating. The Company excludes material non-lease components in determining the future lease payments. Material leases with an initial term of 12 months or less are recorded on the balance sheet. Intangible Assets The Company's finite-lived intangible assets primarily consist of customer relationships and brand names. Intangible assets are amortized on a straight-line basis over their estimated useful lives, which are 10 to 25 years for customer relationships and 15 years for brand names. Impairment of Long-Lived Assets The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. If the carrying amount of an asset is not recoverable, the fair value of the asset is determined typically using an income approach (discounted cash flow analysis). An impairment loss is recognized in earnings for any excess of the carrying amount of the asset over its fair value. Goodwill Goodwill represents the excess in a business combination of the purchase price over the estimated fair value of the identifiable net assets acquired. Goodwill is not amortized but is instead tested for impairment at the reporting unit level at least annually, or whenever events or circumstances change between the annual impairment tests that would indicate the carrying amount of goodwill may be impaired. The Company performs its annual test for goodwill impairment in the fourth quarter of each fiscal year. The Company can elect to qualitatively assess goodwill for impairment if it is more likely than not that the fair value of a reporting unit exceeds its carrying value. If the Company elects to quantitatively assess goodwill, or it is not more likely than not that the fair value of a reporting unit exceeds its carrying value, the Company estimates the fair value of each of its reporting units using an income approach (discounted cash flow method). Goodwill impairment charges are recognized based on the excess of a reporting unit's carrying amount over its fair value. The results of the Company's annual impairment tests for goodwill are described in note 9. Derivative Instruments From time to time, the Company utilizes foreign currency forward contracts to manage its exposure to exchange rate fluctuations relating to foreign currency denominated inventory purchases and operating costs. Contracts are entered into for periods consistent with related underlying exposures and do not constitute positions independent of those exposures. The Company does not enter into contracts for speculative purposes. As at December 31, 2022 and January 1, 2022, the Company had no open foreign currency forward contracts. Foreign currency forward contracts are recognized on the consolidated balance sheets at fair value. Gains or losses in the fair value of foreign currency forward contracts not specifically designated as hedging instruments are included in foreign exchange gain/loss on the consolidated statements of operations. For contracts designated as accounting hedges, gains or losses in fair value are recognized in other comprehensive earnings and subsequently recognized in earnings in the same period the hedged item affects earnings. The ineffective portion of an accounting hedge is recognized immediately in earnings. Debt Issuance Costs Costs incurred in connection with obtaining debt financing are deferred and amortized over the term of the financing arrangement using the effective interest method. Costs incurred to secure revolving credit facilities are recorded in other long-term assets. All other debt issuance costs are recorded as a direct deduction from the related debt liability. Income Taxes The Company follows the asset and liability method of accounting for income taxes whereby deferred income tax assets are recognized for deductible temporary differences and operating loss carryforwards, and deferred income tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the amounts of assets and liabilities recorded for income tax and financial reporting purposes. Deferred income tax assets are recognized only to the extent that management determines that it is more likely than not that the deferred income tax assets will be realized. Deferred income tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The income tax expense or benefit is the income tax payable or recoverable for the year plus or minus the change in deferred income tax assets and liabilities during the year. The Company is subject to ongoing tax exposures, examinations and assessments in various jurisdictions. Accordingly, the Company may incur additional income tax expense based upon the outcomes of such matters. In addition, when applicable, the Company adjusts income tax expense to reflect the Company's ongoing assessments of such matters, which requires judgment and can materially increase or decrease its effective rate as well as impact operating results. The evaluation of tax positions taken or expected to be taken in a tax return is a two-step process, whereby (i) the Company determines whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position, and (ii) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the related tax authority. Stock Incentive Plan The Company maintains a stock incentive plan under which stock options and other stock-based awards may be granted to selected employees and directors. The Company measures stock-based awards at fair value as of the date of grant. Compensation expense is recognized on a straight-line basis over vesting period of the entire stock-based award, based on the number of awards that ultimately vest. Upon exercise, stock-based awards are settled through the issuance of common shares and are therefore treated as equity awards. Revenue Recognition The Company manufactures and sells plant-based and fruit-based food and beverage products to retailers, foodservice operators, branded food companies, and other food manufacturers. The Company recognizes revenue when performance obligations under the terms of a contract with a customer are satisfied, which is upon the transfer of control of the contracted goods. Except for goods sold under bill-and-hold arrangements, control is transferred when title and physical possession of the product transfers to the customer, which is at the point in time that product is shipped from the Company's facilities or delivered to a specified destination, depending on the terms of the contract, and the Company has a present right to payment. Under bill-and-hold arrangements, whereby the Company bills a customer for product to be delivered at a later date, control typically transfers when the product is ready for physical transfer to the customer, and the Company has a present right to payment. A performance obligation is a promise within a contract to transfer distinct goods to the customer. A contract with a customer may involve multiple products and/or multiple delivery dates, with the transfer of each product at each delivery date being considered a distinct performance obligation, as each of the Company's products has standalone utility to the customer. In these cases, the contract's transaction price is allocated to each performance obligation based on relative standalone selling prices and recognized as revenue when each individual product is transferred to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring the goods. Consideration is typically determined based on a fixed unit price for the quantity of product transferred. Certain contracts include rebates and other forms of variable consideration. For contracts involving variable consideration, the Company estimates the transaction price based on the amount of consideration to which it expects to be entitled. These estimates are determined based on historical experience and the expected outcome of the variable consideration, and are updated as new information becomes available, including actual claims paid, which indicate an estimate is not indicative of the expected results. Changes to these estimates are recorded in the period the adjustment is identified. The Company does not typically grant customers a general right of return for goods transferred but will generally accept returns of product for quality-related issues. The cost of satisfying this promise of quality is accounted for as an assurance-type warranty obligation rather than variable consideration. The Company's contracts do not typically include any significant payment terms, as payment is normally due shortly after the time of transfer. Revenue contracts are typically represented by short-term, binding purchase orders from customers, identifying the quantity and pricing for products to be transferred. Customer purchase orders may be issued under long-term master supply arrangements. On their own, these master supply arrangements are typically not considered contracts for purposes of revenue recognition, as they do not create enforceable rights and obligations regarding the quantity, pricing, or timing of goods to be transferred; however, certain master supply agreements impose minimum purchase obligations on the part of the customers, which is considered a form of variable consideration. Other master supply arrangements provide for the transfer of product on a bill-and-hold basis at the specific request of the customer. As goods are produced under these bill-and-hold arrangements to meet individual customer specifications, they are identifiable as belonging to the customer and cannot be directed to another customer. The timing of the Company's revenue recognition, customer billings and cash collections, does not result in significant unbilled receivables (contract assets) or customer advances (contract liabilities) on the consolidated balance sheet. Contract costs, such as sales commissions, are generally expensed as incurred given the short-term nature of the associated contracts. Advertising Costs Advertising costs are expensed as incurred and are included in selling, general and administrative expenses. Research and Development Costs Research and development costs are expensed as incurred and are included in selling, general and administrative expenses. The Company's research and development activities are directed towards custom product formulations, packaging innovations, and production process improvements. The Company's research and development expenditures primarily consist of employee-related compensation and supplies, as well as rental costs and depreciation expense related to the Company's innovation center and pilot plant. Earnings Per Share Basic earnings per share is computed by dividing earnings available to common shareholders by the weighted-average number of common shares outstanding during the year. Earnings attributable to common shareholders is computed by deducting dividends and accretion on convertible preferred stock from net earnings. The potential diluted effect of stock options and other stock-based awards is computed using the treasury stock method whereby the weighted-average number of common shares used in the basic earnings per share calculation is increased to include the number of additional common shares that would have been outstanding if the potential dilutive common shares had been issued at the beginning of the year. The potential dilutive effect of convertible preferred stock is computed using the if-converted method whereby dividends and accretion on the convertible preferred stock are added back to the numerator, and the common shares resulting from the assumed conversion of the convertible preferred stock are included in the denominator of the diluted earnings per share calculation. Contingencies In the normal course of business, the Company is subject to loss contingencies, such as accrued but unpaid bonuses, tax-related matters, and claims or litigation. Accruals for loss contingencies are recorded when the Company determines that it is both probable that a liability has been incurred and the amount of loss can be reasonably estimated. If the estimate of the amount of the loss is a range and some amount within the range appears to be a better estimate than any other amount within the range, that amount is accrued as a liability. If no amount within the range is a better estimate than any other amount, the minimum amount of the range is accrued as a liability. Recent Accounting Pronouncement In September 2022, the Financial Accounting Standards Board issued Accounting Standard Update 2022-04, Liabilities - Supplier Finance Programs (Topic 450-50): Disclosure of Supplier Finance Program Obligations, which requires entities that use supplier finance programs in connection with the purchase of goods and services to disclose the key terms of the programs and information about obligations outstanding at the end of the reporting period, including a roll forward of those obligations. The guidance does not affect the recognition, measurement, or financial statement presentation of supplier finance program obligations. The requirements to disclose the key terms of the programs and information about obligations outstanding are effective for all interim and annual periods beginning fiscal 2023, and the requirement to disclose a roll forward of obligations outstanding is effective beginning fiscal 2024. The Company is currently evaluating the impact that this new guidance will have on its consolidated financial statements.

Discontinued Operations

Discontinued Operations	12 Months Ended
	Dec. 31, 2022
Tradin Organic [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Discontinued Operations [Text Block]	2. Discontinued Operations Tradin Organic On December 30, 2020 (the "Closing Date"), the Company completed the divestiture of its organic ingredient sourcing and production business, Tradin Organic, by selling all of the Company's interests and rights in The Organic Corporation B.V. and Tradin Organics USA LLC to Amsterdam Commodities N.V. ("Acomo"), pursuant to a Master Purchase Agreement, dated November 25, 2020, among the Company, Acomo, and the other parties thereto (the "Transaction"). As of the Closing Date, the Company received cash consideration of $373.7 million (€305.1 million), net of cash acquired and debt assumed by Acomo. The Company realized a cash loss of $12.7 million on a foreign currency forward contract to economically hedge the exchange rate risks on the euro-denominated cash consideration between the date of the Master Purchase Agreement and the Closing Date. The Company recorded this loss in other expense, net, from continuing operations for the year ended January 2, 2021, as the loss was not considered a direct operating item of the discontinued operations of Tradin Organic. For the year ended January 2, 2021, the Company recognized a pre-tax gain on sale of Tradin Organic of $111.8 million, which was recorded in discontinued operations. As described in note 20, on May 25, 2022, the Company and Acomo entered into a Settlement Agreement to resolve all outstanding matters related to the Master Purchase Agreement. In connection with the Settlement Agreement, the Company recognized earnings from discontinued operations of $4.7 million for the year ended December 31, 2022, which reflected the estimated tax benefits resulting from the final allocation of the purchase price between the share capital of The Organic Corporation B.V. and the membership interests of Tradin Organics USA LLC, partially offset by a cash payment of $5.9 million from the Company to Acomo to settle certain post-closing adjustments related to the Transaction, as well as professional fees incurred in connection with the arbitration proceedings. The table below reconciles the major components of the results of discontinued operations to the amounts reported in the consolidated statements of operations for the years ended December 31, 2022 and January 2, 2021. The consolidated statement of operations for the year ended January 1, 2022 did not include any results of discontinued operations. December 31, 2022 January 2, 2021 $ $ Revenues - 503,036 Cost of goods sold - 441,277 Selling, general and administrative expenses (1) - 26,953 Intangible asset amortization - 1,451 Other income, net - (782 ) Foreign exchange loss - 3,142 Interest expense (2) - 2,409 Earnings before gain of sale - 28,586 Pre-tax gain (loss) on sale (8,241 ) 111,818 Earnings from discontinued operations before income taxes (8,241 ) 140,404 Income tax expense (benefit) (12,918 ) 15,885 Loss attributable to non-controlling interests - (301 ) Earnings from discontinued operations 4,677 124,820 (1) (2)

Sale of Sunflower Business

Sale of Sunflower Business	12 Months Ended
	Dec. 31, 2022
Sunflower Business [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of Sunflower Business [Text Block]	3. Sale of Sunflower Business On October 11, 2022, the Company completed the sale of 100% of the assets and liabilities of its sunflower business and related roasted snacks operations, for cash consideration of $16.0 million, subject to closing debt and working capital adjustments. The sunflower business operated from three processing facilities located in Minnesota and North Dakota and was reported in the Company's Plant-Based Foods and Beverages operating segment. For the year ended December 31, 2022, the Company recognized a loss on the sale of the sunflower business, which is recorded in other expense, net, as follows: $ Cash consideration 16,000 Less: debt and working capital adjustments (6,620 ) Less: costs to sell (1,162 ) Net proceeds (1) 8,218 Accounts receivable 10,572 Inventories 13,493 Other current assets 105 Property, plant and equipment 10,328 Operating lease right-of-use assets 1,834 Intangible assets, net 2,512 Accounts payable and accrued liabilities (4,985 ) Operating lease liabilities (2,414 ) Net assets sold 31,445 Pre-tax loss on sale (23,227 ) (1) As the disposal of the sunflower business did not have a major effect on the Company's operations or financial results and, therefore, did not qualify for presentation as discontinued operations on a standalone basis, the operating results for the business prior to October 11, 2022, are reported in continuing operations on the consolidated statements of operations for the current and comparative periods. The following table presents revenues and earnings (loss) before income taxes for the sunflower business included in the Company's consolidated results of operations for years ended December 31, 2022, January 1, 2022 and January 2, 2021: December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Revenues 57,924 63,094 54,618 Earnings (loss) before income taxes (1) 1,182 1,082 (5,689 ) (1)

Accounts Receivable

Accounts Receivable	12 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
Accounts Receivable [Text Block]	4. Accounts Receivable December 31, 2022 January 1, 2022 $ $ Trade receivables 75,102 85,591 Proceeds receivable from sale of sunflower business (see note 3) 385 - Allowance for credit losses (584 ) (889 ) 74,903 84,702 The change in the allowance for credit losses for the years ended December 31, 2022 and January 1, 2022 is comprised as follows: December 31, 2022 January 1, 2022 $ $ Balance, beginning of year 889 1,257 Net addition (reduction) to provision 112 (368 ) Accounts receivable written off, net of recoveries (417 ) - Balance, end of year 584 889

Inventories

Inventories	12 Months Ended
	Dec. 31, 2022
Inventory Disclosure [Abstract]
Inventories [Text Block]	5. Inventories December 31, 2022 January 1, 2022 $ $ Raw materials and work-in-process 124,168 143,016 Finished goods 90,381 81,546 Inventory reserve (7,502 ) (4,784 ) 207,047 219,778 The change in the inventory reserve for the years ended December 31, 2022 and January 1, 2022 is comprised as follows: December 31, 2022 January 1, 2022 $ $ Balance, beginning of year 4,784 5,742 Additions to reserve during the year 10,779 5,854 Reserves applied and inventories written off during the year (8,061 ) (6,812 ) Balance, end of year 7,502 4,784

Property, Plant and Equipment

Property, Plant and Equipment	12 Months Ended
	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Text Block]	6. Property, Plant and Equipment The major components of property, plant and equipment as at December 31, 2022 and January 1, 2022 were as follows: December 31, 2022 January 1, 2022 Cost Accumulated depreciation Net book value Cost Accumulated depreciation Net book value $ $ $ $ $ $ Land 2,433 - 2,433 6,963 - 6,963 Buildings 115,718 19,922 95,796 94,935 22,510 72,425 Machinery and equipment 314,065 99,923 214,142 236,779 107,319 129,460 Enterprise software 22,840 14,873 7,967 19,900 11,740 8,160 Office furniture and equipment 4,241 2,482 1,759 5,429 3,130 2,299 Vehicles 895 601 294 1,445 1,215 230 460,192 137,801 322,391 365,451 145,914 219,537 Interest expense capitalized as part of the construction cost of property, plant and equipment was $1.2 million for the year ended December 31, 2022, and immaterial for the years ended January 1, 2022 and January 2, 2021. As at December 31, 2022, property, plant and equipment included construction in process assets of $132.2 million (January 1, 2022 - $48.7 million) and $8.8 million (January 1, 2022 - $7.0 million) of spare parts inventory. Total depreciation expense included in cost of goods sold and selling, general and administrative expenses on the consolidated statements of operations related to property, plant and equipment for the year ended December 31, 2022 was $27.4 million (January 1, 2022 - $24.7 million; January 2, 2021 - $21.4 million).

Leases

Leases	12 Months Ended
	Dec. 31, 2022
Leases [Abstract]
Leases [Text Block]	7. Leases The Company leases certain manufacturing plants, warehouses, offices, and machinery and equipment. At the lease commencement date, the Company classifies a lease as a finance lease if it has the right to obtain substantially all of the economic benefits from the right-of-use assets, otherwise the lease is classified as an operating lease. The Company's leases have remaining noncancelable lease terms of less than one year to approximately 15 years, and typically require fixed monthly rental payments that may be adjusted annually to give effect to inflation. Real estate leases typically provide the Company options to extend the leases for up to 15 years. Finance leases for machinery and equipment typically include nominal purchase options at the end of the lease term that are reasonably certain of being exercised at the lease commencement date. Machinery and equipment operating leases typically include purchase options for the fair market value of the underlying asset at the end of the lease term, which are uncertain of being exercised at the lease commencement date. The following tables present supplemental information related to leases: December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Lease Costs Operating lease cost 13,830 13,806 16,647 Finance lease cost: Depreciation of right-of-use assets 10,146 5,922 2,647 Interest on lease liabilities 5,147 2,752 675 Sublease income - (281 ) (504 ) Net lease cost 29,123 22,199 19,465 December 31, 2022 January 1, 2022 $ $ Balance Sheet Classification Operating leases: Operating lease right-of-use assets 82,564 47,245 Current portion of operating lease liabilities 13,074 12,203 Operating lease liabilities 77,557 39,028 Total operating lease liabilities 90,631 51,231 Finance leases: Property, plant and equipment, gross 157,801 66,060 Accumulated depreciation (20,494 ) (10,348 ) Property, plant and equipment, net 137,307 55,712 Current portion of long-term debt 33,283 9,760 Long-term debt 90,796 43,034 Total finance lease liabilities 124,079 52,794 December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Cash Flow Information Cash paid (received) for amounts included in measurement of lease liabilities: Operating cash flows from operating leases 13,051 13,391 16,741 Operating cash flows from finance leases 5,147 2,752 675 Financing cash flows from finance leases Cash paid under finance leases (1) 20,457 8,798 2,587 Cash received under finance leases (2) (58,764 ) (13,626 ) - Right-of-use assets obtained in exchange for lease liabilities: Operating leases 49,818 29,015 5,962 Finance leases 32,977 29,906 5,179 Right-of-use assets and liabilities reduced through lease terminations or modifications: Operating leases (4,060 ) (2,261 ) (23,667 ) Finance leases - (686 ) - Impairment of operating lease right-of-use assets - - (1,538 ) (1) (2) December 31, 2022 January 1, 2022 January 2, 2021 Other Information Weighted-average remaining lease term (years): Operating leases 12.8 7.4 3.4 Finance leases 3.5 4.3 5.3 Weighted-average discount rate: Operating leases 8.7% 5.0% 6.6% Finance leases 8.2% 6.6% 5.4% Operating leases Finance leases $ $ Maturities of Lease Liabilities 2023 12,805 40,336 2024 12,461 41,643 2025 11,678 36,863 2026 10,754 23,838 2027 9,727 3,567 Thereafter 152,740 - Total lease payments 210,165 146,247 Less: imputed interest (119,534 ) (22,168 ) Total lease liabilities 90,631 124,079 See note 20 for a discussion of the Company's lease commitments.

Intangible Assets

Intangible Assets	12 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets [Text Block]	8. Intangible Assets The major components of intangible assets as at December 31, 2022 and January 1, 2022 were as follows: December 31, 2022 January 1, 2022 Cost Accumulated Net book Cost Accumulated Net book $ $ $ $ $ $ Customer relationships 177,996 64,578 113,418 189,407 64,867 124,540 Brand names 25,073 2,845 22,228 25,073 1,173 23,900 Other 746 746 - 1,919 1,919 - 203,815 68,169 135,646 216,399 67,959 148,440 Amortization expense associated with intangible assets in each of the next five fiscal years and thereafter is as follows: 2023 2024 2025 2026 2027 Thereafter Total $ $ $ $ $ $ $ Amortization expense 9,784 9,784 9,784 9,784 9,784 86,726 135,646

Goodwill

Goodwill	12 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill [Text Block]	9. Goodwill As at December 31, 2022 and January 1, 2022, the Company had $4.0 million of goodwill recognized on the consolidated balance sheets, all of which was associated with the Fruit Snacks reporting unit of the Fruit-Based Foods and Beverages operating segment. For the years ended December 31, 2022, January 1, 2022 and January 2, 2021, the Company determined that goodwill was not impaired as the fair value of the Fruit Snacks reporting unit significantly exceeded its carrying amount. Prior to fiscal 2020, the Company recognized accumulated impairment losses of $213.8 million related to goodwill.

Accounts Payable and Accrued Li

Accounts Payable and Accrued Liabilities	12 Months Ended
	Dec. 31, 2022
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities [Text Block]	10. Accounts Payable and Accrued Liabilities December 31, 2022 January 1, 2022 $ $ Accounts payable 88,178 105,386 Payroll and benefits 13,914 8,861 Accrued interest 1,685 846 Dividends payable on preferred stock (see note 12) 609 609 Other accruals 4,125 5,453 108,511 121,155

Long-Term Debt

Long-Term Debt	12 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Long-Term Debt [Text Block]	11. Long-Term Debt December 31, 2022 January 1, 2022 $ $ Asset-based credit facilities: Revolving credit facilities 137,253 153,293 Term loan facility 43,748 11,606 Total asset-based credit facilities 181,001 164,899 Finance lease liabilities (see note 7) 124,079 52,794 Other 3,404 6,910 Total debt 308,484 224,603 Less: current portion 38,491 9,760 Total long-term debt 269,993 214,843 Scheduled maturities of long-term debt, including finance lease liabilities (see note 7), are as follows: $ 2023 45,544 2024 47,893 2025 206,407 2026 26,801 2027 4,007 Total gross maturities 330,652 Less: imputed interest (22,168 ) Total debt 308,484 Asset-Based Credit Facilities On December 31, 2020, the Company entered into a Second Amended and Restated Credit Agreement (the "Credit Agreement"), as amended by the First Amendment, dated as of April 15, 2021, the Second Amendment, dated as of July 2, 2021, the Third Amendment, dated as of February 25, 2022, and the Fourth Amendment, dated as of September 2, 2022, among the Company, SunOpta Foods Inc. ("SunOpta Foods"), the other borrowers and guarantors party thereto, and the lenders party thereto (the "Lenders"). As part of the Credit Agreement, the Lenders provided a five-year, $230 million asset-based revolving credit facility, subject to borrowing base capacity (the "Tranche A Subfacility"), a two-year, $20 million first-in-last-out tranche, subject to a separate borrowing base applicable to certain eligible accounts receivable and inventory with advance rates separate from the Tranche A Subfacility (the "Tranche B Subfacility", and together with the Tranche A Subfacility, the "Revolving Credit Facilities"), and a five-year $75 million delayed draw term loan facility which can be used for borrowings on or prior to March 31, 2023 (the "Term Loan Facility," and together with the Revolving Credit Facilities, the "Asset-Based Credit Facilities"), to finance certain capital expenditures. The Tranche A Subfacility includes borrowing capacity for letters of credit (see note 20) and provides for borrowings on same-day notice, including in the form of swingline loans. The Tranche A Subfacility and Term Loan Facility mature on December 31, 2025. Commencing in March 2023, the Term Loan Facility is repayable in monthly installments equal to 1/84 th Borrowings under the Asset-Based Credit Facilities bear interest based on various reference rates, including the Secured Overnight Financing Rate ("SOFR") plus an applicable margin, which are set quarterly based on average borrowing availability for the preceding fiscal quarter. The applicable margin for loans under the Tranche A Subfacility range from 0.50% to 1.00% for base rate loans and from 1.50% to 2.00% for SOFR loans, bankers' acceptance equivalent loans and European base rate loans. The applicable margin on loans under the Tranche B Subfacility are the applicable margin for the Tranche A Subfacility plus 1.00%. With respect to loans under the Term Loan Facility, the applicable margin ranges from 1.25% to 1.75% for base rate loans and from 2.25% to 2.75% for SOFR loans. In addition, a credit spread adjustment of 0.10% applies to all SOFR loans. Effective January 1, 2023, a 0.25% margin reduction applies when the Company's total leverage ratio is less than a specific threshold. For the year ended December 31, 2022, the weighted-average interest rate on all outstanding borrowings under the Asset-Based Credit Facilities was 4.73% (January 1, 2022 - 2.36%). In addition to paying interest on outstanding principal under the Asset-Based Credit Facilities, the Company is required to pay commitment fees quarterly, in arrears, equal to (i) 0.25% of the average daily undrawn portion of the Revolving Credit Facilities and (ii) 0.375% of the undrawn portion of the Term Loan Facility. All obligations under the Asset-Based Credit Facilities are guaranteed by substantially all of the Company's direct and indirect wholly-owned material restricted subsidiaries organized in the U.S. and Canada (the "Guarantors") and, subject to certain exceptions, such obligations are secured by first priority liens on substantially all assets of the Company and the other borrowers and Guarantors. The Asset-Based Credit Facilities are subject to a number of covenants that, among other things, restrict the Company's ability to create liens on assets; sell assets and enter in sale and leaseback transactions; pay dividends, prepay junior lien and unsecured indebtedness and make other restricted payments; incur additional indebtedness, including finance lease obligations in excess of $150 million, and make guarantees; make investments, loans or advances, including acquisitions; and engage in mergers or consolidations. In addition, the Company and its restricted subsidiaries are required to maintain a minimum fixed charge coverage ratio of 1.0 to 1.0 if excess availability is less than the greater of (i) $15.0 million or (ii) 10% of the lesser of (x) the aggregate commitments under the Revolving Credit Facilities and (y) the aggregate borrowing base. The Company and its restricted subsidiaries are also subject to a maximum senior funded leverage ratio with respect to the Term Loan Facility of 4.75 to 1.00 from the fiscal quarter ending March 31, 2023 to the fiscal quarter ending June 30, 2023, 4.25 to 1.00 from the fiscal quarter ending September 30, 2023 to the fiscal quarter ending December 31, 2023, 3.50 to 1.00 from the fiscal quarter ending March 31, 2024 to the fiscal quarter ending June 30, 2024, and 3.25 to 1.00 from the fiscal quarter ending September 30, 2024 until the Term Loan Facility termination date. As at December 31, 2022, the Company was in compliance with all covenants of the Credit Agreement. Interest Expense, Net The components of interest expense, net are as follows: December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Interest expense, net of capitalized interest (see note 6) 13,480 7,685 26,816 Amortization of debt issuance costs 1,601 1,353 4,078 Interest income (347 ) (269 ) (852 ) Interest expense, net 14,734 8,769 30,042 Loss on Retirement of Debt For the year ended January 2, 2021, the Company recorded a loss of $8.9 million on the redemption and retirement in full of the $223.5 million principal amount of outstanding 9.5% senior secured second lien notes due October 2022 issued by SunOpta Foods. The second lien notes were redeemed at a redemption price equal to 102.375% of the principal amount of the notes, together with accrued and unpaid interest on the notes to the date of redemption.

Preferred Stock

Preferred Stock	12 Months Ended
	Dec. 31, 2022
Temporary Equity [Abstract]
Preferred Stock [Text Block]	12. Preferred Stock Series B-1 Preferred Stock On April 15, 2020, the Company and SunOpta Foods entered into a subscription agreement (the "Series B Subscription Agreement") with Oaktree Organics, L.P. and Oaktree Huntington Investment Fund II, L.P. (collectively, "Oaktree") and Engaged Capital, LLC, Engaged Capital Flagship Master Fund, LP and Engaged Capital Co-Invest IV-A, LP (collectively, "Engaged Capital"). On April 24, 2020, pursuant to the Series B Subscription Agreement, SunOpta Foods issued 15,000 shares of Series B-1 Preferred Stock to each of Oaktree and Engaged Capital for aggregate consideration of $30.0 million and 30,000 shares total (the "Series B-1 Preferred Stock"). In connection with the issuance of the Series B-1 Preferred Stock, the Company incurred direct and incremental expenses of $4.0 million, which reduced the carrying value of the Series B-1 Preferred Stock. The carrying value of the Series B-1 Preferred Stock is being accreted through charges to accumulated deficit over the period preceding April 24, 2025. For the year ended December 31, 2022, these accretion charges amounted to $0.7 million (January 1, 2022 - $0.5 million; January 2, 2021 - $0.3 million). The Series B-1 Preferred Stock had an initial stated value and liquidation preference of $1,000 per share, which is adjusted for any non-cash dividends declared on the Series B-1 Preferred Stock (the "Series B-1 Liquidation Preference"). Cumulative preferred dividends accrue daily on the Series B-1 Preferred Stock at an annualized rate of 8.0% of the Series B-1 Liquidation Preference prior to September 30, 2029, and 10.0% of the liquidation preference thereafter (subject to an increase of 1.0% per quarter, up to a maximum rate of 5.0% per quarter on the occurrence of certain events of non-compliance). Prior to September 30, 2029, SunOpta Foods may pay dividends in cash or elect, in lieu of paying cash, to add the amount that would have been paid to the Series B-1 Liquidation Preference. The failure to pay dividends in cash for any quarter ending after September 30, 2029 will be an event of non-compliance. For the second quarter of 2020, SunOpta Foods elected to declare dividends on the Series B-1 Preferred Stock to be paid in kind and, as a result, the aggregate Series B-1 Liquidation Preference increased by $0.4 million to $30.4 million, or approximately $1,015 per share. Since the second quarter of 2020, SunOpta Foods has elected to pay the quarterly dividend amount of $0.6 million in cash. As at December 31, 2022, the Company accrued unpaid dividends of $0.6 million for the fourth quarter of 2022, which are recorded in accounts payable and accrued liabilities on the consolidated balance sheet. At any time, the Series B-1 Preferred Stock may be exchanged, in whole or in part, into the number of Common Shares equal to, per share of Series B-1 Preferred Stock, the quotient of the Series B Liquidation Preference divided by $2.50 (such price, the "Series B-1 Exchange Price" and such quotient, the "Series B-1 Exchange Rate"). As at December 31, 2022, the aggregate shares of Series B-1 Preferred Stock outstanding were exchangeable into approximately 12,178,667 shares of common stock of the Company ("Common Shares"). The Series B-1 Exchange Price is subject to certain anti-dilution adjustments, including a weighted-average adjustment for issuances of Common Shares below the Series B-1 Exchange Price, provided that the Series B-1 Exchange Price may not be lower than $2.00 (subject to adjustment in cer tain circumstances). SunOpta Foods may cause the holders of the Series B-1 Preferred Stock to exchange all of their shares of Series B-1 Preferred Stock into a number of Common Shares equal to the number of shares of Series B-1 Preferred Stock outstanding multiplied by the Series B-1 Exchange Rate if (i) fewer than 10% of the shares of Series B-1 Preferred Stock issued on April 24, 2020 remain outstanding, or (ii) on or after April 24, 2023, the volume-weighted average price of the Common Shares during the then preceding 20 trading day period is greater than 200% of the Series B-1 Exchange Price then in effect. At any time, if a holder of Series B-1 Preferred Stock elects to exchange, or SunOpta Foods causes an exchange of Series B Preferred Stock, the number of Common Shares delivered to each applicable holder may not cause such holder's beneficial ownership to exceed 19.99% of the Common Shares that would be outstanding immediately following such exchange (the "Series B-1 Exchange Cap"). At any time on or after April 24, 2025, SunOpta Foods may redeem all of the Series B-1 Preferred Stock for an amount per share equal to the value of the Series B-1 Liquidation Preference at such time, plus accrued and unpaid dividends. Oaktree and Engaged Capital are entitled to vote the Series B-1 Preferred Stock with the Common Shares on an as-exchanged basis, subject to a permanent 19.99% voting cap. As a result of the voting cap, each of Oaktree and Engaged Capital will only be able to vote its Series B-1 Preferred Stock to the extent that, when taken together with any other voting securities each investor controls, such votes do not exceed 19.99% of the votes eligible to be cast by all security holders of the Company. On April 24, 2020, the Company designated Special Shares, Series 2 to serve as the mechanism for attaching exchanged voting rights to the Series B-1 Preferred Stock. The Special Shares, Series 2 entitle the holder thereof to one vote per Special Share, Series 2 on all matters submitted to a vote of the holders of Common Shares, voting together as a single class, subject to certain exceptions. The Special Shares, Series 2 are not transferrable and the voting rights associated with the Special Shares, Series 2 will terminate upon the transfer of the shares of Series B-1 Preferred Stock to a third party, other than an affiliate of Oaktree or Engaged Capital, as applicable. As at December 31, 2022, 6,089,333 Special Shares, Series 2 were issued to Engaged Capital, equal to the number of Common Shares issuable to Engaged Capital on the exchange of all of the shares of Series B-1 Preferred Stock held by it, and no Special Shares, Series 2 were issued to Oaktree, as Oaktree was subject to the Series B-1 Exchange Cap. On February 28, 2023, the Company received written notice from Engaged Capital that they have exercised their right to exchange their entire holding of 15,000 shares of Series B-1 Preferred Stock into Common Shares (see note 22). Series A Preferred Stock On October 7, 2016, SunOpta Foods issued an aggregate of 85,000 shares of Series A Preferred Stock to Oaktree for consideration in the amount of $85.0 million (the "Series A Preferred Stock"). On February 22, 2021, Oaktree exchanged all of their shares of Series A Preferred Stock for 12,633,427 Common Shares at an exchange price of $7.00. Upon the exchange, the Company derecognized the $87.5 million carrying amount of the Series A Preferred Stock, including dividends paid in kind, and recognized a corresponding amount for the Common Shares issued on exchange, net of share issuance costs of $0.3 million.

Common Shares

Common Shares	12 Months Ended
	Dec. 31, 2022
Equity [Abstract]
Common Shares [Text Block]	13. Common Shares The Company is authorized to issue an unlimited number of Common Shares without par value and an unlimited number of special shares without par value.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Dec. 31, 2022
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation [Text Block]	14. Stock-Based Compensation On May 28, 2013, the Company's shareholders approved the 2013 Stock Incentive Plan, as amended (the "2013 Plan"), which permits the grant of a variety of stock-based awards, including stock options, restricted stock units ("RSUs") and performance share units ("PSUs") to selected employees and directors of the Company. As at December 31, 2022, 114,398 securities remained available for issuance under the 2013 Plan. In addition, in 2019, the Board of Directors approved inducement equity awards related to the appointment of the Company's Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), which totaled 1,222,243 stock options, 840,438 RSUs, and 2,132,352 PSUs. The stock options vested 100% in 2022 and the RSUs vested in three equal annual installments from 2020 through 2022. The vesting of 1,066,176 of the PSUs granted was subject to the Common Shares achieving certain volume-weighted average trading prices during a performance period commencing on the grant dates and ending on December 31, 2022. All of these PSUs vested prior to 2022. The vesting of the other 1,066,176 PSUs granted was subject to the Company achieving predetermined annual thresholds of adjusted earnings before interest, taxes, depreciation and amortization ("EBITDA") during fiscal years 2019 through 2022. December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Selling, general and administrative expenses 13,830 9,100 12,570 Other income (1) - - (894 ) Earnings from discontinued operations (2) - - 540 Total stock-based compensation expense 13,830 9,100 12,216 (1) Represents the reversal of previously recognized stock-based compensation related to forfeited awards previously granted to employees who were terminated in connection with restructuring activities undertaken by the Company. (2) Represents stock-based compensation attributed to employees of Tradin Organic. Stock Options Stock options granted to employees during the three-year period ended December 31, 2022, vest ratably on each of the first through third anniversaries of the grant date and expire on the tenth anniversary of the grant date. Stock options granted by the Company contain an exercise price that is equal to the closing market price of the shares on the day prior to the grant date. Any consideration paid on the exercise of stock options is credited to capital stock. The following table summarizes stock option activity for the year ended December 31, 2022: Weighted- average Weighted- remaining average contractual Aggregate Stock options exercise price term (years) intrinsic value Outstanding, beginning of year 2,281,621 $ 5.29 Granted 1,800,007 5.91 Exercised (69,457 ) 6.18 Forfeited (61,307 ) 8.12 Expired (30,264 ) 5.96 Outstanding, end of year 3,920,600 $ 5.51 7.5 $ 12,734 Exercisable, end of year 1,954,761 $ 4.79 5.9 $ 7,845 The total intrinsic value of stock options exercised during the year ended December 31, 2022 was $0.3 million. The following table summarizes non-vested stock option activity during the year ended December 31, 2022: Weighted- average grant- Stock options date fair value Non-vested, beginning of year 1,615,633 $ 2.28 Granted 1,800,007 3.49 Vested (1,405,905 ) 4.01 Forfeited (43,896 ) 1.89 Non-vested, end of year 1,965,839 $ 3.63 The weighted-average grant-date fair values of all stock options granted in the years ended December 31, 2022, January 1, 2022 and January 2, 2021, were $3.49, $8.10 and $2.52, respectively, using a Black-Scholes option pricing model with the following assumptions: December 31, 2022 January 1, 2022 January 2, 2021 Grant-date stock price $ 5.91 $ 14.77 $ 4.64 Dividend yield (a) 0% 0% 0% Expected volatility (b) 61.6% 61.7% 60.0% Risk-free interest rate (c) 3.0% 1.0% 0.4% Expected life of options (years) (d) 6.0 6.0 6.0 (a) Determined based on expected annual dividend yield at the time of grant. (b) Determined based on historical volatility of the Company’s Common Shares over the expected life of the option. (c) Determined based on the yield on U.S. Treasury zero-coupon issues with maturity dates equal to the expected life of the option. (d) Determined based on the mid-point of vesting (one through three years) and expiration (10 years). Total compensation costs related to non-vested stock option awards not yet recognized as an expense was $5.4 million as at December 31, 2022, which will be amortized over a weighted-average remaining vesting period of 2.2 years. The following table summarizes stock options outstanding and exercisable as at December 31, 2022: Weighted- average remaining Weighted- Weighted- Exercise price range Outstanding contractual life average exercise Exercisable average exercise Low High options (years) price options price $ 2.38 $ 3.32 332,792 6.3 $ 2.57 332,792 $ 2.57 3.33 3.73 960,061 6.3 3.36 960,061 3.36 3.74 5.59 353,387 7.2 4.76 245,703 4.78 5.60 6.28 1,780,431 9.3 5.91 5,793 5.91 6.29 14.77 493,929 4.6 10.74 410,412 9.92 3,920,600 7.5 $ 5.51 1,954,761 $ 4.79 Restricted Stock Units RSUs granted to employees vest ratably on each of the first through third anniversaries of the grant date and RSUs granted to directors vest 100% The weighted-average grant-date fair values of all RSUs granted in the years ended December 31, 2022, January 1, 2022 and January 2, 2021, were $6.40, $13.54 and $3.20, respectively, based on the closing price of the Common Shares on the grant dates. The following table summarizes non-vested RSU activity during the year ended December 31, 2022: Weighted- average grant- RSUs date fair value Non-vested, beginning of year 815,247 $ 6.39 Granted 466,945 6.40 Vested (549,754 ) 5.40 Forfeited (72,789 ) 7.11 Non-vested, end of year 659,649 $ 7.14 The total intrinsic value of RSUs that vested during the year ended December 31, 2022 was $3.8 million. Total compensation costs related to non-vested RSU awards not yet recognized as an expense was $3.1 million as at December 31, 2022, which will be amortized over a weighted-average remaining vesting period of 1.8 years. Performance Share Units The vesting of PSUs granted to employees under the Company's annual short-term incentive plans and 2020 long-term incentive plan are dependent on the Company achieving predetermined measures of adjusted EBITDA (the "EBITDA PSUs"). Each vested EBITDA PSU entitles the employee to receive one Common Share without payment of additional consideration. The weighted-average grant-date fair values of the EBITDA PSUs granted during the years ended December 31, 2022, January 1, 2022 and January 2, 2021, were $5.45, $13.90 and $3.54, respectively, based on the closing price of the Common Shares on the grant dates. The following table summarizes non-vested EBITDA PSU activity during the year ended December 31, 2022: Weighted- average grant- EBITDA PSUs date fair value Non-vested, beginning of year 1,380,955 $ 7.62 Granted 1,846,196 5.45 Vested (58,235 ) 4.91 Cancelled or forfeited (813,485 ) 11.05 Non-vested, end of year 2,355,431 $ 4.80 The total intrinsic value of EBITDA PSUs that vested during the year ended December 31, 2022 was $0.3 million. Each reporting period, the number of unvested EBITDA PSUs that are expected to vest is redetermined and the aggregate grant-date fair value of the redetermined number of EBITDA PSUs is amortized on a straight-line basis over the remaining requisite service period less amounts previously recognized. As at December 31, 2022, the compensation cost not yet recognized as an expense that are currently expected to vest was $2.6 million, which will be amortized over a weighted-average remaining vesting period of 0.3 years. The vesting of PSUs granted to employees under the Company's 2022 and 2021 long-term incentive plans are dependent on the Company's total shareholder return ("TSR") performance relative to food and beverage companies in a designated index during a three-year performance period commencing on January 1 of the year of grant, and the employee's continued employment with the Company through the vesting date (the "TSR PSUs"). The TSR for the Company and each of the companies in the designated index will be calculated at the end of the applicable three-year performance period using a 20-trading day average closing price as of December 31. The percentage of vested PSUs may range from 0% to 200% based on the Company's achievement of predetermined TSR thresholds. Each vested PSU entitles the employee to receive one Common Share without payment of additional consideration. With respect to PSUs granted under the 2022 long-term incentive plan, the Board of Directors of the Company has the option to settle vested PSUs in whole or part in cash in lieu of Common Shares. As at December 31, 2022, the Company had the intent and ability to settle these PSUs in Common Shares. The grant-date fair values of TSR PSUs granted in the years ended December 31, 2022 and January 1, 2022, were $8.48 and $23.40, respectively, using a Monte Carlo valuation model with the following assumptions: December 31, 2022 January 1, 2022 Grant-date stock price $ 5.91 $ 14.77 Dividend yield 0% 0% Expected volatility (a) 67.8% 76.9% Risk-free interest rate (b) 2.8% 0.3% Expected life (in years) (c) 2.7 2.7 (a) (b) (c) The following table summarized non-vested TSR PSU activity during the year ended December 31, 2022: Weighted- average grant- TSR PSUs date fair value Non-vested, beginning of year 71,346 $ 23.40 Granted 547,071 8.48 Vested - - Forfeited (23,544 ) 13.40 Non-vested, end of year 594,873 $ 10.07 Total compensation costs related to non-vested TSR PSU awards not yet recognized as an expense was $4.2 million as at December 31, 2022, which will be amortized over a weighted-average remaining vesting period of 2.2 years. Employee Stock Purchase Plan The Company maintains an Employee Stock Purchase Plan whereby employees can purchase common shares through payroll deductions. For the year ended December 31, 2022, the Company's employees purchased 87,850 Common Shares (January 1, 2022 - 66,834; January 2, 2021 - 113,581) for total proceeds of $0.6 million (January 1, 2022 - $0.6 million; January 2, 2021 - $0.5 million). As at December 31, 2022, 546,232 Common Shares remained available to be granted under this plan.

Other Expense (Income), Net

Other Expense (Income), Net	12 Months Ended
	Dec. 31, 2022
Other Income and Expenses [Abstract]
Other Expense (Income), Net [Text Block]	15. Other Expense (Income), Net The components of other expense (income) are as follows: December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Loss on sale of sunflower business (see note 3) 23,227 - - Gain on sale of frozen fruit processing facility (1) (3,779 ) - - Long-lived asset impairments and facility closure costs (2) 1,812 6,298 9,045 Employee termination and recruitment costs (3) - 1,628 1,881 Divestiture costs (4) - 703 - Loss on foreign currency forward contract (see note 2) - - 12,658 Other 872 261 (191 ) 22,132 8,890 23,393 (1) Gain on sale of frozen fruit processing facility For the year ended December 31, 2022, the Company recognized a $3.8 million pre-tax gain on the sale of its frozen fruit processing facility located in Oxnard, California. Net cash proceeds on the sale were $16.1 million. (2) Long-lived asset impairments and facility closure costs For the year ended December 31, 2022, expense primarily relates to the relocation of certain equipment from the Company's sold Oxnard facility. For the year ended January 1, 2022, expenses include asset impairment charges and asset relocation costs of $3.8 million related to the closure of the Company's South Gate, California, fruit ingredient processing facility in July 2021, and costs of $1.4 million to complete the exit from the Company's Santa Maria, California, frozen fruit processing facility in February 2021, together with costs of $0.8 million related to the relocation of the Company's executive office and innovation center into Eden Prairie, Minnesota, and the related vacating of the Company's former leased facility in December 2021, and other asset impairments of $0.3 million. For the year ended January 2, 2021, expenses include costs of $6.3 million related to the Company's exit from its Santa Maria facility and the consolidation of the Company's corporate offices into Minnesota, together with the write-down of $2.7 million of operating lease right-of-use and owned assets related to the roasting operations of the sunflower business. (3) Employee termination and recruitment costs For the year ended January 1, 2022, expense represents severance benefits of $1.1 million for 55 employees impacted by the closure of the South Gate facility, and $0.5 million of severance benefits for 19 employees following a workforce reduction in the Company's frozen fruit operations. For the year ended January 2, 2021, expense represents severance benefits of $2.8 million mainly related to employees impacted by the exit from the Company's Santa Maria facility, offset by the reversal of $0.9 million of previously recognized stock-based compensation expense related to forfeited awards previously granted to terminated employees. (4) Divestiture costs For the year ended January 1, 2022, expense relates to professional fees incurred in connection with post-closing matters related to the divestiture of Tradin Organic.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes [Text Block]	16. Income Taxes The income tax benefit differs from the amount that would have resulted from applying the combined Canadian federal and provincial statutory income tax rate to loss from continuing operations before income taxes due to the following: December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Loss from continuing operations before income taxes (11,858 ) (7,600 ) (50,042 ) Canadian statutory rate 26.5% 26.5% 26.5% Income tax benefit at statutory rate (3,142 ) (2,014 ) (13,261 ) Stock-based compensation 978 (4,796 ) 2,159 Disallowed executive compensation 374 138 2,801 Foreign tax rate differential 76 (31 ) (105 ) Excess tax benefits related to stock-based compensation Change in valuation allowance (471 ) 975 560 Change in enacted tax rates (340 ) (442 ) 250 CARES Act - - 2,472 Change in valuation of state deferred tax assets - - (3,900 ) Other 185 (258 ) 1,374 Income tax benefit (2,340 ) (6,428 ) (7,650 ) The components of loss from continuing operations before income taxes are shown below: December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Canada (11,181 ) (10,797 ) (14,700 ) U.S. (2,506 ) 3,855 (34,521 ) Other 1,829 (658 ) (821 ) Loss from continuing operations before income taxes (11,858 ) (7,600 ) (50,042 ) The components of income tax expense (benefit) are shown below: December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Current income tax expense (benefit): Canada 84 (9 ) (154 ) U.S. (55 ) (75 ) (14,148 ) Other 2,438 (359 ) 589 2,467 (443 ) (13,713 ) Deferred income tax expense (benefit): Canada - 299 (291 ) U.S. (4,672 ) (6,129 ) 5,532 Other (135 ) (155 ) 822 (4,807 ) (5,985 ) 6,063 Income tax benefit (2,340 ) (6,428 ) (7,650 ) Deferred income taxes of the Company are comprised of the following: December 31, 2022 January 1, 2022 $ $ Differences in property, plant and equipment and intangible assets (28,088 ) (54,761 ) Capital and non-capital losses 17,335 26,751 Interest expense limitation (163j) 9,464 13,064 Tax benefit of scientific research expenditures 2,866 2,744 Stock-based compensation 2,160 680 Inventory basis differences 1,805 1,148 Right-of-use lease assets (23,071 ) (13,224 ) Lease liabilities 23,609 13,346 Other accrued reserves 2,458 1,468 8,538 (8,784 ) Less: valuation allowance 4,826 5,267 Deferred income tax asset (liability) 3,712 (14,051 ) T he components of the deferred income tax asset (liability) are shown below: December 31, 2022 January 1, 2022 $ $ Canada (325 ) (325 ) U.S. 3,978 (13,649 ) Other 59 (77 ) Deferred income tax asset (liability) 3,712 (14,051 ) The components of the deferred income tax valuation allowance are as follows: December 31, 2022 January 1, 2022 $ $ Balance, beginning of year 5,267 4,284 Increase (decrease) in valuation allowance (441 ) 983 Balance, end of year 4,826 5,267 As at December 31, 2022, the Company had approximately $2.3 million (January 1, 2022 - $1.6 million) in U.S. federal scientific research investment tax credits and $0.3 million (January 1, 2022 - $0.9 million) in U.S. state research and development tax credits, which will expire in varying amounts between 2023 and 2041. As at December 31, 2022, the Company had U.S. federal non-capital loss carryforwards of approximately $48.4 million (January 1, 2022 - $64.8 million). In addition, the Company had state loss carryforwards of approximately $3.0 million as at December 31, 2022 (January 1, 2022 - $3.3 million). These amounts are available to reduce future federal and state income taxes. As at December 31, 2022, the Company had Canadian capital losses of approximately $27.8 million (January 1, 2022 - $27.8 million) for which a full valuation allowance exists. These amounts are available to reduce future capital gains and do not expire. In addition, the Company had Canadian non-capital loss carryforwards of approximately $4.0 million (January 1, 2022 - $6.0 million). These amounts are available to reduce future taxable income and do not begin to expire until 2040. The Company records net deferred tax assets to the extent it believes these assets will more likely than not be realized. In making such determinations, the Company considers all available positive and negative evidence, including future reversals of existing temporary differences, projected future taxable income, tax planning strategies and recent financial operations. Based on this evaluation, as at December 31, 2022, a valuation allowance of $4.8 million (January 1, 2022 - $5.3 million) had been recorded against certain assets to reduce the net benefit recorded in the consolidated financial statements. As the undistributed earnings of the Company's non-Canadian affiliates and associated companies are considered to be indefinitely reinvested, no provision for deferred taxes has been provided thereon. For the years ended December 31, 2022, January 1, 2022 and January 2, 2021, the Company did not identify any material uncertain tax positions or recognize any related tax benefits. The Company believes it has adequately examined its tax positions taken or expected to be taken in a tax return; however, amounts asserted by taxing authorities could differ from the Company's positions. Accordingly, additional provisions on federal, provincial, state and foreign tax-related matters could be recorded in the future as revised estimates are made or the underlying matters are settled or otherwise resolved. Consistent with its historical financial reporting, the Company has classified interest and penalties related to income tax liabilities, when applicable, as part of interest expense in its consolidated statements of operations, and with the related liability on the consolidated balance sheets. The number of years with open tax audits varies depending on the tax jurisdiction. The Company's major taxing jurisdictions are the U.S. (including multiple states) and Canada (Ontario). The Company's 2019 through 2021 tax years (and any tax year for which available non-capital loss carryforwards were generated up to the amount of non-capital loss carryforward) remain subject to examination by the Internal Revenue Service for U.S. federal tax purposes, and tax years 2015 through 2021 remain subject to examination by the appropriate governmental agencies for Canadian federal tax purposes. There are other ongoing audits in various other jurisdictions that are not considered material to the Company's consolidated financial statements.

Earnings (Loss) Per Share

Earnings (Loss) Per Share	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Earnings (Loss) Per Share [Text Block]	17. Earnings (Loss) Per Share Basic and diluted earnings (loss) per share were calculated as follows (shares in thousands): December 31, 2022 January 1, 2022 January 2, 2021 Basic Earnings (Loss) Per Share Numerator for basic earnings (loss) per share: Loss from continuing operations $ (9,518 ) $ (1,172 ) $ (42,392 ) Less: dividends and accretion on preferred stock (3,109 ) (4,197 ) (10,328 ) Loss from continuing operations attributable to common shareholders (12,627 ) (5,369 ) (52,720 ) Earnings from discontinued operations 4,677 - 124,820 Earnings (loss) attributable to common shareholders $ (7,950 ) $ (5,369 ) $ 72,100 Denominator for basic earnings (loss) per share: Basic weighted-average number of shares outstanding 107,659 104,098 89,234 Basic earnings (loss) per share: Loss from continuing operations $ (0.12 ) $ (0.05 ) $ (0.59 ) Earnings from discontinued operations 0.04 - 1.40 Earnings (loss) attributable to common shareholders (1) $ (0.07 ) $ (0.05 ) $ 0.81 Diluted Earnings (Loss) Per Share Numerator for diluted earnings (loss) per share: Loss from continuing operations $ (9,518 ) $ (1,172 ) $ (42,392 ) Less: dividends and accretion on preferred stock (3,109 ) (4,197 ) (10,328 ) Loss from continuing operations attributable to common shareholders (12,627 ) (5,369 ) (52,720 ) Earnings from discontinued operations 4,677 - 124,820 Earnings (loss) attributable to common shareholders $ (7,950 ) $ (5,369 ) $ 72,100 Denominator for diluted earnings (loss) per share: Basic weighted-average number of shares outstanding 107,659 104,098 89,234 Dilutive effect of the following: Stock options and restricted stock units (2) - - - Series B-1 Preferred Stock (3) - - - Series A Preferred Stock (4) - - - Diluted weighted-average number of shares outstanding 107,659 104,098 89,234 Diluted earnings (loss) per share: Loss from continuing operations $ (0.12 ) $ (0.05 ) $ (0.59 ) Earnings from discontinued operations 0.04 - 1.40 Earnings (loss) attributable to common shareholders (1) $ (0.07 ) $ (0.05 ) $ 0.81 (1) (2) (3) (4) As described in note 12, on February 22, 2021, all shares of Series A Preferred Stock were exchanged for 12,633,427 Common Shares, representing 12.3% of the Company's issued and outstanding Common Shares on a post-exchange basis as at February 22, 2021. For the year ended January 2, 2021, it was more dilutive to the loss per share from continuing operations to assume the Series A Preferred Stock was not converted into Common Shares and, therefore, the numerator of the diluted loss per share calculation was not adjusted to add back the dividends and accretion on the Series A Preferred Stock and the denominator was not adjusted to include 12,633,427 issuable on an if-converted basis as at January 2, 2021.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	12 Months Ended
	Dec. 31, 2022
Supplemental Cash Flow Elements [Abstract]
Supplemental Cash Flow Information [Text Block]	18. Supplemental Cash Flow Information December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Changes in Operating Assets and Liabilities, Net of Sunflower Business Accounts receivable (2,304 ) (11,978 ) (746 ) Inventories (762 ) (72,030 ) 6,133 Accounts payable and accrued liabilities (3,403 ) 15,920 11,322 Other operating assets and liabilities 5,065 4,423 422 (1,404 ) (63,665 ) 17,131 Non-Cash Investing and Financing Activities Change in additions to property, plant and equipment included in accounts payable and accrued liabilities (4,256 ) 3,482 2,043 Proceeds receivable from sale of sunflower business 385 - - Change in accrued dividends on preferred stock - (1,769 ) 679 Dividends paid in kind on preferred stock - - 3,881 Change in accrued transaction costs related to the divestiture of Tradin Organic (1) - (13,380 ) 13,380 Change in accrued debt issuance costs - (1,690 ) 1,690 Cash Paid Interest 12,295 6,610 30,740 Income taxes 847 3,632 935 (1)

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions [Text Block]	19. Related Party Transactions The Company had no significant related party transactions for the years ended December 31, 2022 and January 1, 2022. For the year ended January 2, 2021, the Company purchased raw fruit, and fruit processing and freight services from companies related to the former Managing Director of the Company's Mexican operations, who left the Company in 2020. These transactions totaled $15.0 million and were included in costs of goods sold on the consolidated statement of operations for the year ended January 2, 2021.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies [Text Block]	20. Commitments and Contingencies Legal Proceedings Various current and potential claims and litigation arising in the ordinary course of business are pending against the Company. The Company believes it has established adequate accruals for liabilities that are probable and reasonably estimable that may be incurred in connection with any such currently pending matter. In the Company's opinion, the eventual resolution of such matters, either individually or in the aggregate, is not expected to have a material impact on the Company's financial position, results of operations, or cash flows. However, litigation is inherently unpredictable and resolutions or dispositions of claims or lawsuits by settlement or otherwise could have an adverse impact on the Company's financial position, results of operations, and cash flows for the reporting period in which any such resolution or disposition occurs. Arbitration Proceedings On January 31, 2022, Acomo submitted a Request for Summary Arbitral Proceedings to the Netherlands Arbitration Institute, which was later amended on February 16, 2022, asserting alleged claims against the Company and its subsidiaries, Coöperatie SunOpta U.A. and SunOpta Holdings LLC, relating to a dispute regarding the allocation of the purchase price Acomo paid to acquire the shares of The Organic Corporation B.V. and the membership interests of Tradin Organics USA LLC in connection with the closing of the transactions contemplated by the Master Purchase Agreement entered into by Acomo, the Company and the aforementioned subsidiaries on November 25, 2020 (the "Transaction"). On May 25, 2022, the parties entered into a definitive Settlement Agreement to resolve all outstanding matters related to the Master Purchase Agreement, which included a cash payment of $5.9 million from the Company to Acomo to settle certain post-closing adjustments related to the Transaction, following which the Request for Summary Arbitral Proceedings was withdrawn. Environmental Laws The Company believes that, with respect to both its operations and real property, it is in material compliance with current environmental laws. Based on known existing conditions and the Company's experience in complying with emerging environmental issues, the Company is of the view that future costs relating to environmental compliance will not have a material adverse effect on its consolidated financial position, but there can be no assurance that unforeseen changes in the laws or enforcement policies of relevant governmental bodies, the discovery of changed conditions on the Company's real property or in its operations, or changes in the use of such properties and any related site restoration requirements, will not result in the incurrence of significant costs. Finance Lease Commitments As at December 31, 2022, the Company had entered into finance lease agreements to provide for up to $55 million of financing related to the build-out of the Company's Midlothian, Texas, plant-based beverage facility. As the Company controls the right-of-use assets during the build-out construction, it recognizes costs incurred related to the build-out as construction in process in property, plant and equipment, with a finance lease liability recognized in long-term debt for the amount funded to date by the lessor, which amounted to $51.4 million as at December 31, 2022. In addition, as at December 31, 2022, the Company had additional commitments under various finance leases that provide for up to approximately $35 million of financing for various expansion projects underway within the Company's plant-based and fruit snacks operations, which are expected to become operational during 2023. As these finance leases had not commenced as at December 31, 2022, no amount of underlying right-of-use assets, or lease liabilities, were recognized on the consolidated balance sheet as of that date. Commitments for Plant Acquisition As at December 31, 2022, the Company had incurred approximately $55 million related to the purchase and installation of manufacturing equipment for its Midlothian, Texas, facility, and had remaining contractual commitments of approximately $10 million, which is expected to be incurred during 2023. These purchases are being principally financed through borrowings under the Term Loan Facility of the Company's Asset-Based Credit Facilities. Letters of Credit As at December 31, 2022, the Company had outstanding letters of credit totaling $5.4 million.

Segment Information

Segment Information	12 Months Ended
	Dec. 31, 2022
Segment Reporting [Abstract]
Segment Information [Text Block]	21. Segment Information The composition of the Company's operating and reportable segments is as follows: Plant-Based Foods and Beverages includes plant-based beverages and liquid and powder ingredients, utilizing oat, almond, soy, coconut, rice, hemp, and other bases, as well as broths, teas, and nutritional beverages. In addition, the sunflower business, which packaged dry- and oil-roasted inshell sunflower and sunflower kernels and processed raw sunflower inshell and kernel for food and feed applications, was part of this segment until it was sold on October 11, 2022 (see note 3). Fruit-Based Foods and Beverages includes individually quick frozen ("IQF") fruit for retail, including strawberries, blueberries, mango, pineapple, and other berries and blends, and IQF and bulk frozen fruit for foodservice, including toppings, purées, and smoothies. In addition, Fruit-Based Foods and Beverages includes fruit snacks, including bars, twists, ropes, and bite-sized varieties, and fruit smoothie bowls. Corporate Services provides a variety of management, financial, information technology, treasury, and administration services to each of the Company's operating segments. When reviewing the operating results of the Company's operating segments, management uses segment revenues from external customers and segment operating income/loss to assess performance and allocate resources. Total segment operating income/loss includes general and administrative expenses incurred by Corporate Services and excludes other income/expense items. In addition, interest on corporate debt and income taxes are not allocated to the operating segments. Segment Revenues and Operating Income Reportable segment operating results for the years ended December 31, 2022, January 1, 2022 and January 2, 2021 were as follows: December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Segment revenues from external customers Plant-Based Foods and Beverages 557,736 470,754 415,164 Fruit-Based Foods and Beverages 376,926 341,870 374,049 Total revenues from external customers 934,662 812,624 789,213 Segment operating income (loss) Plant-Based Foods and Beverages 38,491 36,616 50,780 Fruit-Based Foods and Beverages 6,919 (9,320 ) (7,321 ) Corporate Services (20,402 ) (17,237 ) (31,151 ) Total segment operating income 25,008 10,059 12,308 Other expense, net (see note 15) (22,132 ) (8,890 ) (23,393 ) Interest expense, net (see note 11) (14,734 ) (8,769 ) (30,042 ) Loss on retirement of debt (see note 11) - - (8,915 ) Loss from continuing operations before income taxes (11,858 ) (7,600 ) (50,042 ) Disaggregation of Revenue The following table presents a disaggregation of revenues by operating segment for the years ended December 31, 2022, January 1, 2022 and January 2, 2021, based on categories used by the Company to evaluate sales performance: December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Plant-Based Foods and Beverages Beverages and broths 462,132 376,525 332,390 Plant-based ingredients 37,680 31,135 28,156 Sunflower and roasted snacks (see note 3) 57,924 63,094 54,618 Total Plant-Based Foods and Beverages 557,736 470,754 415,164 Fruit-Based Foods and Beverages Frozen fruit and fruit-based ingredients 285,343 279,128 325,102 Fruit snacks and smoothie bowls 91,583 62,742 48,947 Total Fruit-Based Foods and Beverages 376,926 341,870 374,049 Total revenues 934,662 812,624 789,213 Segment Assets Total assets by reportable segment as at December 31, 2022 and January 1, 2022 were as follows: December 31, 2022 January 1, 2022 $ $ Segment Assets Plant-Based Foods and Beverages 384,507 300,700 Fruit-Based Foods and Beverages 347,678 368,976 Corporate Services 123,667 85,078 Total assets 855,852 754,754 Segment Capital Expenditures, Depreciation and Amortization Capital expenditures, depreciation and amortization by reportable segment for the years ended December 31, 2022, January 1, 2022 and January 2, 2021 were as follows: December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Segment Capital Expenditures Plant-Based Foods and Beverages 109,749 38,760 11,323 Fruit-Based Foods and Beverages 7,822 5,926 10,378 Corporate Services 11,055 13,611 3,053 Total capital expenditures 128,626 58,297 24,754 Segment Depreciation and Amortization Plant-Based Foods and Beverages 18,359 14,942 9,457 Fruit-Based Foods and Beverages 13,788 14,918 16,304 Corporate Services 5,526 4,781 4,547 Total depreciation and amortization 37,673 34,641 30,308 Geographic Information The Company's assets, operations, and employees are located in the U.S., Mexico, and Canada. Revenues from external customers are attributed to countries based on the location of the customer. Revenues from external customers by geographic area for the years ended December 31, 2022, January 1, 2022 and January 2, 2021 were as follows: December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Revenues from External Customers U.S. 883,160 772,333 752,000 Canada 10,625 14,067 12,481 Other 40,877 26,224 24,732 Total revenues from external customers 934,662 812,624 789,213 Long-lived assets consist of property, plant and equipment, net of accumulated depreciation, which are attributed to countries based on the physical location of the assets. Long-lived assets by geographic area as at December 31, 2022 and January 1, 2022 were as follows: December 31, 2022 January 1, 2022 $ $ Long-Lived Assets U.S. 303,406 203,318 Mexico 16,945 14,124 Canada 2,040 2,095 Total long-lived assets 322,391 219,537 Major Customers A customer of the Plant-Based Foods and Beverages operating segment accounted for approximately 19%, 18% and 16% of the Company's consolidated revenues for the years ended December 31, 2022, January 1, 2022 and January 2, 2021, respectively, and a customer of both the Fruit-Based and Plant-Based Foods and Beverages operating segments accounted for approximately 13%, 12% and 14% of consolidated revenues for the years ended December 31, 2022, January 1, 2022 and January 2, 2021, respectively. No other customer accounted for more than 10% of the Company's consolidated revenues.

Subsequent Event

Subsequent Event	12 Months Ended
	Dec. 31, 2022
Subsequent Events Abstract
Subsequent Event [Text Block]	22. Subsequent Event Exchange of Series B-1 Preferred Stock for Common Shares On February 28, 2023, the Company received written notice from Engaged Capital that they have exercised their right to exchange all of their shares of Series B-1 Preferred Stock into 6,089,331 Common Shares, together with a cash payment to adjust for fractional Common Shares, plus accrued and unpaid dividends as of the date of exchange. The Common Shares to be exchanged represent approximately 5.3% of the Company’s issued and outstanding Common Shares on a post-exchange basis. The exchange is expected to be completed on or about March 3, 2023. After the exchange, the exchange shares of Series B-1 Preferred Stock previously held by Engaged will be cancelled and SunOpta Foods will no longer be required to pay the 8.0% per annum dividend on those shares. In addition, in connection with the exchange of the Series B-1 Preferred Stock, all Special Shares, Series 2 held by Engaged Capital will be redeemed by the Company.

Quarterly Results of Operations

Quarterly Results of Operations (unaudited)	12 Months Ended
	Dec. 31, 2022
Quarterly Financial Information Disclosure [Abstract]
Quarterly Results of Operations (unaudited) [Text Block]	23. Quarterly Results of Operations (unaudited) As described in Note 1 - Significant Accounting Policies - Revision of Prior Period Financial Statements, the Company has corrected errors that effected the previously reported unaudited consolidated financial statements for the first three interim periods of fiscal 2022 and each of the four quarterly periods of fiscal 2021. The tables that follow present the unaudited consolidated results of operations of the Company for each of the quarters in the years ended effects of the revisions Fiscal 2022 Third Quarter Ended Fourth Quarter Ended As Previously Reported Adjustment As Revised As Reported Consolidated Statements of Operations $ $ $ $ Revenues 229,665 - 229,665 221,293 Cost of goods sold 198,282 - 198,282 193,076 Gross profit 31,383 - 31,383 28,217 Selling, general and administrative expenses 20,654 - 20,654 22,144 Intangible asset amortization 2,612 - 2,612 2,446 Other expense, net 20,200 - 20,200 105 Foreign exchange loss (gain) 473 - 473 (1,622 ) Earnings (loss) from continuing operations before the following (12,556 ) - (12,556 ) 5,144 Interest expense, net 4,342 - 4,342 4,730 Earnings (loss) from continuing operations before income taxes (16,898 ) - (16,898 ) 414 Income tax expense (benefit) (4,259 ) (705 ) (4,964 ) 1,285 Earnings (loss) from continuing operations (12,639 ) 705 (11,934 ) (871 ) Earnings from discontinued operations - - - 1,925 Net earnings (loss) (12,639 ) 705 (11,934 ) 1,054 Dividends and accretion on preferred stock (764 ) - (764 ) (830 ) Earnings (loss) attributable to common shareholders (13,403 ) 705 (12,698 ) 224 Basic and diluted earnings (loss) per share: Earnings (loss) from continuing operations (1) (0.12 ) 0.01 (0.12 ) (0.02 ) Earnings from discontinued operations - - - 0.02 Earnings (loss) attributable to common shareholders (1) (0.12 ) 0.01 (0.12 ) 0.00 (1) The sum across of individual per share amounts may not add due to rounding. Fiscal 2022 Third Quarter Ended October 1, 2022 Fourth Quarter Ended As Adjustment As Revised As Reported Consolidated Statements of Cash Flows $ $ $ $ Earnings (loss) from continuing operations (12,639 ) 705 (11,934 ) (871 ) Items not affecting cash: Deferred income taxes (2,925 ) (705 ) (3,630 ) (3,188 ) Changes in operating assets and liabilities 2,003 - 2,003 15,854 Net cash provided by operating activities of continuing operations 19,973 - 19,973 27,513 Fiscal 2022 First Quarter Ended April 2, 2022 Second Quarter Ended July 2, 2022 As Previously Reported Adjustment As Revised As Previously Reported Adjustment As Revised Consolidated Statements of Operations $ $ $ $ $ $ Revenues 240,173 - 240,173 243,531 - 243,531 Cost of goods sold 212,182 (365 ) 211,817 208,633 - 208,633 Gross profit 27,991 365 28,356 34,898 - 34,898 Selling, general and administrative expenses 21,935 275 22,210 24,304 - 24,304 Intangible asset amortization 2,612 - 2,612 2,612 - 2,612 Other expense, net 287 - 287 1,540 - 1,540 Foreign exchange gain (472 ) - (472 ) (127 ) - (127 ) Earnings from continuing operations before the following 3,629 90 3,719 6,569 - 6,569 Interest expense, net 2,530 - 2,530 3,132 - 3,132 Earnings from continuing operations before income taxes 1,099 90 1,189 3,437 - 3,437 Income tax expense (benefit) 445 (258 ) 187 939 213 1,152 Earnings from continuing operations 654 348 1,002 2,498 (213 ) 2,285 Earnings (loss) from discontinued operations 3,566 - 3,566 (814 ) - (814 ) Net earnings (loss) 4,220 348 4,568 1,684 (213 ) 1,471 Dividends and accretion on preferred stock (755 ) - (755 ) (760 ) - (760 ) Earnings (loss) attributable to common shareholders 3,465 348 3,813 924 (213 ) 711 Basic and diluted earnings (loss) per share: Earnings (loss) from continuing operations (1) (0.00 ) 0.00 0.00 0.02 (0.00 ) 0.01 Earnings (loss) from discontinued operations 0.03 - 0.03 (0.01 ) - (0.01 ) Earnings (loss) attributable to common shareholders (1) 0.03 0.00 0.04 0.01 (0.00 ) 0.01 (1) The sum across of individual per share amounts may not add due to rounding. Fiscal 2022 First Quarter Ended April 2, 2022 Second Quarter Ended July 2, 2022 As Previously Reported Adjustment As Revised As Previously Reported Adjustment As Revised Consolidated Statements of Cash Flows $ $ $ $ $ $ Earnings (loss) from continuing operations 654 348 1,002 2,498 (213 ) 2,285 Items not affecting cash: Deferred income taxes 80 (258 ) (178 ) 2,128 213 2,341 Changes in operating assets and liabilities 3,281 (90 ) 3,191 (22,452 ) - (22,452 ) Net cash provided by (used in) operating activities of continuing operations 15,543 - 15,543 (2,454 ) - (2,454 ) Fiscal 2021 Third Quarter Ended October 2, 2021 Fourth Quarter Ended January 1, 2022 As Previously Reported Adjustment As Revised As Previously Reported Adjustment As Revised Consolidated Statements of Operations $ $ $ $ $ $ Revenues 198,479 - 198,479 204,232 - 204,232 Cost of goods sold 175,123 - 175,123 185,828 365 186,193 Gross profit 23,356 - 23,356 18,404 (365 ) 18,039 Selling, general and administrative expenses 16,487 - 16,487 16,793 (275 ) 16,518 Intangible asset amortization 2,612 - 2,612 2,612 - 2,612 Other expense, net 1,172 - 1,172 1,442 - 1,442 Foreign exchange loss 336 - 336 579 - 579 Earnings (loss) before the following 2,749 - 2,749 (3,022 ) (90 ) (3,112 ) Interest expense, net 2,854 - 2,854 2,624 - 2,624 Loss before income taxes (105 ) - (105 ) (5,646 ) (90 ) (5,736 ) Income tax expense (benefit) 2,929 (125 ) 2,804 (3,782 ) 4,124 342 Net earnings (loss) (3,034 ) 125 (2,909 ) (1,864 ) (4,214 ) (6,078 ) Dividends and accretion on preferred stock (748 ) - (748 ) (752 ) - (752 ) Earnings (loss) attributable to common shareholders (3,782 ) 125 (3,657 ) (2,616 ) (4,214 ) (6,830 ) Basic and diluted earnings (loss) per share (1) (0.04 ) 0.00 (0.03 ) (0.02 ) (0.04 ) (0.06 ) (1) The sum across of individual per share amounts may not add due to rounding. Fiscal 2021 Third Quarter Ended October 2, 2021 Fourth Quarter Ended January 1, 2022 As Previously Reported Adjustment As Revised As Previously Reported Adjustment As Revised Consolidated Statements of Cash Flows $ $ $ $ $ $ Net earnings (loss) (3,034 ) 125 (2,909 ) (1,864 ) (4,214 ) (6,078 ) Items not affecting cash: Deferred income taxes 3,315 (125 ) 3,190 (2,744 ) 4,124 1,380 Changes in operating assets and liabilities (5,494 ) - (5,494 ) 13,717 90 13,807 Net cash provided by operating activities 5,065 - 5,065 19,665 - 19,665 Fiscal 2021 First Quarter Ended April 3, 2021 Second Quarter Ended July 3, 2021 As Previously Reported Adjustment As Revised As Previously Reported Adjustment As Revised Consolidated Statements of Operations $ $ $ $ $ $ Revenues 207,640 - 207,640 202,273 - 202,273 Cost of goods sold 177,651 - 177,651 175,937 - 175,937 Gross profit 29,989 - 29,989 26,336 - 26,336 Selling, general and administrative expenses 20,874 - 20,874 22,720 - 22,720 Intangible asset amortization 2,194 - 2,194 2,532 - 2,532 Other expense, net 1,615 - 1,615 4,661 - 4,661 Foreign exchange loss (gain) 836 - 836 (639 ) - (639 ) Earnings (loss) before the following 4,470 - 4,470 (2,938 ) - (2,938 ) Interest expense, net 1,660 - 1,660 1,631 - 1,631 Earnings (loss) before income taxes 2,810 - 2,810 (4,569 ) - (4,569 ) Income tax expense (benefit) 1,138 (612 ) 526 (3,651 ) (6,449 ) (10,100 ) Net earnings (loss) 1,672 612 2,284 (918 ) 6,449 5,531 Dividends and accretion on preferred stock (1,953 ) - (1,953 ) (744 ) - (744 ) Earnings (loss) attributable to common shareholders (281 ) 612 331 (1,662 ) 6,449 4,787 Basic and diluted earnings (loss) per share (1) (0.00 ) 0.01 0.00 (0.02 ) 0.06 0.05 (1) The sum across of individual per share amounts may not add due to rounding. Fiscal 2021 First Quarter Ended April 3, 2021 Second Quarter Ended July 3, 2021 As Previously Reported Adjustment As Revised As Previously Reported Adjustment As Revised Consolidated Statements of Cash Flows $ $ $ $ $ $ Net earnings (loss) 1,672 612 2,284 (918 ) 6,449 5,531 Items not affecting cash: Deferred income taxes 837 (612 ) 225 (4,331 ) (6,449 ) (10,780 ) Changes in operating assets and liabilities (21,656 ) - (21,656 ) (50,322 ) - (50,322 ) Net cash used in operating activities (7,015 ) - (7,015 ) (39,147 ) - (39,147 )

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation [Policy Text Block]	Basis of Presentation These consolidated financial statements include the accounts of SunOpta Inc. and those of its wholly-owned subsidiaries (collectively, the "Company" or "SunOpta") and have been prepared by the Company in United States ("U.S.") dollars and in accordance with U.S. generally accepted accounting principles ("U.S. GAAP"). All intercompany accounts and transactions have been eliminated on consolidation.
Fiscal Year [Policy Text Block]	Fiscal Year The fiscal year of the Company consists of a 52- or 53-week period ending on the Saturday closest to December 31. Fiscal years 2022 and 2021 were each 52-week periods ending on December 31, 2022 and January 1, 2022, respectively, and fiscal year 2020 was a 53-week period ending on January 2, 2021. Fiscal year 2023 will be a 52-week period ending on December 30, 2023, with quarterly periods ending on April 1, 2023, July 1, 2023, and September 30, 2023.
Revision of Prior Period Financial Statements [Policy Text Block]	Revision of Prior Period Financial Statements During the fourth quarter of 2022, in connection with the filing of the Company's 2021 tax returns, management identified certain misstatements in income taxes that affected the results for the years ended January 1, 2022 and January 2, 2021. In accordance with ASC 250 – Accounting Changes and Error Corrections and Staff Accounting Bulletins No. 99 – Materiality and No. 108 – Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements, management assessed the materiality of these errors individually and in the aggregate and concluded that the effect of recording all corrections in the fourth quarter of 2022 would materially misstate the financial statements for the year ended December 31, 2022. Management also concluded that the errors were not material to the previously issued financial statements for the years ended January 1, 2022 and January 2, 2021. As a result, the Company has corrected these errors by revising the consolidated financial statements and related disclosures included herein for those prior fiscal periods. The tables that follow present the effect of these revisions, as well as the effect of previously identified immaterial out-of-period adjustments related to income taxes, inventory, and over accrual of expenses on the consolidated statements of operations and cash flows for the years ended January 1, 2022 and January 2, 2021, and the consolidated balance sheet as at January 1, 2022. In addition, the opening accumulated deficit for the year ended January 2, 2021 decreased by $0.5 million. Year Ended January 1, 2022 Year Ended January 2, 2021 As Previously Reported Adjustment As Revised As Previously Reported Adjustment As Revised $ $ $ $ $ $ Consolidated Statements of Operations Revenues 812,624 - 812,624 789,213 - 789,213 Cost of goods sold 714,539 365 714,904 680,136 - 680,136 Gross profit 98,085 (365 ) 97,720 109,077 - 109,077 Selling, general and administrative expenses 76,874 (275 ) 76,599 89,463 - 89,463 Intangible amortization 9,950 - 9,950 8,946 - 8,946 Other expense, net 8,890 - 8,890 23,393 - 23,393 Foreign exchange loss (gain) 1,112 - 1,112 (1,640 ) - (1,640 ) Earnings (loss) from continuing operations before the following 1,259 (90 ) 1,169 (11,085 ) - (11,085 ) Interest expense, net 8,769 - 8,769 30,042 - 30,042 Loss on retirement of debt - - - 8,915 - 8,915 Loss from continuing operations before income taxes (7,510 ) (90 ) (7,600 ) (50,042 ) - (50,042 ) Income tax benefit (3,366 ) (3,062 ) (6,428 ) (2,740 ) (4,910 ) (7,650 ) Earnings (loss) from continuing operations (4,144 ) 2,972 (1,172 ) (47,302 ) 4,910 (42,392 ) Earnings from discontinued operations - - - 124,820 - 124,820 Net earnings (loss) (4,144 ) 2,972 (1,172 ) 77,518 4,910 82,428 Dividends and accretion on preferred stock (4,197 ) - (4,197 ) (10,328 ) - (10,328 ) Earnings (loss) attributable to common shareholders (8,341 ) 2,972 (5,369 ) 67,190 4,910 72,100 Basic and diluted earnings (loss) per share: Earnings (loss) from continuing operations operations (0.08 ) 0.03 (0.05 ) (0.65 ) 0.06 (0.59 ) Earnings from discontinued operations - - - 1.40 - 1.40 Earnings (loss) attributable to common shareholders (0.08 ) 0.03 (0.05 ) 0.75 0.06 0.81 As at January 1, 2022 As Previously Adjustment As Revised $ $ $ Consolidated Balance Sheet Inventories 220,143 (365 ) 219,778 Total current assets 329,969 (365 ) 329,604 Total assets 755,119 (365 ) 754,754 Accounts payable and accrued liabilities 121,430 (275 ) 121,155 Deferred income tax liability - long-term 22,485 (8,434 ) 14,051 Total liabilities 421,990 (8,709 ) 413,281 Accumulated deficit (156,082 ) 8,344 (147,738 ) Total shareholders' equity 304,984 8,344 313,328 Total liabilities and shareholders' equity 755,119 (365 ) 754,754 Year Ended January 1, 2022 Year Ended January 2, 2021 As Adjustment As Revised As Adjustment As Revised $ $ $ $ $ $ Consolidated Statements of Cash Flows Earnings (loss) from continuing operations (4,144 ) 2,972 (1,172 ) (47,302 ) 4,910 (42,392 ) Items not affecting cash: Deferred income taxes (2,923 ) (3,062 ) (5,985 ) 7,553 (4,910 ) 2,643 Changes in operating assets and liabilities (63,755 ) 90 (63,665 ) 17,131 - 17,131 Net cash provided by (used in) operating activities of continuing operations (21,432 ) - (21,432 ) 52,663 - 52,663
Use of estimates [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Areas involving significant estimates and assumptions include: allowances for credit losses; inventory reserves; income tax liabilities and assets, and related valuation allowances; provisions for loss contingencies related to claims and litigation; useful lives of property, plant and equipment and intangible assets; expected lease terms and discount rates in measuring lease assets and liabilities; expected future cash flows used in evaluating long-lived assets for impairment; and reporting unit fair values in testing goodwill for impairment. The estimates and assumptions made require judgment on the part of management and are based on the Company's historical experience and various other factors that are believed to be reasonable in the circumstances. Management continually evaluates the information that forms the basis of its estimates and assumptions as the business of the Company and the general business environment changes.
Fair Value [Policy Text Block]	Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (that is, an exit price). Fair value measurements are estimated based on inputs categorized as follows: • Level 1 inputs include quoted prices (unadjusted) for identical assets or liabilities in active markets that are observable. • Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means. • Level 3 includes unobservable inputs that reflect the Company's own assumptions about what factors market participants would use in pricing the asset or liability. When measuring fair value, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs.
Foreign Currency Translation [Policy Text Block]	Foreign Currency Translation Exchange gains and losses on transactions occurring in a currency other than an operation's functional currency are recognized in earnings. Foreign currency gains and losses related to the remeasurement of the Company's Mexican operations into its U.S. dollar functional currency are recognized in earnings.
Cash and Cash Equivalents [Policy Text Block]	Cash and Cash Equivalents Cash and cash equivalents consist of cash and short-term deposits with an original maturity of 90 days or less. The Company places its cash and cash equivalents with institutions of high creditworthiness.
Accounts Receivable [Policy Text Block]	A ccounts Receivable Accounts receivable includes trade receivables that are recorded at the invoiced amount and do not bear interest. The allowance for credit losses is an estimate of the amount of probable losses in existing accounts receivable. The Company routinely assesses the financial strength of its customers and believes that its accounts receivable credit risk exposure is limited. The Company closely monitors receivable balances and estimates an allowance for credit losses based on historical collection experience, and account aging analysis and trends, and evaluates the adequacy of the allowance each reporting period, considering individual customer account reviews, write-offs recorded in the period, sales forecasts and trends, and current and expected economic and customer-specific conditions. Account balances are charged off against the allowance when the Company determines the receivable will not be recovered. As at December 31, 2022, three long-term customers represented approximately 19%, 13% and 10%, respectively, of the Company's consolidated trade receivables balance. The Company does not believe it is exposed to any significant credit risks with respect to these customers.
Inventories [Policy Text Block]	Inventories Inventories are valued at the lower of cost and net realizable value on a first-in, first-out basis. Shipping and handling costs are included in cost of goods sold on the consolidated statements of operations.
Property, Plant and Equipment [Policy Text Block]	Property, Plant and Equipment Property, plant and equipment assets are stated at cost, less accumulated depreciation. Cost includes capitalized interest on borrowings during the construction of major capital projects. Depreciation begins when an asset is ready for its intended use. Property, plant and equipment assets, other than land, are depreciated on a straight-line basis over the estimated useful lives of the assets, as follows: Buildings 20 - 40 years Machinery and equipment 5 - 20 years Enterprise software 3 - 5 years Office furniture and equipment 3 - 7 years Vehicles 3 - 7 years
Leases [Policy Text Block]	Leases At the lease commencement date, the Company recognizes a right-of-use lease asset for an amount equal to the lease liability, less any lease incentives. The lease liability is determined based on the present value of future lease payments over the lease term. The lease term includes the noncancellable term of the lease, together with periods covered by options to extend the lease that the Company is reasonably certain to exercise. The discount rate used to determine the present value of the future lease payments is the implicit rate in the lease if readily determinable. When that rate is not readily determinable, the Company applies its incremental borrowing rate, which its estimated using relevant interest rate yield curves and credit spreads derived from available market data and the Company's corporate credit rating. The Company excludes material non-lease components in determining the future lease payments. Material leases with an initial term of 12 months or less are recorded on the balance sheet.
Intangible Assets [Policy Text Block]	Intangible Assets The Company's finite-lived intangible assets primarily consist of customer relationships and brand names. Intangible assets are amortized on a straight-line basis over their estimated useful lives, which are 10 to 25 years for customer relationships and 15 years for brand names.
Impairment of Long-Lived Assets [Policy Text Block]	Impairment of Long-Lived Assets The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. If the carrying amount of an asset is not recoverable, the fair value of the asset is determined typically using an income approach (discounted cash flow analysis). An impairment loss is recognized in earnings for any excess of the carrying amount of the asset over its fair value.
Goodwill [Policy Text Block]	Goodwill Goodwill represents the excess in a business combination of the purchase price over the estimated fair value of the identifiable net assets acquired. Goodwill is not amortized but is instead tested for impairment at the reporting unit level at least annually, or whenever events or circumstances change between the annual impairment tests that would indicate the carrying amount of goodwill may be impaired. The Company performs its annual test for goodwill impairment in the fourth quarter of each fiscal year. The Company can elect to qualitatively assess goodwill for impairment if it is more likely than not that the fair value of a reporting unit exceeds its carrying value. If the Company elects to quantitatively assess goodwill, or it is not more likely than not that the fair value of a reporting unit exceeds its carrying value, the Company estimates the fair value of each of its reporting units using an income approach (discounted cash flow method). Goodwill impairment charges are recognized based on the excess of a reporting unit's carrying amount over its fair value. The results of the Company's annual impairment tests for goodwill are described in note 9.
Derivative Instruments [Policy Text Block]	Derivative Instruments From time to time, the Company utilizes foreign currency forward contracts to manage its exposure to exchange rate fluctuations relating to foreign currency denominated inventory purchases and operating costs. Contracts are entered into for periods consistent with related underlying exposures and do not constitute positions independent of those exposures. The Company does not enter into contracts for speculative purposes. As at December 31, 2022 and January 1, 2022, the Company had no open foreign currency forward contracts. Foreign currency forward contracts are recognized on the consolidated balance sheets at fair value. Gains or losses in the fair value of foreign currency forward contracts not specifically designated as hedging instruments are included in foreign exchange gain/loss on the consolidated statements of operations. For contracts designated as accounting hedges, gains or losses in fair value are recognized in other comprehensive earnings and subsequently recognized in earnings in the same period the hedged item affects earnings. The ineffective portion of an accounting hedge is recognized immediately in earnings.
Debt Issuance Costs [Policy Text Block]	Debt Issuance Costs Costs incurred in connection with obtaining debt financing are deferred and amortized over the term of the financing arrangement using the effective interest method. Costs incurred to secure revolving credit facilities are recorded in other long-term assets. All other debt issuance costs are recorded as a direct deduction from the related debt liability.
Income Taxes [Policy Text Block]	Income Taxes The Company follows the asset and liability method of accounting for income taxes whereby deferred income tax assets are recognized for deductible temporary differences and operating loss carryforwards, and deferred income tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the amounts of assets and liabilities recorded for income tax and financial reporting purposes. Deferred income tax assets are recognized only to the extent that management determines that it is more likely than not that the deferred income tax assets will be realized. Deferred income tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The income tax expense or benefit is the income tax payable or recoverable for the year plus or minus the change in deferred income tax assets and liabilities during the year. The Company is subject to ongoing tax exposures, examinations and assessments in various jurisdictions. Accordingly, the Company may incur additional income tax expense based upon the outcomes of such matters. In addition, when applicable, the Company adjusts income tax expense to reflect the Company's ongoing assessments of such matters, which requires judgment and can materially increase or decrease its effective rate as well as impact operating results. The evaluation of tax positions taken or expected to be taken in a tax return is a two-step process, whereby (i) the Company determines whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position, and (ii) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the related tax authority.
Stock Incentive Plan [Policy Text Block]	Stock Incentive Plan The Company maintains a stock incentive plan under which stock options and other stock-based awards may be granted to selected employees and directors. The Company measures stock-based awards at fair value as of the date of grant. Compensation expense is recognized on a straight-line basis over vesting period of the entire stock-based award, based on the number of awards that ultimately vest. Upon exercise, stock-based awards are settled through the issuance of common shares and are therefore treated as equity awards.
Revenue Recognition [Policy Text Block]	Revenue Recognition The Company manufactures and sells plant-based and fruit-based food and beverage products to retailers, foodservice operators, branded food companies, and other food manufacturers. The Company recognizes revenue when performance obligations under the terms of a contract with a customer are satisfied, which is upon the transfer of control of the contracted goods. Except for goods sold under bill-and-hold arrangements, control is transferred when title and physical possession of the product transfers to the customer, which is at the point in time that product is shipped from the Company's facilities or delivered to a specified destination, depending on the terms of the contract, and the Company has a present right to payment. Under bill-and-hold arrangements, whereby the Company bills a customer for product to be delivered at a later date, control typically transfers when the product is ready for physical transfer to the customer, and the Company has a present right to payment. A performance obligation is a promise within a contract to transfer distinct goods to the customer. A contract with a customer may involve multiple products and/or multiple delivery dates, with the transfer of each product at each delivery date being considered a distinct performance obligation, as each of the Company's products has standalone utility to the customer. In these cases, the contract's transaction price is allocated to each performance obligation based on relative standalone selling prices and recognized as revenue when each individual product is transferred to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring the goods. Consideration is typically determined based on a fixed unit price for the quantity of product transferred. Certain contracts include rebates and other forms of variable consideration. For contracts involving variable consideration, the Company estimates the transaction price based on the amount of consideration to which it expects to be entitled. These estimates are determined based on historical experience and the expected outcome of the variable consideration, and are updated as new information becomes available, including actual claims paid, which indicate an estimate is not indicative of the expected results. Changes to these estimates are recorded in the period the adjustment is identified. The Company does not typically grant customers a general right of return for goods transferred but will generally accept returns of product for quality-related issues. The cost of satisfying this promise of quality is accounted for as an assurance-type warranty obligation rather than variable consideration. The Company's contracts do not typically include any significant payment terms, as payment is normally due shortly after the time of transfer. Revenue contracts are typically represented by short-term, binding purchase orders from customers, identifying the quantity and pricing for products to be transferred. Customer purchase orders may be issued under long-term master supply arrangements. On their own, these master supply arrangements are typically not considered contracts for purposes of revenue recognition, as they do not create enforceable rights and obligations regarding the quantity, pricing, or timing of goods to be transferred; however, certain master supply agreements impose minimum purchase obligations on the part of the customers, which is considered a form of variable consideration. Other master supply arrangements provide for the transfer of product on a bill-and-hold basis at the specific request of the customer. As goods are produced under these bill-and-hold arrangements to meet individual customer specifications, they are identifiable as belonging to the customer and cannot be directed to another customer. The timing of the Company's revenue recognition, customer billings and cash collections, does not result in significant unbilled receivables (contract assets) or customer advances (contract liabilities) on the consolidated balance sheet. Contract costs, such as sales commissions, are generally expensed as incurred given the short-term nature of the associated contracts.
Advertising Costs [Policy Text Block]	Advertising Costs Advertising costs are expensed as incurred and are included in selling, general and administrative expenses.
Research and Development Costs [Policy Text Block]	Research and Development Costs Research and development costs are expensed as incurred and are included in selling, general and administrative expenses. The Company's research and development activities are directed towards custom product formulations, packaging innovations, and production process improvements. The Company's research and development expenditures primarily consist of employee-related compensation and supplies, as well as rental costs and depreciation expense related to the Company's innovation center and pilot plant.
Earnings Per Share [Policy Text Block]	Earnings Per Share Basic earnings per share is computed by dividing earnings available to common shareholders by the weighted-average number of common shares outstanding during the year. Earnings attributable to common shareholders is computed by deducting dividends and accretion on convertible preferred stock from net earnings. The potential diluted effect of stock options and other stock-based awards is computed using the treasury stock method whereby the weighted-average number of common shares used in the basic earnings per share calculation is increased to include the number of additional common shares that would have been outstanding if the potential dilutive common shares had been issued at the beginning of the year. The potential dilutive effect of convertible preferred stock is computed using the if-converted method whereby dividends and accretion on the convertible preferred stock are added back to the numerator, and the common shares resulting from the assumed conversion of the convertible preferred stock are included in the denominator of the diluted earnings per share calculation.
Contingencies [Policy Text Block]	Contingencies In the normal course of business, the Company is subject to loss contingencies, such as accrued but unpaid bonuses, tax-related matters, and claims or litigation. Accruals for loss contingencies are recorded when the Company determines that it is both probable that a liability has been incurred and the amount of loss can be reasonably estimated. If the estimate of the amount of the loss is a range and some amount within the range appears to be a better estimate than any other amount within the range, that amount is accrued as a liability. If no amount within the range is a better estimate than any other amount, the minimum amount of the range is accrued as a liability.
Recent Accounting Pronouncement [Policy Text Block]	Recent Accounting Pronouncement In September 2022, the Financial Accounting Standards Board issued Accounting Standard Update 2022-04, Liabilities - Supplier Finance Programs (Topic 450-50): Disclosure of Supplier Finance Program Obligations, which requires entities that use supplier finance programs in connection with the purchase of goods and services to disclose the key terms of the programs and information about obligations outstanding at the end of the reporting period, including a roll forward of those obligations. The guidance does not affect the recognition, measurement, or financial statement presentation of supplier finance program obligations. The requirements to disclose the key terms of the programs and information about obligations outstanding are effective for all interim and annual periods beginning fiscal 2023, and the requirement to disclose a roll forward of obligations outstanding is effective beginning fiscal 2024. The Company is currently evaluating the impact that this new guidance will have on its consolidated financial statements.

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of consolidated statements of operations, balance sheet and cash flows [Table Text Block]	Year Ended January 1, 2022 Year Ended January 2, 2021 As Previously Reported Adjustment As Revised As Previously Reported Adjustment As Revised $ $ $ $ $ $ Consolidated Statements of Operations Revenues 812,624 - 812,624 789,213 - 789,213 Cost of goods sold 714,539 365 714,904 680,136 - 680,136 Gross profit 98,085 (365 ) 97,720 109,077 - 109,077 Selling, general and administrative expenses 76,874 (275 ) 76,599 89,463 - 89,463 Intangible amortization 9,950 - 9,950 8,946 - 8,946 Other expense, net 8,890 - 8,890 23,393 - 23,393 Foreign exchange loss (gain) 1,112 - 1,112 (1,640 ) - (1,640 ) Earnings (loss) from continuing operations before the following 1,259 (90 ) 1,169 (11,085 ) - (11,085 ) Interest expense, net 8,769 - 8,769 30,042 - 30,042 Loss on retirement of debt - - - 8,915 - 8,915 Loss from continuing operations before income taxes (7,510 ) (90 ) (7,600 ) (50,042 ) - (50,042 ) Income tax benefit (3,366 ) (3,062 ) (6,428 ) (2,740 ) (4,910 ) (7,650 ) Earnings (loss) from continuing operations (4,144 ) 2,972 (1,172 ) (47,302 ) 4,910 (42,392 ) Earnings from discontinued operations - - - 124,820 - 124,820 Net earnings (loss) (4,144 ) 2,972 (1,172 ) 77,518 4,910 82,428 Dividends and accretion on preferred stock (4,197 ) - (4,197 ) (10,328 ) - (10,328 ) Earnings (loss) attributable to common shareholders (8,341 ) 2,972 (5,369 ) 67,190 4,910 72,100 Basic and diluted earnings (loss) per share: Earnings (loss) from continuing operations operations (0.08 ) 0.03 (0.05 ) (0.65 ) 0.06 (0.59 ) Earnings from discontinued operations - - - 1.40 - 1.40 Earnings (loss) attributable to common shareholders (0.08 ) 0.03 (0.05 ) 0.75 0.06 0.81 As at January 1, 2022 As Previously Adjustment As Revised $ $ $ Consolidated Balance Sheet Inventories 220,143 (365 ) 219,778 Total current assets 329,969 (365 ) 329,604 Total assets 755,119 (365 ) 754,754 Accounts payable and accrued liabilities 121,430 (275 ) 121,155 Deferred income tax liability - long-term 22,485 (8,434 ) 14,051 Total liabilities 421,990 (8,709 ) 413,281 Accumulated deficit (156,082 ) 8,344 (147,738 ) Total shareholders' equity 304,984 8,344 313,328 Total liabilities and shareholders' equity 755,119 (365 ) 754,754 Year Ended January 1, 2022 Year Ended January 2, 2021 As Adjustment As Revised As Adjustment As Revised $ $ $ $ $ $ Consolidated Statements of Cash Flows Earnings (loss) from continuing operations (4,144 ) 2,972 (1,172 ) (47,302 ) 4,910 (42,392 ) Items not affecting cash: Deferred income taxes (2,923 ) (3,062 ) (5,985 ) 7,553 (4,910 ) 2,643 Changes in operating assets and liabilities (63,755 ) 90 (63,665 ) 17,131 - 17,131 Net cash provided by (used in) operating activities of continuing operations (21,432 ) - (21,432 ) 52,663 - 52,663
Schedule of useful life for property plant and equipment [Table Text Block]	Buildings 20 - 40 years Machinery and equipment 5 - 20 years Enterprise software 3 - 5 years Office furniture and equipment 3 - 7 years Vehicles 3 - 7 years

Discontinued Operations (Tables

Discontinued Operations (Tables)	12 Months Ended
	Dec. 31, 2022
Tradin Organic [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Schedule of discontinued operations to amounts reported in the consolidated statements of operations [Table Text Block]	December 31, 2022 January 2, 2021 $ $ Revenues - 503,036 Cost of goods sold - 441,277 Selling, general and administrative expenses (1) - 26,953 Intangible asset amortization - 1,451 Other income, net - (782 ) Foreign exchange loss - 3,142 Interest expense (2) - 2,409 Earnings before gain of sale - 28,586 Pre-tax gain (loss) on sale (8,241 ) 111,818 Earnings from discontinued operations before income taxes (8,241 ) 140,404 Income tax expense (benefit) (12,918 ) 15,885 Loss attributable to non-controlling interests - (301 ) Earnings from discontinued operations 4,677 124,820 (1) (2)

Sale of Sunflower Business (Tab

Sale of Sunflower Business (Tables) - Sunflower Business [Member]	12 Months Ended
	Dec. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Schedule of gain (loss) on sale [Table Text Block]	$ Cash consideration 16,000 Less: debt and working capital adjustments (6,620 ) Less: costs to sell (1,162 ) Net proceeds (1) 8,218 Accounts receivable 10,572 Inventories 13,493 Other current assets 105 Property, plant and equipment 10,328 Operating lease right-of-use assets 1,834 Intangible assets, net 2,512 Accounts payable and accrued liabilities (4,985 ) Operating lease liabilities (2,414 ) Net assets sold 31,445 Pre-tax loss on sale (23,227 ) (1)
Schedule of revenues and earnings (loss) included in the Company's consolidated results of operations [Table Text Block]	December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Revenues 57,924 63,094 54,618 Earnings (loss) before income taxes (1) 1,182 1,082 (5,689 ) (1)

Accounts Receivable (Tables)

Accounts Receivable (Tables)	12 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
Schedule of trade receivables [Table Text Block]	December 31, 2022 January 1, 2022 $ $ Trade receivables 75,102 85,591 Proceeds receivable from sale of sunflower business (see note 3) 385 - Allowance for credit losses (584 ) (889 ) 74,903 84,702
Schedule of allowance for doubtful accounts [Table Text Block]	December 31, 2022 January 1, 2022 $ $ Balance, beginning of year 889 1,257 Net addition (reduction) to provision 112 (368 ) Accounts receivable written off, net of recoveries (417 ) - Balance, end of year 584 889

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2022
Inventory Disclosure [Abstract]
Schedule of inventory, current [Table Text Block]	December 31, 2022 January 1, 2022 $ $ Raw materials and work-in-process 124,168 143,016 Finished goods 90,381 81,546 Inventory reserve (7,502 ) (4,784 ) 207,047 219,778
Schedule of inventory reserve [Table Text Block]	December 31, 2022 January 1, 2022 $ $ Balance, beginning of year 4,784 5,742 Additions to reserve during the year 10,779 5,854 Reserves applied and inventories written off during the year (8,061 ) (6,812 ) Balance, end of year 7,502 4,784

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	12 Months Ended
	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Schedule of property, plant and equipment [Table Text Block]	December 31, 2022 January 1, 2022 Cost Accumulated depreciation Net book value Cost Accumulated depreciation Net book value $ $ $ $ $ $ Land 2,433 - 2,433 6,963 - 6,963 Buildings 115,718 19,922 95,796 94,935 22,510 72,425 Machinery and equipment 314,065 99,923 214,142 236,779 107,319 129,460 Enterprise software 22,840 14,873 7,967 19,900 11,740 8,160 Office furniture and equipment 4,241 2,482 1,759 5,429 3,130 2,299 Vehicles 895 601 294 1,445 1,215 230 460,192 137,801 322,391 365,451 145,914 219,537

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2022
Leases [Abstract]
Schedule of lease costs [Table Text Block]	December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Lease Costs Operating lease cost 13,830 13,806 16,647 Finance lease cost: Depreciation of right-of-use assets 10,146 5,922 2,647 Interest on lease liabilities 5,147 2,752 675 Sublease income - (281 ) (504 ) Net lease cost 29,123 22,199 19,465
Schedule of Balance Sheet Classification, Cash Flow Information, Other Information [Table Text Block]	December 31, 2022 January 1, 2022 $ $ Balance Sheet Classification Operating leases: Operating lease right-of-use assets 82,564 47,245 Current portion of operating lease liabilities 13,074 12,203 Operating lease liabilities 77,557 39,028 Total operating lease liabilities 90,631 51,231 Finance leases: Property, plant and equipment, gross 157,801 66,060 Accumulated depreciation (20,494 ) (10,348 ) Property, plant and equipment, net 137,307 55,712 Current portion of long-term debt 33,283 9,760 Long-term debt 90,796 43,034 Total finance lease liabilities 124,079 52,794 December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Cash Flow Information Cash paid (received) for amounts included in measurement of lease liabilities: Operating cash flows from operating leases 13,051 13,391 16,741 Operating cash flows from finance leases 5,147 2,752 675 Financing cash flows from finance leases Cash paid under finance leases (1) 20,457 8,798 2,587 Cash received under finance leases (2) (58,764 ) (13,626 ) - Right-of-use assets obtained in exchange for lease liabilities: Operating leases 49,818 29,015 5,962 Finance leases 32,977 29,906 5,179 Right-of-use assets and liabilities reduced through lease terminations or modifications: Operating leases (4,060 ) (2,261 ) (23,667 ) Finance leases - (686 ) - Impairment of operating lease right-of-use assets - - (1,538 ) (1) (2) December 31, 2022 January 1, 2022 January 2, 2021 Other Information Weighted-average remaining lease term (years): Operating leases 12.8 7.4 3.4 Finance leases 3.5 4.3 5.3 Weighted-average discount rate: Operating leases 8.7% 5.0% 6.6% Finance leases 8.2% 6.6% 5.4%
Schedule of lease liabilities maturities [Table Text Block]	Operating leases Finance leases $ $ Maturities of Lease Liabilities 2023 12,805 40,336 2024 12,461 41,643 2025 11,678 36,863 2026 10,754 23,838 2027 9,727 3,567 Thereafter 152,740 - Total lease payments 210,165 146,247 Less: imputed interest (119,534 ) (22,168 ) Total lease liabilities 90,631 124,079

Intangible Assets (Tables)

Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]	December 31, 2022 January 1, 2022 Cost Accumulated Net book Cost Accumulated Net book $ $ $ $ $ $ Customer relationships 177,996 64,578 113,418 189,407 64,867 124,540 Brand names 25,073 2,845 22,228 25,073 1,173 23,900 Other 746 746 - 1,919 1,919 - 203,815 68,169 135,646 216,399 67,959 148,440
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	2023 2024 2025 2026 2027 Thereafter Total $ $ $ $ $ $ $ Amortization expense 9,784 9,784 9,784 9,784 9,784 86,726 135,646

Accounts Payable and Accrued _2

Accounts Payable and Accrued Liabilities (Tables)	12 Months Ended
	Dec. 31, 2022
Payables and Accruals [Abstract]
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	December 31, 2022 January 1, 2022 $ $ Accounts payable 88,178 105,386 Payroll and benefits 13,914 8,861 Accrued interest 1,685 846 Dividends payable on preferred stock (see note 12) 609 609 Other accruals 4,125 5,453 108,511 121,155

Long-Term Debt (Tables)

Long-Term Debt (Tables)	12 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Schedule of Line of Credit Facilities [Table Text Block]	December 31, 2022 January 1, 2022 $ $ Asset-based credit facilities: Revolving credit facilities 137,253 153,293 Term loan facility 43,748 11,606 Total asset-based credit facilities 181,001 164,899 Finance lease liabilities (see note 7) 124,079 52,794 Other 3,404 6,910 Total debt 308,484 224,603 Less: current portion 38,491 9,760 Total long-term debt 269,993 214,843
Schedule of Maturities of Long-term Debt [Table Text Block]	$ 2023 45,544 2024 47,893 2025 206,407 2026 26,801 2027 4,007 Total gross maturities 330,652 Less: imputed interest (22,168 ) Total debt 308,484
Schedule of Interest Expense and Interest Income [Table Text Block]	December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Interest expense, net of capitalized interest (see note 6) 13,480 7,685 26,816 Amortization of debt issuance costs 1,601 1,353 4,078 Interest income (347 ) (269 ) (852 ) Interest expense, net 14,734 8,769 30,042

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of allocation of share-based compensation expense [Table Text Block]	December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Selling, general and administrative expenses 13,830 9,100 12,570 Other income (1) - - (894 ) Earnings from discontinued operations (2) - - 540 Total stock-based compensation expense 13,830 9,100 12,216
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of stock option activity [Table Text Block]	Weighted- average Weighted- remaining average contractual Aggregate Stock options exercise price term (years) intrinsic value Outstanding, beginning of year 2,281,621 $ 5.29 Granted 1,800,007 5.91 Exercised (69,457 ) 6.18 Forfeited (61,307 ) 8.12 Expired (30,264 ) 5.96 Outstanding, end of year 3,920,600 $ 5.51 7.5 $ 12,734 Exercisable, end of year 1,954,761 $ 4.79 5.9 $ 7,845 Weighted- average grant- Stock options date fair value Non-vested, beginning of year 1,615,633 $ 2.28 Granted 1,800,007 3.49 Vested (1,405,905 ) 4.01 Forfeited (43,896 ) 1.89 Non-vested, end of year 1,965,839 $ 3.63
Schedule of stock options granted using the Black-Scholes option pricing model [Table Text Block]	December 31, 2022 January 1, 2022 January 2, 2021 Grant-date stock price $ 5.91 $ 14.77 $ 4.64 Dividend yield (a) 0% 0% 0% Expected volatility (b) 61.6% 61.7% 60.0% Risk-free interest rate (c) 3.0% 1.0% 0.4% Expected life of options (years) (d) 6.0 6.0 6.0
Share-based Compensation Arrangements by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]	Weighted- average remaining Weighted- Weighted- Exercise price range Outstanding contractual life average exercise Exercisable average exercise Low High options (years) price options price $ 2.38 $ 3.32 332,792 6.3 $ 2.57 332,792 $ 2.57 3.33 3.73 960,061 6.3 3.36 960,061 3.36 3.74 5.59 353,387 7.2 4.76 245,703 4.78 5.60 6.28 1,780,431 9.3 5.91 5,793 5.91 6.29 14.77 493,929 4.6 10.74 410,412 9.92 3,920,600 7.5 $ 5.51 1,954,761 $ 4.79
Restricted stock units ("RSUs") [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]	The following table summarizes non-vested RSU activity during the year ended December 31, 2022: Weighted- average grant- RSUs date fair value Non-vested, beginning of year 815,247 $ 6.39 Granted 466,945 6.40 Vested (549,754 ) 5.40 Forfeited (72,789 ) 7.11 Non-vested, end of year 659,649 $ 7.14
Performance Share Unit ("PSUs") [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of stock options granted using the Black-Scholes option pricing model [Table Text Block]	December 31, 2022 January 1, 2022 Grant-date stock price $ 5.91 $ 14.77 Dividend yield 0% 0% Expected volatility (a) 67.8% 76.9% Risk-free interest rate (b) 2.8% 0.3% Expected life (in years) (c) 2.7 2.7 (a) (b) (c)
Schedule of non-vested PSU activity [Table Text Block]	The following table summarizes non-vested EBITDA PSU activity during the year ended December 31, 2022: Weighted- average grant- EBITDA PSUs date fair value Non-vested, beginning of year 1,380,955 $ 7.62 Granted 1,846,196 5.45 Vested (58,235 ) 4.91 Cancelled or forfeited (813,485 ) 11.05 Non-vested, end of year 2,355,431 $ 4.80
Total Shareholder Return Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of stock options granted using the Black-Scholes option pricing model [Table Text Block]	Weighted- average grant- TSR PSUs date fair value Non-vested, beginning of year 71,346 $ 23.40 Granted 547,071 8.48 Vested - - Forfeited (23,544 ) 13.40 Non-vested, end of year 594,873 $ 10.07

Other Expense (Income), Net (Ta

Other Expense (Income), Net (Tables)	12 Months Ended
	Dec. 31, 2022
Other Income and Expenses [Abstract]
Schedule of Other Nonoperating Income (Expense) [Table Text Block]	December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Loss on sale of sunflower business (see note 3) 23,227 - - Gain on sale of frozen fruit processing facility (1) (3,779 ) - - Long-lived asset impairments and facility closure costs (2) 1,812 6,298 9,045 Employee termination and recruitment costs (3) - 1,628 1,881 Divestiture costs (4) - 703 - Loss on foreign currency forward contract (see note 2) - - 12,658 Other 872 261 (191 ) 22,132 8,890 23,393 (1) Gain on sale of frozen fruit processing facility For the year ended December 31, 2022, the Company recognized a $3.8 million pre-tax gain on the sale of its frozen fruit processing facility located in Oxnard, California. Net cash proceeds on the sale were $16.1 million. (2) Long-lived asset impairments and facility closure costs For the year ended December 31, 2022, expense primarily relates to the relocation of certain equipment from the Company's sold Oxnard facility. For the year ended January 1, 2022, expenses include asset impairment charges and asset relocation costs of $3.8 million related to the closure of the Company's South Gate, California, fruit ingredient processing facility in July 2021, and costs of $1.4 million to complete the exit from the Company's Santa Maria, California, frozen fruit processing facility in February 2021, together with costs of $0.8 million related to the relocation of the Company's executive office and innovation center into Eden Prairie, Minnesota, and the related vacating of the Company's former leased facility in December 2021, and other asset impairments of $0.3 million. For the year ended January 2, 2021, expenses include costs of $6.3 million related to the Company's exit from its Santa Maria facility and the consolidation of the Company's corporate offices into Minnesota, together with the write-down of $2.7 million of operating lease right-of-use and owned assets related to the roasting operations of the sunflower business. (3) Employee termination and recruitment costs For the year ended January 1, 2022, expense represents severance benefits of $1.1 million for 55 employees impacted by the closure of the South Gate facility, and $0.5 million of severance benefits for 19 employees following a workforce reduction in the Company's frozen fruit operations. For the year ended January 2, 2021, expense represents severance benefits of $2.8 million mainly related to employees impacted by the exit from the Company's Santa Maria facility, offset by the reversal of $0.9 million of previously recognized stock-based compensation expense related to forfeited awards previously granted to terminated employees. (4) Divestiture costs For the year ended January 1, 2022, expense relates to professional fees incurred in connection with post-closing matters related to the divestiture of Tradin Organic.

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Schedule of components of income tax expense (benefit) [Table Text Block]	December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Loss from continuing operations before income taxes (11,858 ) (7,600 ) (50,042 ) Canadian statutory rate 26.5% 26.5% 26.5% Income tax benefit at statutory rate (3,142 ) (2,014 ) (13,261 ) Stock-based compensation 978 (4,796 ) 2,159 Disallowed executive compensation 374 138 2,801 Foreign tax rate differential 76 (31 ) (105 ) Excess tax benefits related to stock-based compensation Change in valuation allowance (471 ) 975 560 Change in enacted tax rates (340 ) (442 ) 250 CARES Act - - 2,472 Change in valuation of state deferred tax assets - - (3,900 ) Other 185 (258 ) 1,374 Income tax benefit (2,340 ) (6,428 ) (7,650 ) December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Canada (11,181 ) (10,797 ) (14,700 ) U.S. (2,506 ) 3,855 (34,521 ) Other 1,829 (658 ) (821 ) Loss from continuing operations before income taxes (11,858 ) (7,600 ) (50,042 ) December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Current income tax expense (benefit): Canada 84 (9 ) (154 ) U.S. (55 ) (75 ) (14,148 ) Other 2,438 (359 ) 589 2,467 (443 ) (13,713 ) Deferred income tax expense (benefit): Canada - 299 (291 ) U.S. (4,672 ) (6,129 ) 5,532 Other (135 ) (155 ) 822 (4,807 ) (5,985 ) 6,063 Income tax benefit (2,340 ) (6,428 ) (7,650 )
Schedule of deferred tax assets and liabilities [Table Text Block]	December 31, 2022 January 1, 2022 $ $ Differences in property, plant and equipment and intangible assets (28,088 ) (54,761 ) Capital and non-capital losses 17,335 26,751 Interest expense limitation (163j) 9,464 13,064 Tax benefit of scientific research expenditures 2,866 2,744 Stock-based compensation 2,160 680 Inventory basis differences 1,805 1,148 Right-of-use lease assets (23,071 ) (13,224 ) Lease liabilities 23,609 13,346 Other accrued reserves 2,458 1,468 8,538 (8,784 ) Less: valuation allowance 4,826 5,267 Deferred income tax asset (liability) 3,712 (14,051 )
Schedule of deferred tax assets and liabilities by geographic segment [Table Text Block]	December 31, 2022 January 1, 2022 $ $ Canada (325 ) (325 ) U.S. 3,978 (13,649 ) Other 59 (77 ) Deferred income tax asset (liability) 3,712 (14,051 )
Schedule of deferred income tax valuation allowance [Table Text Block]	December 31, 2022 January 1, 2022 $ $ Balance, beginning of year 5,267 4,284 Increase (decrease) in valuation allowance (441 ) 983 Balance, end of year 4,826 5,267

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	December 31, 2022 January 1, 2022 January 2, 2021 Basic Earnings (Loss) Per Share Numerator for basic earnings (loss) per share: Loss from continuing operations $ (9,518 ) $ (1,172 ) $ (42,392 ) Less: dividends and accretion on preferred stock (3,109 ) (4,197 ) (10,328 ) Loss from continuing operations attributable to common shareholders (12,627 ) (5,369 ) (52,720 ) Earnings from discontinued operations 4,677 - 124,820 Earnings (loss) attributable to common shareholders $ (7,950 ) $ (5,369 ) $ 72,100 Denominator for basic earnings (loss) per share: Basic weighted-average number of shares outstanding 107,659 104,098 89,234 Basic earnings (loss) per share: Loss from continuing operations $ (0.12 ) $ (0.05 ) $ (0.59 ) Earnings from discontinued operations 0.04 - 1.40 Earnings (loss) attributable to common shareholders (1) $ (0.07 ) $ (0.05 ) $ 0.81 Diluted Earnings (Loss) Per Share Numerator for diluted earnings (loss) per share: Loss from continuing operations $ (9,518 ) $ (1,172 ) $ (42,392 ) Less: dividends and accretion on preferred stock (3,109 ) (4,197 ) (10,328 ) Loss from continuing operations attributable to common shareholders (12,627 ) (5,369 ) (52,720 ) Earnings from discontinued operations 4,677 - 124,820 Earnings (loss) attributable to common shareholders $ (7,950 ) $ (5,369 ) $ 72,100 Denominator for diluted earnings (loss) per share: Basic weighted-average number of shares outstanding 107,659 104,098 89,234 Dilutive effect of the following: Stock options and restricted stock units (2) - - - Series B-1 Preferred Stock (3) - - - Series A Preferred Stock (4) - - - Diluted weighted-average number of shares outstanding 107,659 104,098 89,234 Diluted earnings (loss) per share: Loss from continuing operations $ (0.12 ) $ (0.05 ) $ (0.59 ) Earnings from discontinued operations 0.04 - 1.40 Earnings (loss) attributable to common shareholders (1) $ (0.07 ) $ (0.05 ) $ 0.81

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information (Tables)	12 Months Ended
	Dec. 31, 2022
Supplemental Cash Flow Elements [Abstract]
Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]	December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Changes in Operating Assets and Liabilities, Net of Sunflower Business Accounts receivable (2,304 ) (11,978 ) (746 ) Inventories (762 ) (72,030 ) 6,133 Accounts payable and accrued liabilities (3,403 ) 15,920 11,322 Other operating assets and liabilities 5,065 4,423 422 (1,404 ) (63,665 ) 17,131 Non-Cash Investing and Financing Activities Change in additions to property, plant and equipment included in accounts payable and accrued liabilities (4,256 ) 3,482 2,043 Proceeds receivable from sale of sunflower business 385 - - Change in accrued dividends on preferred stock - (1,769 ) 679 Dividends paid in kind on preferred stock - - 3,881 Change in accrued transaction costs related to the divestiture of Tradin Organic (1) - (13,380 ) 13,380 Change in accrued debt issuance costs - (1,690 ) 1,690 Cash Paid Interest 12,295 6,610 30,740 Income taxes 847 3,632 935

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2022
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Segment revenues from external customers Plant-Based Foods and Beverages 557,736 470,754 415,164 Fruit-Based Foods and Beverages 376,926 341,870 374,049 Total revenues from external customers 934,662 812,624 789,213 Segment operating income (loss) Plant-Based Foods and Beverages 38,491 36,616 50,780 Fruit-Based Foods and Beverages 6,919 (9,320 ) (7,321 ) Corporate Services (20,402 ) (17,237 ) (31,151 ) Total segment operating income 25,008 10,059 12,308 Other expense, net (see note 15) (22,132 ) (8,890 ) (23,393 ) Interest expense, net (see note 11) (14,734 ) (8,769 ) (30,042 ) Loss on retirement of debt (see note 11) - - (8,915 ) Loss from continuing operations before income taxes (11,858 ) (7,600 ) (50,042 )
Schedule of disaggregation of revenue [Table Text Block]	December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Plant-Based Foods and Beverages Beverages and broths 462,132 376,525 332,390 Plant-based ingredients 37,680 31,135 28,156 Sunflower and roasted snacks (see note 3) 57,924 63,094 54,618 Total Plant-Based Foods and Beverages 557,736 470,754 415,164 Fruit-Based Foods and Beverages Frozen fruit and fruit-based ingredients 285,343 279,128 325,102 Fruit snacks and smoothie bowls 91,583 62,742 48,947 Total Fruit-Based Foods and Beverages 376,926 341,870 374,049 Total revenues 934,662 812,624 789,213
Schedule of Assets from Segment to Consolidated [Table Text Block]	December 31, 2022 January 1, 2022 $ $ Segment Assets Plant-Based Foods and Beverages 384,507 300,700 Fruit-Based Foods and Beverages 347,678 368,976 Corporate Services 123,667 85,078 Total assets 855,852 754,754
Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]	December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Segment Capital Expenditures Plant-Based Foods and Beverages 109,749 38,760 11,323 Fruit-Based Foods and Beverages 7,822 5,926 10,378 Corporate Services 11,055 13,611 3,053 Total capital expenditures 128,626 58,297 24,754 Segment Depreciation and Amortization Plant-Based Foods and Beverages 18,359 14,942 9,457 Fruit-Based Foods and Beverages 13,788 14,918 16,304 Corporate Services 5,526 4,781 4,547 Total depreciation and amortization 37,673 34,641 30,308
Schedule of Segment Revenue from External Customers by Segment [Table Text Block]	December 31, 2022 January 1, 2022 January 2, 2021 $ $ $ Revenues from External Customers U.S. 883,160 772,333 752,000 Canada 10,625 14,067 12,481 Other 40,877 26,224 24,732 Total revenues from external customers 934,662 812,624 789,213
Schedule of Segment Long-lived Assets by Geographic Areas [Table Text Block]	December 31, 2022 January 1, 2022 $ $ Long-Lived Assets U.S. 303,406 203,318 Mexico 16,945 14,124 Canada 2,040 2,095 Total long-lived assets 322,391 219,537

Quarterly Results of Operatio_2

Quarterly Results of Operations (unaudited) (Tables)	12 Months Ended
	Dec. 31, 2022
Quarterly Financial Information Disclosure [Abstract]
Schedule of quarterly financial information [Table Text Block]	Fiscal 2022 Third Quarter Ended Fourth Quarter Ended As Previously Reported Adjustment As Revised As Reported Consolidated Statements of Operations $ $ $ $ Revenues 229,665 - 229,665 221,293 Cost of goods sold 198,282 - 198,282 193,076 Gross profit 31,383 - 31,383 28,217 Selling, general and administrative expenses 20,654 - 20,654 22,144 Intangible asset amortization 2,612 - 2,612 2,446 Other expense, net 20,200 - 20,200 105 Foreign exchange loss (gain) 473 - 473 (1,622 ) Earnings (loss) from continuing operations before the following (12,556 ) - (12,556 ) 5,144 Interest expense, net 4,342 - 4,342 4,730 Earnings (loss) from continuing operations before income taxes (16,898 ) - (16,898 ) 414 Income tax expense (benefit) (4,259 ) (705 ) (4,964 ) 1,285 Earnings (loss) from continuing operations (12,639 ) 705 (11,934 ) (871 ) Earnings from discontinued operations - - - 1,925 Net earnings (loss) (12,639 ) 705 (11,934 ) 1,054 Dividends and accretion on preferred stock (764 ) - (764 ) (830 ) Earnings (loss) attributable to common shareholders (13,403 ) 705 (12,698 ) 224 Basic and diluted earnings (loss) per share: Earnings (loss) from continuing operations (1) (0.12 ) 0.01 (0.12 ) (0.02 ) Earnings from discontinued operations - - - 0.02 Earnings (loss) attributable to common shareholders (1) (0.12 ) 0.01 (0.12 ) 0.00 (1) The sum across of individual per share amounts may not add due to rounding. Fiscal 2022 Third Quarter Ended October 1, 2022 Fourth Quarter Ended As Adjustment As Revised As Reported Consolidated Statements of Cash Flows $ $ $ $ Earnings (loss) from continuing operations (12,639 ) 705 (11,934 ) (871 ) Items not affecting cash: Deferred income taxes (2,925 ) (705 ) (3,630 ) (3,188 ) Changes in operating assets and liabilities 2,003 - 2,003 15,854 Net cash provided by operating activities of continuing operations 19,973 - 19,973 27,513 Fiscal 2022 First Quarter Ended April 2, 2022 Second Quarter Ended July 2, 2022 As Previously Reported Adjustment As Revised As Previously Reported Adjustment As Revised Consolidated Statements of Operations $ $ $ $ $ $ Revenues 240,173 - 240,173 243,531 - 243,531 Cost of goods sold 212,182 (365 ) 211,817 208,633 - 208,633 Gross profit 27,991 365 28,356 34,898 - 34,898 Selling, general and administrative expenses 21,935 275 22,210 24,304 - 24,304 Intangible asset amortization 2,612 - 2,612 2,612 - 2,612 Other expense, net 287 - 287 1,540 - 1,540 Foreign exchange gain (472 ) - (472 ) (127 ) - (127 ) Earnings from continuing operations before the following 3,629 90 3,719 6,569 - 6,569 Interest expense, net 2,530 - 2,530 3,132 - 3,132 Earnings from continuing operations before income taxes 1,099 90 1,189 3,437 - 3,437 Income tax expense (benefit) 445 (258 ) 187 939 213 1,152 Earnings from continuing operations 654 348 1,002 2,498 (213 ) 2,285 Earnings (loss) from discontinued operations 3,566 - 3,566 (814 ) - (814 ) Net earnings (loss) 4,220 348 4,568 1,684 (213 ) 1,471 Dividends and accretion on preferred stock (755 ) - (755 ) (760 ) - (760 ) Earnings (loss) attributable to common shareholders 3,465 348 3,813 924 (213 ) 711 Basic and diluted earnings (loss) per share: Earnings (loss) from continuing operations (1) (0.00 ) 0.00 0.00 0.02 (0.00 ) 0.01 Earnings (loss) from discontinued operations 0.03 - 0.03 (0.01 ) - (0.01 ) Earnings (loss) attributable to common shareholders (1) 0.03 0.00 0.04 0.01 (0.00 ) 0.01 (1) The sum across of individual per share amounts may not add due to rounding. Fiscal 2022 First Quarter Ended April 2, 2022 Second Quarter Ended July 2, 2022 As Previously Reported Adjustment As Revised As Previously Reported Adjustment As Revised Consolidated Statements of Cash Flows $ $ $ $ $ $ Earnings (loss) from continuing operations 654 348 1,002 2,498 (213 ) 2,285 Items not affecting cash: Deferred income taxes 80 (258 ) (178 ) 2,128 213 2,341 Changes in operating assets and liabilities 3,281 (90 ) 3,191 (22,452 ) - (22,452 ) Net cash provided by (used in) operating activities of continuing operations 15,543 - 15,543 (2,454 ) - (2,454 ) Fiscal 2021 Third Quarter Ended October 2, 2021 Fourth Quarter Ended January 1, 2022 As Previously Reported Adjustment As Revised As Previously Reported Adjustment As Revised Consolidated Statements of Operations $ $ $ $ $ $ Revenues 198,479 - 198,479 204,232 - 204,232 Cost of goods sold 175,123 - 175,123 185,828 365 186,193 Gross profit 23,356 - 23,356 18,404 (365 ) 18,039 Selling, general and administrative expenses 16,487 - 16,487 16,793 (275 ) 16,518 Intangible asset amortization 2,612 - 2,612 2,612 - 2,612 Other expense, net 1,172 - 1,172 1,442 - 1,442 Foreign exchange loss 336 - 336 579 - 579 Earnings (loss) before the following 2,749 - 2,749 (3,022 ) (90 ) (3,112 ) Interest expense, net 2,854 - 2,854 2,624 - 2,624 Loss before income taxes (105 ) - (105 ) (5,646 ) (90 ) (5,736 ) Income tax expense (benefit) 2,929 (125 ) 2,804 (3,782 ) 4,124 342 Net earnings (loss) (3,034 ) 125 (2,909 ) (1,864 ) (4,214 ) (6,078 ) Dividends and accretion on preferred stock (748 ) - (748 ) (752 ) - (752 ) Earnings (loss) attributable to common shareholders (3,782 ) 125 (3,657 ) (2,616 ) (4,214 ) (6,830 ) Basic and diluted earnings (loss) per share (1) (0.04 ) 0.00 (0.03 ) (0.02 ) (0.04 ) (0.06 ) (1) The sum across of individual per share amounts may not add due to rounding. Fiscal 2021 Third Quarter Ended October 2, 2021 Fourth Quarter Ended January 1, 2022 As Previously Reported Adjustment As Revised As Previously Reported Adjustment As Revised Consolidated Statements of Cash Flows $ $ $ $ $ $ Net earnings (loss) (3,034 ) 125 (2,909 ) (1,864 ) (4,214 ) (6,078 ) Items not affecting cash: Deferred income taxes 3,315 (125 ) 3,190 (2,744 ) 4,124 1,380 Changes in operating assets and liabilities (5,494 ) - (5,494 ) 13,717 90 13,807 Net cash provided by operating activities 5,065 - 5,065 19,665 - 19,665 Fiscal 2021 First Quarter Ended April 3, 2021 Second Quarter Ended July 3, 2021 As Previously Reported Adjustment As Revised As Previously Reported Adjustment As Revised Consolidated Statements of Operations $ $ $ $ $ $ Revenues 207,640 - 207,640 202,273 - 202,273 Cost of goods sold 177,651 - 177,651 175,937 - 175,937 Gross profit 29,989 - 29,989 26,336 - 26,336 Selling, general and administrative expenses 20,874 - 20,874 22,720 - 22,720 Intangible asset amortization 2,194 - 2,194 2,532 - 2,532 Other expense, net 1,615 - 1,615 4,661 - 4,661 Foreign exchange loss (gain) 836 - 836 (639 ) - (639 ) Earnings (loss) before the following 4,470 - 4,470 (2,938 ) - (2,938 ) Interest expense, net 1,660 - 1,660 1,631 - 1,631 Earnings (loss) before income taxes 2,810 - 2,810 (4,569 ) - (4,569 ) Income tax expense (benefit) 1,138 (612 ) 526 (3,651 ) (6,449 ) (10,100 ) Net earnings (loss) 1,672 612 2,284 (918 ) 6,449 5,531 Dividends and accretion on preferred stock (1,953 ) - (1,953 ) (744 ) - (744 ) Earnings (loss) attributable to common shareholders (281 ) 612 331 (1,662 ) 6,449 4,787 Basic and diluted earnings (loss) per share (1) (0.00 ) 0.01 0.00 (0.02 ) 0.06 0.05 (1) The sum across of individual per share amounts may not add due to rounding. Fiscal 2021 First Quarter Ended April 3, 2021 Second Quarter Ended July 3, 2021 As Previously Reported Adjustment As Revised As Previously Reported Adjustment As Revised Consolidated Statements of Cash Flows $ $ $ $ $ $ Net earnings (loss) 1,672 612 2,284 (918 ) 6,449 5,531 Items not affecting cash: Deferred income taxes 837 (612 ) 225 (4,331 ) (6,449 ) (10,780 ) Changes in operating assets and liabilities (21,656 ) - (21,656 ) (50,322 ) - (50,322 ) Net cash used in operating activities (7,015 ) - (7,015 ) (39,147 ) - (39,147 )

Significant Accounting Polici_4

Significant Accounting Policies (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Jan. 02, 2021
Significant Accounting Policies [Line Items]
Operating cycle	The fiscal year of the Company consists of a 52- or 53-week period ending on the Saturday closest to December 31. Fiscal years 2022 and 2021 were each 52-week periods ending on December 31, 2022 and January 1, 2022, respectively, and fiscal year 2020 was a 53-week period ending on January 2, 2021. Fiscal year 2023 will be a 52-week period ending on December 30, 2023, with quarterly periods ending on April 1, 2023, July 1, 2023, and September 30, 2023.
Description of trade receivable balance	As at December 31, 2022, three long-term customers represented approximately 19%, 13% and 10%, respectively, of the Company's consolidated trade receivables balance.
Description of threshold limit of income tax positions	for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the related tax authority
Adjustment [Member]
Significant Accounting Policies [Line Items]
Decrease in accumulated deficit		$ 0.5
Customer relationships [Member] | Minimum [Member]
Significant Accounting Policies [Line Items]
Finite-Lived Intangible Asset, Useful Life	10 years
Customer relationships [Member] | Maximum [Member]
Significant Accounting Policies [Line Items]
Finite-Lived Intangible Asset, Useful Life	25 years
Brand names [Member]
Significant Accounting Policies [Line Items]
Finite-Lived Intangible Asset, Useful Life	15 years

Significant Accounting Polici_5

Significant Accounting Policies (Schedule of consolidated statements of operations) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Consolidated Statements of Operations
Revenues	$ 221,293	$ 229,665	$ 243,531	$ 240,173	$ 204,232	$ 198,479	$ 202,273	$ 207,640	$ 934,662	$ 812,624	$ 789,213
Cost of goods sold	193,076	198,282	208,633	211,817	186,193	175,123	175,937	177,651	811,808	714,904	680,136
Gross profit	28,217	31,383	34,898	28,356	18,039	23,356	26,336	29,989	122,854	97,720	109,077
Selling, general and administrative expenses	22,144	20,654	24,304	22,210	16,518	16,487	22,720	20,874	89,312	76,599	89,463
Intangible asset amortization	2,446	2,612	2,612	2,612	2,612	2,612	2,532	2,194	10,282	9,950	8,946
Other expense, net	105	20,200	1,540	287	1,442	1,172	4,661	1,615	22,132	8,890	23,393
Foreign exchange loss (gain)	(1,622)	473	(127)	(472)	579	336	(639)	836	(1,748)	1,112	(1,640)
Earnings (loss) from continuing operations before the following	5,144	(12,556)	6,569	3,719	(3,112)	2,749	(2,938)	4,470	2,876	1,169	(11,085)
Interest expense, net	4,730	4,342	3,132	2,530	2,624	2,854	1,631	1,660	14,734	8,769	30,042
Loss on retirement of debt									0	0	8,915
Loss from continuing operations before income taxes	414	(16,898)	3,437	1,189	(5,736)	(105)	(4,569)	2,810	(11,858)	(7,600)	(50,042)
Income tax benefit	1,285	(4,964)	1,152	187	342	2,804	(10,100)	526	(2,340)	(6,428)	(7,650)
Earnings (loss) from continuing operations	(871)	(11,934)	2,285	1,002					(9,518)	(1,172)	(42,392)
Earnings from discontinued operations	1,925	0	(814)	3,566					4,677	0	124,820
Net earnings (loss)	1,054	(11,934)	1,471	4,568	(6,078)	(2,909)	5,531	2,284	(4,841)	(1,172)	82,428
Dividends and accretion on preferred stock	(830)	(764)	(760)	(755)	(752)	(748)	(744)	(1,953)	(3,109)	(4,197)	(10,328)
Earnings (loss) attributable to common shareholders	$ 224	$ (12,698)	$ 711	$ 3,813	$ (6,830)	$ (3,657)	$ 4,787	$ 331	$ (7,950)	$ (5,369)	$ 72,100
Basic and diluted earnings (loss) per share
Earnings (loss) from continuing operations	$ (0.02)	$ (0.12)	$ 0.01	$ 0					$ (0.12)	$ (0.05)	$ (0.59)
Earnings from discontinued operations	0.02	0	(0.01)	0.03					0.04	0	1.4
Earnings (loss) attributable to common shareholders (Basic)		(0.12)	0.01	0.04	$ (0.06)	$ (0.03)	$ 0.05	$ 0	(0.07)	(0.05)	0.81
Earnings (loss) attributable to common shareholders (Diluted)		$ (0.12)	$ 0.01	$ 0.04	$ (0.06)	$ (0.03)	$ 0.05	$ 0	$ (0.07)	$ (0.05)	$ 0.81
As Previously Reported [Member]
Consolidated Statements of Operations
Revenues		$ 229,665	$ 243,531	$ 240,173	$ 204,232	$ 198,479	$ 202,273	$ 207,640		$ 812,624	$ 789,213
Cost of goods sold		198,282	208,633	212,182	185,828	175,123	175,937	177,651		714,539	680,136
Gross profit		31,383	34,898	27,991	18,404	23,356	26,336	29,989		98,085	109,077
Selling, general and administrative expenses		20,654	24,304	21,935	16,793	16,487	22,720	20,874		76,874	89,463
Intangible asset amortization		2,612	2,612	2,612	2,612	2,612	2,532	2,194		9,950	8,946
Other expense, net		20,200	1,540	287	1,442	1,172	4,661	1,615		8,890	23,393
Foreign exchange loss (gain)		473	(127)	(472)	579	336	(639)	836		1,112	(1,640)
Earnings (loss) from continuing operations before the following		(12,556)	6,569	3,629	(3,022)	2,749	(2,938)	4,470		1,259	(11,085)
Interest expense, net		4,342	3,132	2,530	2,624	2,854	1,631	1,660		8,769	30,042
Loss on retirement of debt										0	8,915
Loss from continuing operations before income taxes		(16,898)	3,437	1,099	(5,646)	(105)	(4,569)	2,810		(7,510)	(50,042)
Income tax benefit		(4,259)	939	445	(3,782)	2,929	(3,651)	1,138		(3,366)	(2,740)
Earnings (loss) from continuing operations		(12,639)	2,498	654						(4,144)	(47,302)
Earnings from discontinued operations		0	(814)	3,566						0	124,820
Net earnings (loss)		(12,639)	1,684	4,220	(1,864)	(3,034)	(918)	1,672		(4,144)	77,518
Dividends and accretion on preferred stock		(764)	(760)	(755)	(752)	(748)	(744)	(1,953)		(4,197)	(10,328)
Earnings (loss) attributable to common shareholders		$ (13,403)	$ 924	$ 3,465	$ (2,616)	$ (3,782)	$ (1,662)	$ (281)		$ (8,341)	$ 67,190
Basic and diluted earnings (loss) per share
Earnings (loss) from continuing operations		$ (0.12)	$ 0.02	$ 0						$ (0.08)	$ (0.65)
Earnings from discontinued operations		0	(0.01)	0.03						0	1.4
Earnings (loss) attributable to common shareholders (Basic)		(0.12)	0.01	0.03	$ (0.02)	$ (0.04)	$ (0.02)	$ 0		(0.08)	0.75
Earnings (loss) attributable to common shareholders (Diluted)		$ (0.12)	$ 0.01	$ 0.03	$ (0.02)	$ (0.04)	$ (0.02)	$ 0		$ (0.08)	$ 0.75
Adjustment [Member]
Consolidated Statements of Operations
Revenues		$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0		$ 0	$ 0
Cost of goods sold		0		(365)	365	0	0	0		365
Gross profit		0	0	365	(365)	0	0	0		(365)	0
Selling, general and administrative expenses		0	0	275	(275)	0	0	0		(275)	0
Intangible asset amortization		0	0	0	0	0	0	0		0	0
Other expense, net		0	0	0	0	0	0	0		0	0
Foreign exchange loss (gain)		0	0	0	0	0	0	0		0	0
Earnings (loss) from continuing operations before the following		0	0	90	(90)	0	0	0		(90)	0
Interest expense, net		0	0	0	0	0	0	0		0	0
Loss on retirement of debt										0	0
Loss from continuing operations before income taxes		0	0	90	(90)	0	0	0		(90)	0
Income tax benefit		(705)	213	(258)	4,124	(125)	(6,449)	(612)		(3,062)	(4,910)
Earnings (loss) from continuing operations		705	(213)	348						2,972	4,910
Earnings from discontinued operations		0	0	0						0	0
Net earnings (loss)		705	(213)	348	(4,214)	125	6,449	612		2,972	4,910
Dividends and accretion on preferred stock		0	0	0	0	0	0	0		0	0
Earnings (loss) attributable to common shareholders		$ 705	$ (213)	$ 348	$ (4,214)	$ 125	$ 6,449	$ 612		$ 2,972	$ 4,910
Basic and diluted earnings (loss) per share
Earnings (loss) from continuing operations		$ 0.01	$ 0	$ 0						$ 0.03	$ 0.06
Earnings from discontinued operations		0	0	0						0	0
Earnings (loss) attributable to common shareholders (Basic)	0	0.01	0	0	$ (0.04)	$ 0	$ 0.06	$ 0.01		0.03	0.06
Earnings (loss) attributable to common shareholders (Diluted)	$ 0	$ 0.01	$ 0	$ 0	$ (0.04)	$ 0	$ 0.06	$ 0.01		$ 0.03	$ 0.06

Significant Accounting Polici_6

Significant Accounting Policies (Schedule of consolidated balance sheet) (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
ASSETS
Inventories	$ 207,047	$ 219,778
Total current assets	302,357	329,604
Total assets	855,852	754,754
LIABILITIES
Accounts payable and accrued liabilities	108,511	121,155
Net deferred income tax liability	(3,712)	14,051
Total liabilities	508,583	413,281
Accumulated deficit	(155,688)	(147,738)
Total Equity	319,207	313,328	$ 223,401	$ 130,371
Total equity and liabilities	$ 855,852	754,754
As Previously Reported [Member]
ASSETS
Inventories		220,143
Total current assets		329,969
Total assets		755,119
LIABILITIES
Accounts payable and accrued liabilities		121,430
Net deferred income tax liability		22,485
Total liabilities		421,990
Accumulated deficit		(156,082)
Total Equity		304,984
Total equity and liabilities		755,119
Adjustment [Member]
ASSETS
Inventories		(365)
Total current assets		(365)
Total assets		(365)
LIABILITIES
Accounts payable and accrued liabilities		(275)
Net deferred income tax liability		(8,434)
Total liabilities		(8,709)
Accumulated deficit		8,344
Total Equity		8,344
Total equity and liabilities		$ (365)

Significant Accounting Polici_7

Significant Accounting Policies (Schedule of consolidated statements of cash flows) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Consolidated Statements of Cash Flows
Earnings (loss) from continuing operations	$ (871)	$ (11,934)	$ 2,285	$ 1,002	$ (6,078)	$ (2,909)	$ 5,531	$ 2,284	$ (9,518)	$ (1,172)	$ (42,392)
Items not affecting cash:
Deferred income taxes	(3,188)	(3,630)	2,341	(178)	1,380	3,190	(10,780)	225	(4,655)	(5,985)	2,643
Changes in operating assets and liabilities	$ 15,854	2,003	(22,452)	3,191	13,807	(5,494)	(50,322)	(21,656)	(1,404)	(63,665)	17,131
Net cash provided by (used in) operating activities of continuing operations									$ 60,575	(21,432)	52,663
As Previously Reported [Member]
Consolidated Statements of Cash Flows
Earnings (loss) from continuing operations		(12,639)	2,498	654	(1,864)	(3,034)	(918)	1,672		(4,144)	(47,302)
Items not affecting cash:
Deferred income taxes		(2,925)	2,128	80	(2,744)	3,315	(4,331)	837		(2,923)	7,553
Changes in operating assets and liabilities		2,003	(22,452)	3,281	13,717	(5,494)	(50,322)	(21,656)		(63,755)	17,131
Net cash provided by (used in) operating activities of continuing operations										(21,432)	52,663
Adjustment [Member]
Consolidated Statements of Cash Flows
Earnings (loss) from continuing operations		705	(213)	348	(4,214)	125	6,449	612		2,972	4,910
Items not affecting cash:
Deferred income taxes		(705)	213	(258)	4,124	(125)	(6,449)	(612)		(3,062)	(4,910)
Changes in operating assets and liabilities		$ 0	$ 0	$ (90)	$ 90	$ 0	$ 0	$ 0		90	0
Net cash provided by (used in) operating activities of continuing operations										$ 0	$ 0

Significant Accounting Polici_8

Significant Accounting Policies (Schedule of useful life for property plant and equipment) (Details)	12 Months Ended
	Dec. 31, 2022
Buildings [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	20 years
Buildings [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	40 years
Machinery and equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	5 years
Machinery and equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	20 years
Enterprise software [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	3 years
Enterprise software [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	5 years
Office furniture and equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	3 years
Office furniture and equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	7 years
Vehicles [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	3 years
Vehicles [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	7 years

Discontinued Operations (Narrat

Discontinued Operations (Narrative) (Details) $ in Thousands, € in Millions	12 Months Ended
	Dec. 31, 2022 USD ($)	Jan. 01, 2022 USD ($)	Jan. 02, 2021 USD ($)	Dec. 30, 2020 EUR (€)	Dec. 30, 2020 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss on foreign currency forward contract	$ 0	$ 0	$ 12,658
Tradin Organic [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash consideration				€ 305.1	$ 373,700
Loss on foreign currency forward contract			12,700
Pre-tax gain on sale	(8,241)		$ 111,818
Settlement Agreement [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Earnings from discontinued operations	4,700
Cash payment to settle certain post-closing adjustments	$ 5,900

Discontinued Operations (Schedu

Discontinued Operations (Schedule of disposal groups including discontinued operations, income statement, balance sheet and additional disclosures) (Details) - USD ($) $ in Thousands	3 Months Ended				12 Months Ended
	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Earnings from discontinued operations	$ 1,925	$ 0	$ (814)	$ 3,566	$ 4,677	$ 0	$ 124,820
Tradin Organic [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues					0		503,036
Cost of goods sold					0		441,277
Selling, general and administrative expenses					0		26,953
Intangible asset amortization					0		1,451
Other income, net					0		(782)
Foreign exchange loss					0		3,142
Interest expense					0		2,409
Earnings before gain of sale					0		28,586
Pre-tax gain (loss) on sale					(8,241)		111,818
Earnings from discontinued operations before income taxes					(8,241)		140,404
Income tax expense (benefit)					(12,918)		15,885
Loss attributable to non-controlling interests					0		(301)
Earnings from discontinued operations					$ 4,677		$ 124,820

Sale of Sunflower Business (Nar

Sale of Sunflower Business (Narrative) (Details) - USD ($) $ in Thousands		12 Months Ended
	Oct. 11, 2022	Dec. 31, 2022	Jan. 01, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds receivable from sale of sunflower business		$ 385	$ 0
Sunflower Business [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of business, description	On October 11, 2022, the Company completed the sale of 100% of the assets and liabilities of its sunflower business and related roasted snacks operations
Cash consideration	$ 16,000	16,000
Net proceeds from sale of Sunflower Business		7,800
Proceeds receivable from sale of sunflower business		$ 400

Sale of Sunflower Business (Sch

Sale of Sunflower Business (Schedule of assets and liabilities held for sale on the consolidated balance sheet) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021	Oct. 11, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Pre-tax loss on sale	$ (23,227)	$ 0	$ 0
Sunflower Business [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash consideration	16,000			$ 16,000
Less: debt and working capital adjustments	(6,620)
Less: costs to sell	(1,162)
Net proceeds	8,218
Accounts receivable	10,572
Inventories	13,493
Other current assets	105
Property, plant and equipment	10,328
Operating lease right-of-use assets	1,834
Intangible assets, net	2,512
Accounts payable and accrued liabilities	(4,985)
Operating lease liabilities	(2,414)
Net assets sold	31,445
Pre-tax loss on sale	$ (23,227)

Sale of Sunflower Business (S_2

Sale of Sunflower Business (Schedule of revenues and earnings (loss) before income taxes) (Details) - Sunflower Business [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues	$ 57,924	$ 63,094	$ 54,618
Earnings (loss) before income taxes	$ 1,182	$ 1,082	$ (5,689)

Accounts Receivable (Schedule o

Accounts Receivable (Schedule of trade receivables) (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 01, 2022
Receivables [Abstract]
Trade receivables	$ 75,102	$ 85,591
Proceeds receivable from sale of sunflower business	385	0
Allowance for credit losses	(584)	(889)
Total	$ 74,903	$ 84,702

Accounts Receivable (Schedule_2

Accounts Receivable (Schedule of allowance for doubtful accounts) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2022
Receivables [Abstract]
Balance, beginning of year	$ 889	$ 1,257
Net addition (reduction) to provision	112	(368)
Accounts receivable written off, net of recoveries	(417)	0
Balance, end of year	$ 584	$ 889

Inventories (Schedule of invent

Inventories (Schedule of inventory, current) (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Inventory Disclosure [Abstract]
Raw materials and work-in-process	$ 124,168	$ 143,016
Finished goods	90,381	81,546
Inventory reserve	(7,502)	(4,784)	$ (5,742)
Total Inventory, Net	$ 207,047	$ 219,778

Inventories (Schedule of inve_2

Inventories (Schedule of inventory reserve) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2022
Inventories [Roll Forward]
Balance, beginning of year	$ 4,784	$ 5,742
Additions to reserve during the year	10,779	5,854
Reserves applied and inventories written off during the year	(8,061)	(6,812)
Balance, end of year	$ 7,502	$ 4,784

Property, Plant and Equipment_2

Property, Plant and Equipment (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Property, Plant and Equipment [Line Items]
Interest costs capitalized	$ 1.2
Construction in process assets	132.2	$ 48.7
Inventory, parts and components, net of reserves	8.8	7
Depreciation	$ 27.4	$ 24.7	$ 21.4

Property, Plant and Equipment_3

Property, Plant and Equipment (Schedule of property, plant and equipment) (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 01, 2022
Property, Plant and Equipment [Line Items]
Cost	$ 460,192	$ 365,451
Accumulated depreciation	137,801	145,914
Net book value	322,391	219,537
Land [Member]
Property, Plant and Equipment [Line Items]
Cost	2,433	6,963
Accumulated depreciation	0	0
Net book value	2,433	6,963
Building [Member]
Property, Plant and Equipment [Line Items]
Cost	115,718	94,935
Accumulated depreciation	19,922	22,510
Net book value	95,796	72,425
Machinery and equipment [Member]
Property, Plant and Equipment [Line Items]
Cost	314,065	236,779
Accumulated depreciation	99,923	107,319
Net book value	214,142	129,460
Enterprise software [Member]
Property, Plant and Equipment [Line Items]
Cost	22,840	19,900
Accumulated depreciation	14,873	11,740
Net book value	7,967	8,160
Office furniture and equipment [Member]
Property, Plant and Equipment [Line Items]
Cost	4,241	5,429
Accumulated depreciation	2,482	3,130
Net book value	1,759	2,299
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Cost	895	1,445
Accumulated depreciation	601	1,215
Net book value	$ 294	$ 230

Leases (Narrative) (Details)

Leases (Narrative) (Details)	Dec. 31, 2022
Minimum [Member]
Operating Leased Assets [Line Items]
Lessee, Operating Lease, Term of Contract	1 year
Maximum [Member]
Operating Leased Assets [Line Items]
Lessee, Operating Lease, Term of Contract	15 years
Real estate operating leases [Member] | Maximum [Member]
Operating Leased Assets [Line Items]
Lessee, Operating Lease, Renewal Term	15 years

Lease (Schedule of cost) (Detai

Lease (Schedule of cost) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Lease Costs
Operating lease cost	$ 13,830	$ 13,806	$ 16,647
Finance lease cost, Depreciation of right-of-use assets	10,146	5,922	2,647
Finance lease cost, Interest on lease liabilities	5,147	2,752	675
Sublease income	0	(281)	(504)
Net lease cost	$ 29,123	$ 22,199	$ 19,465

Leases (Schedule of balance she

Leases (Schedule of balance sheet classification) (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 01, 2022
Operating leases
Operating lease right-of-use assets	$ 82,564	$ 47,245
Current portion of operating lease liabilities	13,074	12,203
Operating lease liabilities	77,557	39,028
Total operating lease liabilities	90,631	51,231
Finance leases
Property, plant and equipment, gross	460,192	365,451
Accumulated depreciation	(137,801)	(145,914)
Property, plant and equipment, net	322,391	219,537
Current portion of long-term debt	33,283	9,760
Long-term debt	90,796	43,034
Finance lease liabilities	124,079	52,794
Finance Leases [Member]
Finance leases
Property, plant and equipment, gross	157,801	66,060
Accumulated depreciation	(20,494)	(10,348)
Property, plant and equipment, net	$ 137,307	$ 55,712

Leases (Schedule of cash flow i

Leases (Schedule of cash flow information) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Cash Flow Information
Operating cash flows from operating leases	$ 13,051	$ 13,391	$ 16,741
Operating cash flows from finance leases	5,147	2,752	675
Cash paid under finance leases	20,457	8,798	2,587
Cash received under finance leases	(58,764)	(13,626)	0
Right-of-use assets obtained in exchange for lease liabilities:
Operating leases	49,818	29,015	5,962
Finance Leases	32,977	29,906	5,179
Right-of-use assets and liabilities reduced through lease terminations or modifications:
Impairment of operating lease right-of-use assets	0	0	(1,538)
Operating Leases [Member]
Right-of-use assets and liabilities reduced through lease terminations or modifications:
Gain (Loss) on Termination of Lease	(4,060)	(2,261)	23,667
Finance Leases [Member]
Right-of-use assets and liabilities reduced through lease terminations or modifications:
Gain (Loss) on Termination of Lease	$ 0	$ (686)	$ 0

Leases (Schedule of other infor

Leases (Schedule of other information) (Details)	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Leases [Abstract]
Weighted-average remaining lease term (years), Operating leases	12 years 9 months 18 days	7 years 4 months 24 days	3 years 4 months 24 days
Weighted-average remaining lease term (years), Finance leases	3 years 6 months	4 years 3 months 18 days	5 years 3 months 18 days
Weighted-average discount rate, Operating leases	8.70%	5%	6.60%
Weighted-average discount rate, Finance leases	8.20%	6.60%	5.40%

Leases (Schedule of lessee, ope

Leases (Schedule of lessee, operating lease liability, maturity) (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 01, 2022
Operating leases
2022	$ 12,805
2023	12,461
2024	11,678
2025	10,754
2026	9,727
Thereafter	152,740
Total lease payments	210,165
Less: imputed interest	(119,534)
Total operating lease liabilities	90,631	$ 51,231
Finance leases
2022	40,336
2023	41,643
2024	36,863
2025	23,838
2026	3,567
Thereafter	0
Total lease payments	146,247
Less: imputed interest	(22,168)
Total lease liabilities	$ 124,079	$ 52,794

Intangible assets (Schedule of

Intangible assets (Schedule of major components) (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 01, 2022
Finite-Lived Intangible Assets [Line Items]
Cost	$ 203,815	$ 216,399
Accumulated amortization	68,169	67,959
Net book value	135,646	148,440
Customer relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	177,996	189,407
Accumulated amortization	64,578	64,867
Net book value	113,418	124,540
Brand names [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	25,073	25,073
Accumulated amortization	2,845	1,173
Net book value	22,228	23,900
Other [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	746	1,919
Accumulated amortization	746	1,919
Net book value	$ 0	$ 0

Intangible assets (Schedule o_2

Intangible assets (Schedule of future amortization) (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 01, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
2023	$ 9,784
2024	9,784
2025	9,784
2026	9,784
2027	9,784
Thereafter	86,726
Total	$ 135,646	$ 148,440

Goodwill (Narrative) (Details)

Goodwill (Narrative) (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 01, 2022
Goodwill [Line Items]
Goodwill	$ 3,998	$ 3,998
Goodwill, accumulated impairment loss	$ 213,800

Accounts Payable and Accrued _3

Accounts Payable and Accrued Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 01, 2022
Payables and Accruals [Abstract]
Accounts payable	$ 88,178	$ 105,386
Payroll and benefits	13,914	8,861
Accrued interest	1,685	846
Dividends payable on preferred stock	609	609
Other accruals	4,125	5,453
Accounts Payable and Accrued Liabilities	$ 108,511	$ 121,155

Long-Term Debt (Narrative) (Det

Long-Term Debt (Narrative) (Details) - USD ($) $ in Thousands	1 Months Ended		12 Months Ended
	Apr. 15, 2021	Dec. 31, 2020	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Debt Instrument [Line Items]
Loss on the retirement of note			$ 0	$ 0	$ 8,915
Term Loan Facility [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		$ 75,000
Debt Instrument, Term		5 years
Senior Secured Second Lien Notes [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage					9.50%
Debt Instrument, Redemption Price, Percentage					102.375%
Debt redeemed and retired, amount					$ 223,500
Loss on the retirement of note					$ 8,900
Tranche A Subfacility [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Covenant Terms			The Asset-Based Credit Facilities are subject to a number of covenants that, among other things, restrict the Company's ability to create liens on assets; sell assets and enter in sale and leaseback transactions; pay dividends, prepay junior lien and unsecured indebtedness and make other restricted payments; incur additional indebtedness, including finance lease obligations in excess of $150 million, and make guarantees; make investments, loans or advances, including acquisitions; and engage in mergers or consolidations. In addition, the Company and its restricted subsidiaries are required to maintain a minimum fixed charge coverage ratio of 1.0 to 1.0 if excess availability is less than the greater of (i) $15.0 million or (ii) 10% of the lesser of (x) the aggregate commitments under the Revolving Credit Facilities and (y) the aggregate borrowing base. The Company and its restricted subsidiaries are also subject to a maximum senior funded leverage ratio with respect to the Term Loan Facility of 4.75 to 1.00 from the fiscal quarter ending March 31, 2023 to the fiscal quarter ending June 30, 2023, 4.25 to 1.00 from the fiscal quarter ending September 30, 2023 to the fiscal quarter ending December 31, 2023, 3.50 to 1.00 from the fiscal quarter ending March 31, 2024 to the fiscal quarter ending June 30, 2024, and 3.25 to 1.00 from the fiscal quarter ending September 30, 2024 until the Term Loan Facility termination date. As at December 31, 2022, the Company was in compliance with all covenants of the Credit Agreement.
Line of Credit Facility, Interest Rate Description			Borrowings under the Asset-Based Credit Facilities bear interest based on various reference rates, including the Secured Overnight Financing Rate ("SOFR") plus an applicable margin, which are set quarterly based on average borrowing availability for the preceding fiscal quarter. The applicable margin for loans under the Tranche A Subfacility range from 0.50% to 1.00% for base rate loans and from 1.50% to 2.00% for SOFR loans, bankers' acceptance equivalent loans and European base rate loans. The applicable margin on loans under the Tranche B Subfacility are the applicable margin for the Tranche A Subfacility plus 1.00%. With respect to loans under the Term Loan Facility, the applicable margin ranges from 1.25% to 1.75% for base rate loans and from 2.25% to 2.75% for SOFR loans. In addition, a credit spread adjustment of 0.10% applies to all SOFR loans. Effective January 1, 2023, a 0.25% margin reduction applies when the Company's total leverage ratio is less than a specific threshold. For the year ended December 31, 2022, the weighted-average interest rate on all outstanding borrowings under the Asset-Based Credit Facilities was 4.73% (January 1, 2022 - 2.36%). In addition to paying interest on outstanding principal under the Asset-Based Credit Facilities, the Company is required to pay commitment fees quarterly, in arrears, equal to (i) 0.25% of the average daily undrawn portion of the Revolving Credit Facilities and (ii) 0.375% of the undrawn portion of the Term Loan Facility.
Tranche A Subfacility [Member] | Line of credit facility, maximum borrowing capacity [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		$ 230,000	$ 250,000
Debt Instrument, Term		5 years
Tranche B Subfacility [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 20,000
Debt Instrument, Term	2 years
Line of Credit Facility, Periodic Payment, Principal			$ 2,500

Long-Term Debt (Schedule of Lin

Long-Term Debt (Schedule of Line of Credit Facilities) (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 01, 2022
Line of Credit Facility [Line Items]
Total asset-based credit facilities	$ 181,001	$ 164,899
Finance lease liabilities	124,079	52,794
Other	3,404	6,910
Total debt	308,484	224,603
Less: current portion	38,491	9,760
Total long-term debt	269,993	214,843
Revolving credit facilities [Member]
Line of Credit Facility [Line Items]
Total asset-based credit facilities	137,253	153,293
Term loan facility [Member]
Line of Credit Facility [Line Items]
Total asset-based credit facilities	$ 43,748	$ 11,606

Long-Term Debt (Schedule of Mat

Long-Term Debt (Schedule of Maturities of Long-term Debt) (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 01, 2022
Debt Disclosure [Abstract]
2023	$ 45,544
2024	47,893
2025	206,407
2026	26,801
2027	4,007
Total gross maturities	330,652
Less: imputed interest	(22,168)
Total debt	$ 308,484	$ 224,603

Long-Term Debt (Schedule of Int

Long-Term Debt (Schedule of Interest Expense and Interest Income) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Debt Disclosure [Abstract]
Interest expense, net of capitalized interest									$ 13,480	$ 7,685	$ 26,816
Amortization of debt issuance costs									1,601	1,353	4,078
Interest income									(347)	(269)	(852)
Interest expense, net	$ 4,730	$ 4,342	$ 3,132	$ 2,530	$ 2,624	$ 2,854	$ 1,631	$ 1,660	$ 14,734	$ 8,769	$ 30,042

Preferred Stock (Narrative) (De

Preferred Stock (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	12 Months Ended
	Feb. 28, 2023	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021	Feb. 22, 2021	Apr. 24, 2020	Oct. 07, 2016
Temporary Equity [Line Items]
Dividends, Preferred Stock, Paid-in-kind		$ 0	$ 0	$ 3,881
Preferred stock accretion to redemption value		673	720	1,692
Series A Preferred Stock [Member] | Oaktree Organics, L.P. and Oaktree Huntington Investment Fund II, L.P.
Temporary Equity [Line Items]
Number of share issue for conversion preferred stock					12,633,427
Preferred Stock, Shares Issued							85,000
Preferred Stock, Value, Issued					$ 87,500		$ 85,000
Preferred stock, conversion price					$ 7
Preferred Stock Issuance Costs					$ 300
Series B-1 Preferred Stock [Member] | Stock issued to each recipient [Member]
Temporary Equity [Line Items]
Preferred Stock, Shares Issued	15,000					15,000
Series B-1 Preferred Stock [Member] | Engaged Capital [Member] | Subsequent Event [Member]
Temporary Equity [Line Items]
Preferred Stock, Dividend Rate, Percentage	8%
Series B-1 Preferred Stock [Member] | Oaktree and Engaged [Member]
Temporary Equity [Line Items]
Preferred Stock, Shares Issued						30,000
Preferred Stock, Value, Issued						$ 30,000
Preferred Stock Issuance Costs						$ 4,000
Payment of cash dividends		600
Dividends, Preferred Stock, Paid-in-kind		$ 400
Preferred Stock, Liquidation Preference Per Share		$ 1,015				$ 1,000
Preferred Stock, Liquidation Preference, Value		$ 30,400
Preferred Stock, Dividend Payment Terms		Cumulative preferred dividends accrue daily on the Series B-1 Preferred Stock at an annualized rate of 8.0% of the Series B-1 Liquidation Preference prior to September 30, 2029, and 10.0% of the liquidation preference thereafter (subject to an increase of 1.0% per quarter, up to a maximum rate of 5.0% per quarter on the occurrence of certain events of non-compliance).
Accrued Unpaid Dividends		$ 600
Preferred stock accretion to redemption value		$ 700	$ 500	$ 300
Preferred Stock, Convertible, Terms		At any time, the Series B-1 Preferred Stock may be exchanged, in whole or in part, into the number of Common Shares equal to, per share of Series B-1 Preferred Stock, the quotient of the Series B Liquidation Preference divided by $2.50 (such price, the "Series B-1 Exchange Price" and such quotient, the "Series B-1 Exchange Rate").
Convertible Preferred Stock, Settlement Terms		SunOpta Foods may cause the holders of the Series B-1 Preferred Stock to exchange all of their shares of Series B-1 Preferred Stock into a number of Common Shares equal to the number of shares of Series B-1 Preferred Stock outstanding multiplied by the Series B-1 Exchange Rate if (i) fewer than 10% of the shares of Series B-1 Preferred Stock issued on April 24, 2020 remain outstanding, or (ii) on or after April 24, 2023, the volume-weighted average price of the Common Shares during the then preceding 20 trading day period is greater than 200% of the Series B-1 Exchange Price then in effect.
Maximum holder beneficial ownership		19.99%
Preferred stock, convertible shares issuable		12,178,667
Preferred stock exchange, description of exchange price		The Series B-1 Exchange Price is subject to certain anti-dilution adjustments, including a weighted-average adjustment for issuances of Common Shares below the Series B-1 Exchange Price, provided that the Series B-1 Exchange Price may not be lower than $2.00 (subject to adjustment in cer
Series B Preferred Stock [Member] | Oaktree and Engaged [Member]
Temporary Equity [Line Items]
Preferred Stock, Convertible, Terms		Oaktree and Engaged Capital are entitled to vote the Series B-1 Preferred Stock with the Common Shares on an as-exchanged basis, subject to a permanent 19.99% voting cap. As a result of the voting cap, each of Oaktree and Engaged Capital will only be able to vote its Series B-1 Preferred Stock to the extent that, when taken together with any other voting securities each investor controls, such votes do not exceed 19.99% of the votes eligible to be cast by all security holders of the Company. On April 24, 2020, the Company designated Special Shares, Series 2 to serve as the mechanism for attaching exchanged voting rights to the Series B-1 Preferred Stock. The Special Shares, Series 2 entitle the holder thereof to one vote per Special Share, Series 2 on all matters submitted to a vote of the holders of Common Shares, voting together as a single class, subject to certain exceptions. The Special Shares, Series 2 are not transferrable and the voting rights associated with the Special Shares, Series 2 will terminate upon the transfer of the shares of Series B-1 Preferred Stock to a third party, other than an affiliate of Oaktree or Engaged Capital, as applicable. As at December 31, 2022, 6,089,333 Special Shares, Series 2 were issued to Engaged Capital, equal to the number of Common Shares issuable to Engaged Capital on the exchange of all of the shares of Series B-1 Preferred Stock held by it, and no Special Shares, Series 2 were issued to Oaktree, as Oaktree was subject to the Series B-1 Exchange Cap.
Special Voting Shares, issued and outstanding		6,089,333

Stock-Based Compensation (Narra

Stock-Based Compensation (Narrative) (Details) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) $ / shares $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares	Jan. 01, 2022 USD ($) $ / shares shares	Jan. 02, 2021 $ / shares $ / shares	Jan. 02, 2021 USD ($) $ / shares shares	Dec. 28, 2019 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reversal of previously recognized stock-based compensation expense related to forfeited awards					$ 900
Intrinsic value of stock options exercised		$ 300
Employee share purchase plan		$ 575	$ 583		$ 462
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, Granted | shares		1,800,007				1,222,243
Exercise price of stock option to purchase one common share | $ / shares		$ 5.91
Weighted-average grant-date fair value of options | $ / shares		$ 3.49	$ 8.1		$ 2.52
Compensation costs related to awards not yet recognized	$ 5,400	$ 5,400
Vesting period		2 years 2 months 12 days
Trading price | $ / shares	$ 5.91	$ 5.91	$ 14.77	$ 4.64	$ 4.64
Expected life of options (years)		6 years	6 years		6 years
Employee share purchase plan		$ 600	$ 600		$ 500
Employee stock purchase plan (in shares) | shares		87,850	66,834		113,581
Common Shares remained available to be granted | shares	546,232	546,232
Percentage of vesting PSU's						100%
Restricted stock units ("RSUs") [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, Granted | shares		466,945				840,438
Weighted-average grant-date fair value of options | $ / shares		$ 6.4	$ 13.54		$ 3.2
Compensation costs related to awards not yet recognized	$ 3,100	$ 3,100
Vesting period		1 year 9 months 18 days
Intrinsic value	3,800	$ 3,800
Percentage of vesting PSU's		100%
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, Granted | shares		1,846,196				2,132,352
Weighted-average grant-date fair value of options | $ / shares		$ 5.45	$ 13.9		$ 3.54
Compensation costs related to awards not yet recognized	2,600	$ 2,600
Vesting period		3 months 18 days
Intrinsic value	$ 300	$ 300
Performance Shares [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of vesting PSU's		0%
Performance Shares [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of vesting PSU's		200%
Performance Shares [Member] | Fiscal Years 2019 Through 2022 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, Granted | shares						1,066,176
Performance Shares [Member] | Vest upon Common Shares achieving certain volume-weighted average trading prices [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, Granted | shares						1,066,176
Total Shareholder Return Performance Share Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, Granted | shares		547,071
Weighted-average grant-date fair value of options | $ / shares	$ 8.48			$ 23.4
Vesting period		2 years 2 months 12 days
Intrinsic value	$ 4,200	$ 4,200
2013 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of securities remained available for issuance under the Plan | shares	114,398	114,398

Stock-Based Compensation (Sched

Stock-Based Compensation (Schedule of stock-based compensation) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 13,830	$ 9,100	$ 12,216
Selling, general and administrative expenses [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	13,830	9,100	12,570
Other income [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	0	0	(894)
Earnings from discontinued operations [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 0	$ 0	$ 540

Stock-Based Compensation (Sch_2

Stock-Based Compensation (Schedule of stock option activity) (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 28, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options Outstanding, Exercisable, end of year	1,954,761
Stock options Exercisable, Weighted-average exercise price end of year	$ 4.79
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, Outstanding, beginning of year	2,281,621
Stock options, Granted	1,800,007	1,222,243
Stock options, Exercised	(69,457)
Stock options, Forfeited	(61,307)
Stock options, Expired	(30,264)
Stock options Outstanding, Outstanding, end of year	3,920,600
Stock options Outstanding, Exercisable, end of year	1,954,761
Stock options Outstanding, Weighted- average exercise price beginning of year	$ 5.29
Stock options, Granted, Weighted- average exercise price	5.91
Stock options, Exercised, Weighted- average exercise price	6.18
Stock options, Forfeited, Weighted- average exercise price	8.12
Stock options, Expired, Weighted- average exercise price	5.96
Stock options Outstanding, Weighted-average exercise price end of year	5.51
Stock options Exercisable, Weighted-average exercise price end of year	$ 4.79
Stock options, Outstanding, Weighted- average remaining contractual term (years)	7 years 6 months
Stock options, Exercisable, Weighted- average remaining contractual term (years)	5 years 10 months 24 days
Stock options, Outstanding, Aggregate intrinsic value	$ 12,734
Stock options, Exercisable, Aggregate intrinsic value	$ 7,845

Stock-Based Compensation (Sch_3

Stock-Based Compensation (Schedule of non-vested stock option activity) (Details) - Stock Options [Member] - $ / shares	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Non-vested, beginning of year	1,615,633
Granted	1,800,007			1,222,243
Vested	(1,405,905)
Forfeited	(43,896)
Non-vested, end of year	1,965,839	1,615,633
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Non-vested, beginning of year	$ 2.28
Granted	3.49	$ 8.1	$ 2.52
Vested	4.01
Forfeited	1.89
Non-vested, end of year	$ 3.63	$ 2.28

Stock-Based Compensation (Sch_4

Stock-Based Compensation (Schedule of weighted-average assumptions to determine fair value of stock options granted) (Details) - Stock Options [Member] - $ / shares	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant-date stock price	$ 5.91	$ 14.77	$ 4.64
Dividend yield	0%	0%	0%
Expected volatility	61.60%	61.70%	60%
Risk-free interest rate	3%	1%	0.40%
Expected life of options (years)	6 years	6 years	6 years

Stock-Based Compensation (Sch_5

Stock-Based Compensation (Schedule of stock options outstanding and exercisable) (Details)	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding options | shares	3,920,600
Weighted- average remaining contractual life (years)	7 years 6 months
Weighted-average exercise price	$ 5.51
Exercisable options | shares	1,954,761
Weighted- average exercise price	$ 4.79
Exercise Price Range 1 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range Low	2.38
Exercise price range High	$ 3.32
Outstanding options | shares	332,792
Weighted- average remaining contractual life (years)	6 years 3 months 18 days
Weighted-average exercise price	$ 2.57
Exercisable options | shares	332,792
Weighted- average exercise price	$ 2.57
Exercise Price Range 2 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range Low	3.33
Exercise price range High	$ 3.73
Outstanding options | shares	960,061
Weighted- average remaining contractual life (years)	6 years 3 months 18 days
Weighted-average exercise price	$ 3.36
Exercisable options | shares	960,061
Weighted- average exercise price	$ 3.36
Exercise Price Range 3 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range Low	3.74
Exercise price range High	$ 5.59
Outstanding options | shares	353,387
Weighted- average remaining contractual life (years)	7 years 2 months 12 days
Weighted-average exercise price	$ 4.76
Exercisable options | shares	245,703
Weighted- average exercise price	$ 4.78
Exercise Price Range 4 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range Low	5.6
Exercise price range High	$ 6.28
Outstanding options | shares	1,780,431
Weighted- average remaining contractual life (years)	9 years 3 months 18 days
Weighted-average exercise price	$ 5.91
Exercisable options | shares	5,793
Weighted- average exercise price	$ 5.91
Exercise Price Range 5 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range Low	6.29
Exercise price range High	$ 14.77
Outstanding options | shares	493,929
Weighted- average remaining contractual life (years)	4 years 7 months 6 days
Weighted-average exercise price	$ 10.74
Exercisable options | shares	410,412
Weighted- average exercise price	$ 9.92

Stock-Based Compensation (Sch_6

Stock-Based Compensation (Schedule of non-vested RSU activity) (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Non-vested, beginning of year	815,247
Granted	466,945			840,438
Vested	(549,754)
Forfeited	(72,789)
Non-vested, end of year	659,649	815,247
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Non-vested, beginning of year	$ 6.39
Granted	6.4	$ 13.54	$ 3.2
Vested	5.4
Forfeited	7.11
Non-vested, end of year	$ 7.14	$ 6.39

Stock-Based Compensation (Sch_7

Stock-Based Compensation (Schedule of non-vested PSU activity) (Details) - EBITDA PSU [Member] - $ / shares	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Non-vested, beginning of year	1,380,955
Granted	1,846,196			2,132,352
Vested	(58,235)
Forfeited	(813,485)
Non-vested, end of year	2,355,431	1,380,955
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Non-vested, beginning of year	$ 7.62
Granted	5.45	$ 13.9	$ 3.54
Vested	4.91
Forfeited	11.05
Non-vested, end of year	$ 4.8	$ 7.62

Stock-Based Compensation (Sch_8

Stock-Based Compensation (Schedule of TSR PSUs using a Monte Carlo valuation model (Details) - Monte Carlo valuation model [Member] - $ / shares	12 Months Ended
	Dec. 31, 2022	Jan. 02, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant-date stock price	$ 5.91	$ 14.77
Dividend yield	0%	0%
Expected volatility	67.80%	76.90%
Risk-free interest rate	2.80%	0.30%
Expected life of options (years)	2 years 8 months 12 days	2 years 8 months 12 days

Stock-Based Compensation (Sch_9

Stock-Based Compensation (Schedule of non-vested TSR PSU activity (Details) - Total Shareholder Return Performance Share Units [Member] - $ / shares	12 Months Ended
	Dec. 31, 2022	Jan. 02, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Non-vested, beginning of year	71,346
Granted	547,071
Vested	0
Forfeited	(23,544)
Non-vested, end of year	594,873
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Non-vested, beginning of year	$ 23.4
Granted	8.48	$ 23.4
Vested	0
Forfeited	13.4
Non-vested, end of year	$ 10.07

Other Expense (Income), Net (Na

Other Expense (Income), Net (Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Other Income And Expenses [Line Items]
Pre-tax gain (loss)	$ 3,779	$ 0	$ 0
Other asset impairments		300
Severance benefits		500	2,800
Reversal of previously recognized stock-based compensation expense related to forfeited awards			900
Frozen Fruit Processing Facility [Member]
Other Income And Expenses [Line Items]
Pre-tax gain (loss)	3,800
Proceeds from sale of assets	$ 16,100
South Gate, CA Facility [Member]
Other Income And Expenses [Line Items]
Exit costs		3,800
Severance benefits		1,100
Santa Maria, CA Frozen Fruit Processing Facility [Member]
Other Income And Expenses [Line Items]
Exit costs		1,400	6,300
Executive Office and Innovation Center [Member]
Other Income And Expenses [Line Items]
Exit costs		$ 800
Crookston, MN Facility [Member]
Other Income And Expenses [Line Items]
Other asset impairments			$ 2,700

Other Expense (Income), Net (De

Other Expense (Income), Net (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Other Income and Expenses [Abstract]
Loss on sale of sunflower business									$ 23,227	$ 0	$ 0
Gain on sale of frozen fruit processing facility									(3,779)	0	0
Long-lived asset impairments and facility closure costs									1,812	6,298	9,045
Employee termination and recruitment costs									0	1,628	1,881
Divestiture costs									0	703	0
Loss on foreign currency forward contract									0	0	12,658
Other									872	261	(191)
Total Other Expense, net	$ 105	$ 20,200	$ 1,540	$ 287	$ 1,442	$ 1,172	$ 4,661	$ 1,615	$ 22,132	$ 8,890	$ 23,393

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Income Tax Disclosure [Line Items]
Deferred tax assets, valuation allowance	$ 4,826	$ 5,267	$ 4,284
U.S. [Member] | Scientific research investment tax credits [Member] | Federal [Member]
Income Tax Disclosure [Line Items]
Tax credit carryforward, amount	2,300	1,600
U.S. [Member] | Research and development tax credits [Member] | State [Member]
Income Tax Disclosure [Line Items]
Tax credit carryforward, amount	300	900
U.S. [Member] | Capital loss carryforward [Member] | Federal [Member]
Income Tax Disclosure [Line Items]
Operating loss carryforwards	48,400	64,800
U.S. [Member] | Capital loss carryforward [Member] | State [Member]
Income Tax Disclosure [Line Items]
Operating loss carryforwards	3,000	3,300
Canada [Member] | Capital loss carryforward [Member]
Income Tax Disclosure [Line Items]
Operating loss carryforwards	27,800	27,800
Canada [Member] | Capital loss carryforward [Member] | Foreign tax authority [Member]
Income Tax Disclosure [Line Items]
Operating loss carryforwards	$ 4,000	$ 6,000

Income Taxes (Schedule of compo

Income Taxes (Schedule of components of income tax expense) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Income Tax Disclosure [Abstract]
Loss from continuing operations before income taxes	$ 414	$ (16,898)	$ 3,437	$ 1,189	$ (5,736)	$ (105)	$ (4,569)	$ 2,810	$ (11,858)	$ (7,600)	$ (50,042)
Canadian statutory rate									26.50%	26.50%	26.50%
Income tax benefit at statutory rate									$ (3,142)	$ (2,014)	$ (13,261)
Stock-based compensation									978	(4,796)	2,159
Disallowed executive compensation									374	138	2,801
Foreign tax rate differential									76	(31)	(105)
Change in valuation allowance									(471)	975	560
Change in enacted tax rates									(340)	(442)	250
CARES Act									0	0	2,472
Change in valuation of state deferred tax assets									0	0	(3,900)
Other									185	(258)	1,374
Income tax benefit	$ 1,285	$ (4,964)	$ 1,152	$ 187	$ 342	$ 2,804	$ (10,100)	$ 526	$ (2,340)	$ (6,428)	$ (7,650)

Income Taxes (Schedule of com_2

Income Taxes (Schedule of components of earnings (loss) before income taxes) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Income Tax Disclosure [Line Items]
Loss from continuing operations before income taxes	$ 414	$ (16,898)	$ 3,437	$ 1,189	$ (5,736)	$ (105)	$ (4,569)	$ 2,810	$ (11,858)	$ (7,600)	$ (50,042)
Canada [Member]
Income Tax Disclosure [Line Items]
Loss from continuing operations before income taxes									(11,181)	(10,797)	(14,700)
U.S. [Member]
Income Tax Disclosure [Line Items]
Loss from continuing operations before income taxes									(2,506)	3,855	(34,521)
Other [Member]
Income Tax Disclosure [Line Items]
Loss from continuing operations before income taxes									$ 1,829	$ (658)	$ (821)

Income Taxes (Schedule of com_3

Income Taxes (Schedule of components of income tax expense (benefit)) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Income Tax Disclosure [Line Items]
Current income tax expense (benefit)									$ 2,467	$ (443)	$ (13,713)
Deferred income tax expense (benefit)									(4,807)	(5,985)	6,063
Income tax expense (benefit)	$ 1,285	$ (4,964)	$ 1,152	$ 187	$ 342	$ 2,804	$ (10,100)	$ 526	(2,340)	(6,428)	(7,650)
Canada [Member]
Income Tax Disclosure [Line Items]
Current income tax expense (benefit)									84	(9)	(154)
Deferred income tax expense (benefit)									0	299	(291)
U.S. [Member]
Income Tax Disclosure [Line Items]
Current income tax expense (benefit)									(55)	(75)	(14,148)
Deferred income tax expense (benefit)									(4,672)	(6,129)	5,532
Other [Member]
Income Tax Disclosure [Line Items]
Current income tax expense (benefit)									2,438	(359)	589
Deferred income tax expense (benefit)									$ (135)	$ (155)	$ 822

Income Taxes (Schedule of defer

Income Taxes (Schedule of deferred tax assets and liabilities) (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Income Tax Disclosure [Abstract]
Differences in property, plant and equipment and intangible assets	$ (28,088)	$ (54,761)
Capital and non-capital losses	17,335	26,751
Interest expense limitation	9,464	13,064
Tax benefit of scientific research expenditures	2,866	2,744
Stock-based compensation	2,160	680
Inventory basis differences	1,805	1,148
Right-of-use lease assets	(23,071)	(13,224)
Lease liabilities	23,609	13,346
Other accrued reserves	2,458	1,468
Gross deferred income tax liability	8,538	(8,784)
Less: valuation allowance	4,826	5,267	$ 4,284
Deferred income tax asset (liability)	$ 3,712	$ (14,051)

Income Taxes (Schedule of def_2

Income Taxes (Schedule of deferred tax assets and liabilities by geographic segment) (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 01, 2022
Income Tax Disclosure [Line Items]
Deferred income tax asset (liability)	$ 3,712	$ (14,051)
Canada [Member]
Income Tax Disclosure [Line Items]
Deferred income tax asset (liability)	(325)	(325)
U.S. [Member]
Income Tax Disclosure [Line Items]
Deferred income tax asset (liability)	3,978	(13,649)
Other [Member]
Income Tax Disclosure [Line Items]
Deferred income tax asset (liability)	$ 59	$ (77)

Income Taxes (Schedule of def_3

Income Taxes (Schedule of deferred income tax valuation allowance) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2022
Income Tax Disclosure [Abstract]
Balance, beginning of year	$ 5,267	$ 4,284
Increase (decrease) in valuation allowance	(441)	983
Balance, end of year	$ 4,826	$ 5,267

Earnings (Loss) Per Share (Narr

Earnings (Loss) Per Share (Narrative) (Details) - shares	1 Months Ended	12 Months Ended
	Feb. 22, 2021	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Stock options, RSUs, and certain contingently issuable PSUs [Member]
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount		2,587,501	2,889,014	2,305,630
Stock options and RSUs [Member]
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount		2,427,146	347,236	1,913,751
Series B-1 Preferred Stock [Member]
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Common shares issuable on an if-converted basis adjusted to diluted EPS		12,178,667	12,178,667	12,178,667
Series A Preferred Stock [Member]
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Common shares issuable on an if-converted basis adjusted to diluted EPS				12,633,427
Series A Preferred Stock [Member] | Oaktree Capital Management L.P. [Member]
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Exchange of Series A preferred stock, net of share issuance costs of $287 (in shares)	12,633,427
Percentage of issued and outstanding common shares on a post-exchange basis	12.30%

Earnings (Loss) Per Share (Basi

Earnings (Loss) Per Share (Basic and diluted loss per share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Numerator for basic loss per share
Loss from continuing operations	$ (871)	$ (11,934)	$ 2,285	$ 1,002					$ (9,518)	$ (1,172)	$ (42,392)
Less: dividends and accretion on preferred stock	(830)	(764)	(760)	(755)	$ (752)	$ (748)	$ (744)	$ (1,953)	(3,109)	(4,197)	(10,328)
Loss from continuing operations attributable to common shareholders									(12,627)	(5,369)	(52,720)
Earnings from discontinued operations									4,677	0	124,820
Earnings (loss) attributable to common shareholders	$ 224	$ (12,698)	$ 711	$ 3,813	$ (6,830)	$ (3,657)	$ 4,787	$ 331	$ (7,950)	$ (5,369)	$ 72,100
Denominator for basic earnings (loss) per share:
Basic weighted-average number of shares outstanding									107,659	104,098	89,234
From continuing operations	$ (0.02)	$ (0.12)	$ 0.01	$ 0					$ (0.12)	$ (0.05)	$ (0.59)
From discontinued operations	$ 0.02	0	(0.01)	0.03					0.04	0	1.4
Earnings (loss) attributable to common shareholders		(0.12)	0.01	0.04	$ (0.06)	$ (0.03)	$ 0.05	$ 0	$ (0.07)	$ (0.05)	$ 0.81
Numerator for diluted earnings (loss) per share:
Loss from continuing operations									$ (9,518)	$ (1,172)	$ (42,392)
Less: dividends and accretion on preferred stock									(3,109)	(4,197)	(10,328)
Loss from continuing operations attributable to common shareholders									(12,627)	(5,369)	(52,720)
Earnings from discontinued operations									4,677	0	124,820
Earnings (loss) attributable to common shareholders									$ (7,950)	$ (5,369)	$ 72,100
Denominator for diluted loss per share
Basic weighted-average number of shares outstanding									107,659	104,098	89,234
Dilutive effect of the following:
Diluted weighted-average number of shares outstanding									107,659	104,098	89,234
From continuing operations									$ (0.12)	$ (0.05)	$ (0.59)
From discontinued operations									0.04	0	1.4
Earnings (loss) attributable to common shareholders		$ (0.12)	$ 0.01	$ 0.04	$ (0.06)	$ (0.03)	$ 0.05	$ 0	$ (0.07)	$ (0.05)	$ 0.81
Series A Preferred Stock [Member]
Dilutive effect of the following:
Diluted weighted-average number of shares outstanding									0	0	0
Series B-1 Preferred Stock [Member]
Dilutive effect of the following:
Diluted weighted-average number of shares outstanding									0	0	0
Stock options and restricted stock units [Member]
Dilutive effect of the following:
Diluted weighted-average number of shares outstanding									0	0	0

Supplemental Cash Flow Inform_3

Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Changes in Operating Assets and Liabilities, Net of Businesses Sold
Accounts receivable									$ (2,304)	$ (11,978)	$ (746)
Inventories									(762)	(72,030)	6,133
Accounts payable and accrued liabilities									(3,403)	15,920	11,322
Other operating assets and liabilities									5,065	4,423	422
Changes in Non-Cash Working Capital, Net of Businesses Acquired or Sold, Total	$ 15,854	$ 2,003	$ (22,452)	$ 3,191	$ 13,807	$ (5,494)	$ (50,322)	$ (21,656)	(1,404)	(63,665)	17,131
Non-Cash Investing and Financing Activities
Change in additions to property, plant and equipment included in accounts payable and accrued liabilities									(4,256)	3,482	2,043
Proceed receivables from sale of sunflower business									385	0	0
Change in accrued dividends on preferred stock									0	(1,769)	679
Dividends paid in kind on preferred stock									0	0	3,881
Change in accrued transaction costs related to the divestiture of Tradin Organic									0	(13,380)	13,380
Change in accrued debt issuance costs									0	(1,690)	1,690
Cash Paid
Interest									12,295	6,610	30,740
Income taxes									$ 847	$ 3,632	$ 935

Related Party Transactions (Nar

Related Party Transactions (Narrative) (Details) $ in Millions	12 Months Ended
	Jan. 02, 2021 USD ($)
Related Party Transaction [Line Items]
Related party transaction, purchases from related party	$ 15

Commitments and Contingencies (

Commitments and Contingencies (Narrative) (Details) - USD ($) $ in Thousands		12 Months Ended
	May 22, 2022	Dec. 31, 2022	Jan. 01, 2022
Loss Contingencies [Line Items]
Letters of Credit Outstanding, Amount		$ 5,400
Additional commitments under various finance leases		$ 124,079	$ 52,794
Master Purchase Agreement [Member]
Loss Contingencies [Line Items]
Cash payment to settle certain post-closing adjustments	$ 5,900
Midlothian, TX plant-based beverage facility [Member]
Loss Contingencies [Line Items]
Finance lease liabilities		As at December 31, 2022, the Company had entered into finance lease agreements to provide for up to $55 million of financing related to the build-out of the Company's Midlothian, Texas, plant-based beverage facility. As the Company controls the right-of-use assets during the build-out construction, it recognizes costs incurred related to the build-out as construction in process in property, plant and equipment, with a finance lease liability recognized in long-term debt for the amount funded to date by the lessor, which amounted to $51.4 million as at December 31, 2022.
Finance lease liability recognized long-term debt		$ 51,400
Midlothian, TX plant-based beverage facility [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Additional commitments under various finance leases		55,000
Commitments for Plant Acquisition [Member]
Loss Contingencies [Line Items]
Additional commitments under various finance leases		35,000
Capital Lease Obligations		55,000
Remaining contractual commitment		$ 10,000

Segment Information (Narrative)

Segment Information (Narrative) (Details) - Revenue Benchmark [Member] - Customer Concentration Risk [Member]	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Customer of Plant-Based Foods and Beverages [Member]
Segment Reporting Information [Line Items]
Percentage of consolidated revenues from major customer	19%	18%	16%
Customer of Fruit-Based and Plant-Based Foods and Beverages [Member]
Segment Reporting Information [Line Items]
Percentage of consolidated revenues from major customer	13%	12%	14%

Segment Information (Segment Re

Segment Information (Segment Revenues and Operating Income) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Segment Reporting, Revenue Reconciling Item [Line Items]
Segment revenues from external customers	$ 221,293	$ 229,665	$ 243,531	$ 240,173	$ 204,232	$ 198,479	$ 202,273	$ 207,640	$ 934,662	$ 812,624	$ 789,213
Segment operating income (loss)									25,008	10,059	(12,308)
Other income (expense), net	(105)	(20,200)	(1,540)	(287)	(1,442)	(1,172)	(4,661)	(1,615)	(22,132)	(8,890)	(23,393)
Interest expense, net	(4,730)	(4,342)	(3,132)	(2,530)	(2,624)	(2,854)	(1,631)	(1,660)	(14,734)	(8,769)	(30,042)
Loss on retirement of debt									0	0	(8,915)
Loss from continuing operations before income taxes	$ 414	$ (16,898)	$ 3,437	$ 1,189	$ (5,736)	$ (105)	$ (4,569)	$ 2,810	(11,858)	(7,600)	(50,042)
Plant-Based Foods and Beverages [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Segment revenues from external customers									557,736	470,754	415,164
Segment operating income (loss)									38,491	36,616	50,780
Fruit-Based Foods and Beverages [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Segment revenues from external customers									376,926	341,870	374,049
Segment operating income (loss)									6,919	(9,320)	(7,321)
Corporate Services [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Segment operating income (loss)									$ (20,402)	$ (17,237)	$ (31,151)

Segment Information (Disaggrega

Segment Information (Disaggregation of Revenue) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Disaggregation of Revenue [Line Items]
Segment revenues from external customers	$ 221,293	$ 229,665	$ 243,531	$ 240,173	$ 204,232	$ 198,479	$ 202,273	$ 207,640	$ 934,662	$ 812,624	$ 789,213
Plant-Based Foods and Beverages [Member]
Disaggregation of Revenue [Line Items]
Segment revenues from external customers									557,736	470,754	415,164
Plant-Based Foods and Beverages [Member] | Beverages and broths [Member]
Disaggregation of Revenue [Line Items]
Segment revenues from external customers									462,132	376,525	332,390
Plant-Based Foods and Beverages [Member] | Plant-based ingredients [Member]
Disaggregation of Revenue [Line Items]
Segment revenues from external customers									37,680	31,135	28,156
Plant-Based Foods and Beverages [Member] | Sunflower and roasted snacks [Member]
Disaggregation of Revenue [Line Items]
Segment revenues from external customers									57,924	63,094	54,618
Fruit-Based Foods and Beverages [Member]
Disaggregation of Revenue [Line Items]
Segment revenues from external customers									376,926	341,870	374,049
Fruit-Based Foods and Beverages [Member] | Frozen fruit and fruit-based ingredients [Member]
Disaggregation of Revenue [Line Items]
Segment revenues from external customers									285,343	279,128	325,102
Fruit-Based Foods and Beverages [Member] | Fruit snacks and smoothie bowls [Member]
Disaggregation of Revenue [Line Items]
Segment revenues from external customers									$ 91,583	$ 62,742	$ 48,947

Segment Information (Segment As

Segment Information (Segment Assets) (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 01, 2022
Segment Reporting Information [Line Items]
Total assets	$ 855,852	$ 754,754
Plant-Based Foods and Beverages [Member]
Segment Reporting Information [Line Items]
Total assets	384,507	300,700
Fruit-Based Foods and Beverages [Member]
Segment Reporting Information [Line Items]
Total assets	347,678	368,976
Corporate Services [Member]
Segment Reporting Information [Line Items]
Total assets	$ 123,667	$ 85,078

Segment Information (Segment Ca

Segment Information (Segment Capital Expenditures, Depreciation and Amortization) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Segment Reporting Information [Line Items]
Capital expenditures	$ 128,626	$ 58,297	$ 24,754
Total depreciation and amortization	37,673	34,641	30,308
Plant-Based Foods and Beverages [Member]
Segment Reporting Information [Line Items]
Capital expenditures	109,749	38,760	11,323
Total depreciation and amortization	18,359	14,942	9,457
Fruit-Based Foods and Beverages [Member]
Segment Reporting Information [Line Items]
Capital expenditures	7,822	5,926	10,378
Total depreciation and amortization	13,788	14,918	16,304
Corporate Segment [Member]
Segment Reporting Information [Line Items]
Capital expenditures	11,055	13,611	3,053
Total depreciation and amortization	$ 5,526	$ 4,781	$ 4,547

Segment Information (Revenues f

Segment Information (Revenues from External Customers) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Segment Reporting Information [Line Items]
Segment revenues from external customers	$ 221,293	$ 229,665	$ 243,531	$ 240,173	$ 204,232	$ 198,479	$ 202,273	$ 207,640	$ 934,662	$ 812,624	$ 789,213
U.S. [Member]
Segment Reporting Information [Line Items]
Segment revenues from external customers									883,160	772,333	752,000
Canada [Member]
Segment Reporting Information [Line Items]
Segment revenues from external customers									10,625	14,067	12,481
Other [Member]
Segment Reporting Information [Line Items]
Segment revenues from external customers									$ 40,877	$ 26,224	$ 24,732

Segment Information (Long-Lived

Segment Information (Long-Lived Assets) (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 01, 2022
Segment Reporting Information [Line Items]
Total long-lived assets	$ 322,391	$ 219,537
U.S. [Member]
Segment Reporting Information [Line Items]
Total long-lived assets	303,406	203,318
Mexico [Member]
Segment Reporting Information [Line Items]
Total long-lived assets	16,945	14,124
Canada [Member]
Segment Reporting Information [Line Items]
Total long-lived assets	$ 2,040	$ 2,095

Subsequent Event (Narrative) (D

Subsequent Event (Narrative) (Details) - Subsequent Event [Member] - Series B-1 Preferred Stock [Member] - Engaged Capital [Member]	1 Months Ended
	Feb. 28, 2023 shares
Subsequent Event [Line Items]
Exchange of Series B-1 preferred stock, net	6,089,331
Percentage of issued and outstanding common shares on a post-exchange basis	5.30%
Annual dividend company is no longer required to pay	8%

Quarterly Results of Operatio_3

Quarterly Results of Operations (unaudited) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Apr. 03, 2021	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Consolidated Statements of Operations
Revenues	$ 221,293	$ 229,665	$ 243,531	$ 240,173	$ 204,232	$ 198,479	$ 202,273	$ 207,640	$ 934,662	$ 812,624	$ 789,213
Cost of goods sold	193,076	198,282	208,633	211,817	186,193	175,123	175,937	177,651	811,808	714,904	680,136
Gross profit	28,217	31,383	34,898	28,356	18,039	23,356	26,336	29,989	122,854	97,720	109,077
Selling, general and administrative expenses	22,144	20,654	24,304	22,210	16,518	16,487	22,720	20,874	89,312	76,599	89,463
Intangible asset amortization	2,446	2,612	2,612	2,612	2,612	2,612	2,532	2,194	10,282	9,950	8,946
Other expense, net	105	20,200	1,540	287	1,442	1,172	4,661	1,615	22,132	8,890	23,393
Foreign exchange loss (gain)	(1,622)	473	(127)	(472)	579	336	(639)	836	(1,748)	1,112	(1,640)
Earnings (loss) from continuing operations before the following	5,144	(12,556)	6,569	3,719	(3,112)	2,749	(2,938)	4,470	2,876	1,169	(11,085)
Interest expense, net	4,730	4,342	3,132	2,530	2,624	2,854	1,631	1,660	14,734	8,769	30,042
Earnings (loss) from continuing operations before income taxes	414	(16,898)	3,437	1,189	(5,736)	(105)	(4,569)	2,810	(11,858)	(7,600)	(50,042)
Income tax expense (benefit)	1,285	(4,964)	1,152	187	342	2,804	(10,100)	526	(2,340)	(6,428)	(7,650)
Earnings (loss) from continuing operations	(871)	(11,934)	2,285	1,002					(9,518)	(1,172)	(42,392)
Earnings from discontinued operations	1,925	0	(814)	3,566					4,677	0	124,820
Net earnings (loss)	1,054	(11,934)	1,471	4,568	(6,078)	(2,909)	5,531	2,284	(4,841)	(1,172)	82,428
Dividends and accretion on preferred stock	(830)	(764)	(760)	(755)	(752)	(748)	(744)	(1,953)	(3,109)	(4,197)	(10,328)
Earnings (loss) attributable to common shareholders	$ 224	$ (12,698)	$ 711	$ 3,813	$ (6,830)	$ (3,657)	$ 4,787	$ 331	$ (7,950)	$ (5,369)	$ 72,100
Basic and diluted earnings (loss) per share
Earnings (loss) from continuing operations	$ (0.02)	$ (0.12)	$ 0.01	$ 0					$ (0.12)	$ (0.05)	$ (0.59)
Earnings from discontinued operations	$ 0.02	0	(0.01)	0.03					0.04	0	1.4
Earnings (loss) attributable to common shareholders		(0.12)	0.01	0.04	$ (0.06)	$ (0.03)	$ 0.05	$ 0	(0.07)	(0.05)	0.81
Earnings (loss) attributable to common shareholders (Diluted)		$ (0.12)	$ 0.01	$ 0.04	$ (0.06)	$ (0.03)	$ 0.05	$ 0	$ (0.07)	$ (0.05)	$ 0.81
Consolidated Statements of Cash Flows
Earnings (loss) from continuing operations	$ (871)	$ (11,934)	$ 2,285	$ 1,002	$ (6,078)	$ (2,909)	$ 5,531	$ 2,284	$ (9,518)	$ (1,172)	$ (42,392)
Items not affecting cash:
Deferred income taxes	(3,188)	(3,630)	2,341	(178)	1,380	3,190	(10,780)	225	(4,655)	(5,985)	2,643
Changes in operating assets and liabilities	15,854	2,003	(22,452)	3,191	13,807	(5,494)	(50,322)	(21,656)	(1,404)	(63,665)	17,131
Net cash provided by operating activities of continuing operations	$ 27,513	19,973	(2,454)	15,543	19,665	5,065	(39,147)	(7,015)	$ 60,575	(21,432)	91,696
As Previously Reported [Member]
Consolidated Statements of Operations
Revenues		229,665	243,531	240,173	204,232	198,479	202,273	207,640		812,624	789,213
Cost of goods sold		198,282	208,633	212,182	185,828	175,123	175,937	177,651		714,539	680,136
Gross profit		31,383	34,898	27,991	18,404	23,356	26,336	29,989		98,085	109,077
Selling, general and administrative expenses		20,654	24,304	21,935	16,793	16,487	22,720	20,874		76,874	89,463
Intangible asset amortization		2,612	2,612	2,612	2,612	2,612	2,532	2,194		9,950	8,946
Other expense, net		20,200	1,540	287	1,442	1,172	4,661	1,615		8,890	23,393
Foreign exchange loss (gain)		473	(127)	(472)	579	336	(639)	836		1,112	(1,640)
Earnings (loss) from continuing operations before the following		(12,556)	6,569	3,629	(3,022)	2,749	(2,938)	4,470		1,259	(11,085)
Interest expense, net		4,342	3,132	2,530	2,624	2,854	1,631	1,660		8,769	30,042
Earnings (loss) from continuing operations before income taxes		(16,898)	3,437	1,099	(5,646)	(105)	(4,569)	2,810		(7,510)	(50,042)
Income tax expense (benefit)		(4,259)	939	445	(3,782)	2,929	(3,651)	1,138		(3,366)	(2,740)
Earnings (loss) from continuing operations		(12,639)	2,498	654						(4,144)	(47,302)
Earnings from discontinued operations		0	(814)	3,566						0	124,820
Net earnings (loss)		(12,639)	1,684	4,220	(1,864)	(3,034)	(918)	1,672		(4,144)	77,518
Dividends and accretion on preferred stock		(764)	(760)	(755)	(752)	(748)	(744)	(1,953)		(4,197)	(10,328)
Earnings (loss) attributable to common shareholders		$ (13,403)	$ 924	$ 3,465	$ (2,616)	$ (3,782)	$ (1,662)	$ (281)		$ (8,341)	$ 67,190
Basic and diluted earnings (loss) per share
Earnings (loss) from continuing operations		$ (0.12)	$ 0.02	$ 0						$ (0.08)	$ (0.65)
Earnings from discontinued operations		0	(0.01)	0.03						0	1.4
Earnings (loss) attributable to common shareholders		(0.12)	0.01	0.03	$ (0.02)	$ (0.04)	$ (0.02)	$ 0		(0.08)	0.75
Earnings (loss) attributable to common shareholders (Diluted)		$ (0.12)	$ 0.01	$ 0.03	$ (0.02)	$ (0.04)	$ (0.02)	$ 0		$ (0.08)	$ 0.75
Consolidated Statements of Cash Flows
Earnings (loss) from continuing operations		$ (12,639)	$ 2,498	$ 654	$ (1,864)	$ (3,034)	$ (918)	$ 1,672		$ (4,144)	$ (47,302)
Items not affecting cash:
Deferred income taxes		(2,925)	2,128	80	(2,744)	3,315	(4,331)	837		(2,923)	7,553
Changes in operating assets and liabilities		2,003	(22,452)	3,281	13,717	(5,494)	(50,322)	(21,656)		(63,755)	17,131
Net cash provided by operating activities of continuing operations		19,973	(2,454)	15,543	19,665	5,065	(39,147)	(7,015)
Adjustment [Member]
Consolidated Statements of Operations
Revenues		0	0	0	0	0	0	0		0	0
Cost of goods sold		0		(365)	365	0	0	0		365
Gross profit		0	0	365	(365)	0	0	0		(365)	0
Selling, general and administrative expenses		0	0	275	(275)	0	0	0		(275)	0
Intangible asset amortization		0	0	0	0	0	0	0		0	0
Other expense, net		0	0	0	0	0	0	0		0	0
Foreign exchange loss (gain)		0	0	0	0	0	0	0		0	0
Earnings (loss) from continuing operations before the following		0	0	90	(90)	0	0	0		(90)	0
Interest expense, net		0	0	0	0	0	0	0		0	0
Earnings (loss) from continuing operations before income taxes		0	0	90	(90)	0	0	0		(90)	0
Income tax expense (benefit)		(705)	213	(258)	4,124	(125)	(6,449)	(612)		(3,062)	(4,910)
Earnings (loss) from continuing operations		705	(213)	348						2,972	4,910
Earnings from discontinued operations		0	0	0						0	0
Net earnings (loss)		705	(213)	348	(4,214)	125	6,449	612		2,972	4,910
Dividends and accretion on preferred stock		0	0	0	0	0	0	0		0	0
Earnings (loss) attributable to common shareholders		$ 705	$ (213)	$ 348	$ (4,214)	$ 125	$ 6,449	$ 612		$ 2,972	$ 4,910
Basic and diluted earnings (loss) per share
Earnings (loss) from continuing operations		$ 0.01	$ 0	$ 0						$ 0.03	$ 0.06
Earnings from discontinued operations		0	0	0						0	0
Earnings (loss) attributable to common shareholders	$ 0	0.01	0	0	$ (0.04)	$ 0	$ 0.06	$ 0.01		0.03	0.06
Earnings (loss) attributable to common shareholders (Diluted)	$ 0	$ 0.01	$ 0	$ 0	$ (0.04)	$ 0	$ 0.06	$ 0.01		$ 0.03	$ 0.06
Consolidated Statements of Cash Flows
Earnings (loss) from continuing operations		$ 705	$ (213)	$ 348	$ (4,214)	$ 125	$ 6,449	$ 612		$ 2,972	$ 4,910
Items not affecting cash:
Deferred income taxes		(705)	213	(258)	4,124	(125)	(6,449)	(612)		(3,062)	(4,910)
Changes in operating assets and liabilities		0	0	(90)	90	0	0	0		$ 90	$ 0
Net cash provided by operating activities of continuing operations		$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0